Ionizing Radiation Exposure and Risk of
Gastrointestinal Cancer: A Study of the Ontario
Uranium Miners
by
Minh Tam Do
A thesis submitted in conformity with
the requirements for the degree of
Doctor of Philosophy Epidemiology (PhD)
Graduate Department of the Dalla Lana School of Public Health
The University of Toronto
© Copyright by Minh Tam Do 2009
ii
Ionizing Radiation Exposure and Risk of Gastrointestinal Cancers:
A Study of the Ontario Uranium Miners
Minh Tam Do
Doctor of Philosophy Epidemiology (PhD)
Dalla Lana School of Public Health
University of Toronto
2009
Abstract
Rationale/Objective: Excess lung cancer risks associated with exposure to
inhaled radon decay products among uranium miners has well been
established. Although ingestion is also a potentially important route of exposure,
the relationship between ingested radon decay products and gastrointestinal
cancer risks are not well examined. The objective of this study is to determine
the relationship between exposure to radon decay products and the incidence
and mortality of gastrointestinal (esophagus, stomach, and colorectal) cancer
among men employed as uranium miners in Ontario. Secondly, to determine
whether the duration of exposure (dose rate), years since last exposure and age
at first exposure modify these associations.
Methods: A cohort of miners who had ever worked in an Ontario uranium mine
between 1954 and 1996 was created using the Mining Master File and the
National Dose Registry. Cumulative radon exposures measured in Working Level
iii
Months (WLM) were previously estimated for each miner. Cancer diagnoses
(1964-2004) and cancer deaths (1954-2004) occurring in Ontario were
determined by probabilistic record linkage with the Ontario Cancer Registry. To
calculate person-years at risk, non-cancer deaths were also ascertained from
the Ontario mortality file for the period between 1954 and 2004. Poisson
regression methods for grouped data were used to estimate the relative risks
(RR) and 95% Confidence Intervals (CI) by exposure level.
Results/Conclusions: The final cohort consisted of 28,273 Ontario uranium miners.
By the end of 2004, 34 miners had been diagnosed with esophageal cancer, 86
with stomach cancer, and 359 with colorectal cancer. There were 40 deaths
due to esophageal cancer, 69 from stomach cancer, and 176 from colorectal
cancer. When comparing the highest cumulative exposure category (>40 WLM)
to the referent group (0 WLM), significant increases in both stomach (RRIncidence=
2.30, 95% CI;1.02-5.17 and RRMortality=2.90, 95% CI;1.11-7.63) and colorectal
cancers (RRIncidence =1.56, 95% CI;1.07-2.27 and RRMortality =1.74, 95% CI;1.01-2.99)
after adjusting for age at risk and period effects. However, no relationships were
observed for esophageal cancer. Suggestive evidence of modifying effects of
these associations by duration of employment (dose rate) and years since last
exposure for colorectal cancer was also observed.
iv
Acknowledgments
This thesis would not have been possible without the selfless contributions of many individuals. First and foremost, I would like to thank Loraine whom I consider to be the perfect mentor. Despite her many competing commitments, Loraine always had time to discuss new ideas and challenged me to think while keeping me on track. I would like to thank Jim for our countless discussions about exposures and biologically relevant doses. This directed me to delve into the ICRP literature, which at the time seemed quite intimidating, but in the end, enriched my knowledge of radiation dosimetry. I would also like to thank Wendy for her infectious enthusiasm of biostatistics and Jennifer for her epidemiological expertise.
My friends at Cancer Care Ontario have made this experience an enjoyable one. I am
particularly indebted to Yen for her constant ‘gentle reminders’ of upcoming deadlines and to Nelson for his amazing ability for remembering minute details of cancer registration and for his expertise in record linkage. Who would have thought that a friendship could develop from geek talk about data?
This thesis has benefited from a number of experts in this specialized area of radiation
epidemiology, all of whom I have pestered over the years. Specifically, I would like to thank Willem Sont at the National Dose Registry, Bob Kusiak formerly of the Ontario Ministry of Labour, and Doug Chambers at Senes for their knowledge and insight. I would also like to thank Paul Villeneuve for his willingness to share his knowledge and for his technical assistance.
I would like to thank all my examiners, Drs Andrea Sass-Kortsak, Paul Corey, Cameron
Mustard, and Kristan Aronson for taking time from their busy schedules and for providing invaluable suggestions, enhancing the thesis and subsequent manuscripts. In particular, I would like to thank Dr. Aronson who drove from Kingston in order to be present for my defence.
I would also like to acknowledge the financial assistance provided to me over the years through my work with the Occupational Cancer Research and Surveillance Pilot project at Cancer Care Ontario and stipends received from the Programme of Research in the Environmental Etiology of Cancer (PREECAN) and a research grant jointly provided by the Canadian Institutes for Health Research (CIHR Grant # MOP-77725) and Workplace Safety Insurance Board of Ontario (WSIB Grant #05034).
Finally, I would like to thank my parents (Van and Thuy) for their constant encouragement who kept asking: Are you done yet? What’s taking you so long? On a more serious note, I am forever indebted to my partner and lifelong friend Doreen, who had the misfortune of sharing this journey with me. Thank You for your patience and understanding! Finally, I would like to thank Yuliah, my Little Girl, for providing the ultimate inspiration and incentive for finishing this thesis. Little Girl, Daddy is done!
Minh
June 15th, 2009
v
Thesis Table of Contents
Chapter 1: Objectives and review of the literature..…………………………..……… 1
Chapter 2: Research methodology ……………………………………….….………… 45
Chapter 3: Assessment of the loss to follow-up ……………………………………… 85
Chapter 4: Gastrointestinal cancer risks associated with exposure to radon decay
products ……………………………….……………..…………………….. 117
Chapter 5: Summary discussions and conclusions ……..…………………………... 191
Appendices ……………………………………………………………….…………… 207
vi
Chapter 1 Table of Contents
Abstract..................................................................................................................................................... ii
Acknowledgments .............................................................................................................................. iv
Description of thesis ............................................................................................................................vii
Statement of Author Contributions.............................................................................................. ix
Statement of Contributions from Others .................................................................................... x
Abbreviation .......................................................................................................................................... xi
Chapter 1: Objectives and Review of the Literature
Introduction ............................................................................................................................................. 2
Objectives ................................................................................................................................................ 4
Gastrointestinal Cancers: Esophagus, Stomach, and Colorectal .................................. 5
Justification for Selected Cancers ..............................................................................5
Gastrointestinal Cancer Incidence and Mortality ...................................................6
Ionizing Radiation ............................................................................................................................... 16
Sources of Ionizing Radiation Exposure....................................................................16
Occupational Exposures to Ionizing Radiation...................................................17
Radon Decay Products ..............................................................................................18
Carcinogenic Effects of Ionizing Radiation .............................................................20
Carcinogenic Potential of the Gastrointestinal Tract ............................................22
Factors Influencing Carcinogenic Risks of Radon Decay Products ....................24
Duration of exposure...............................................................................................24
Years Since Last Exposure.......................................................................................25
Age at Exposure ......................................................................................................26
Gastrointestinal Cancer Risks of Radon Decay Products .....................................26
Uranium Mining in Ontario......................................................................................30
Cancer Risks at Low Doses.....................................................................................31
Summary of Review ........................................................................................................................... 33
Scientific and Practical Relevance of this Research.......................................................... 33
Chapter 1 References ...................................................................................................................... 35
vii
Description of thesis
This thesis is organized into 5 chapters. The content of each chapter is as follows:
Chapter 1 sets the context of this research by synthesizing the literature and
identifying the knowledge gaps regarding the cancer effects of
exposure to ionizing radiation on the development of and death
from esophageal, stomach, and colorectal cancers. This chapter
also contains the objectives that this work addresses.
Chapter 2 contains the methodology used in this thesis. Specifically, it
contains detailed descriptions of the databases used to create the
cohort and assemble exposure information, record linkage
procedures used to determine cancer status of the cohort
members, persons-years estimation, and the statistical methods
used to derive risk estimates associated with exposure to radon
decay products.
Chapters 3 and 4 contain the main results of this study. Since the cohort was
linked to the provincial (Ontario) rather than national database,
Chapter 3 focuses on the impact of the loss to follow-up of miners
who emigrated from Ontario and whose diagnosis and deaths
status could not be determined as a result. Chapter 4 presents the
results for cancer risks estimates associated with exposure to
viii
cumulative exposure to low levels of alpha radiation emitted from
radon decay products.
Chapter 5: Given the state of knowledge and issues raised in chapter 1 and
the findings in chapters 3 and 4 the relevance of this study, its
strengths, limitations, and recommendations for future work in this
area are discussed in this Chapter.
ix
Statement of Author Contributions
The author played a substantial role in all aspects of this study, including its
conceptualization, protocol development, data acquisition from three data
custodians as needed, ethics approval from Health Canada and the University
of Toronto, analysis, writing of the thesis and presentation of study findings.
Methods and preliminary results from this work have been presented at the
following venues:
1. University of Toronto, Public Health Sciences Research Day, Toronto,
Ontario. (Poster, February 2006);
2. Canadian Society for Epidemiology and Biostatistics 3rd National Student
Conference Calgary, Alberta. (Oral, May 2007);
3. 19th International Conference on Epidemiology in Occupational Health
(EPICOH 2007), Banff, Alberta. (Oral, October 2007);
4. Centre for Research in Environmental Epidemiology (CREAL), Barcelona,
Spain (Post-doctoral interview with Dr. Elisabeth Cardis, July 2008).
5. Canadian Society for Epidemiology and Biostatistics 4th National Student
Conference Ottawa, Ontario. (Oral, May 2009); and,
6. Canadian Society for Epidemiology and Biostatistics (CSEB) and
Association of Public Health Epidemiologists in Ontario (APHEO) Joint
Conference Ottawa, Ontario. (Oral, May 2009).
x
Statement of Contributions from Others
This research is a sub-component of a larger funded study where Dr.
Loraine Marrett is the principal investigator and Drs. Jennifer Payne and John
McLaughlin the co-investigators. Continuous assistance was obtained from all
committee members. Specifically, Dr. Marrett provided the overall guidance on
this study; Dr. Payne provided additional epidemiological support, while
statistical expertise and exposure assessment were sought from Drs. Wendy Lou
and James Purdham. Nelson Chong (Research Associate, Cancer Care Ontario)
conducted the record linkages and provided technical assistance on the SAS
programming as needed. External expert advice was also sought from Dr.
Willem Sont (National Dose Registry of Health Canada), Mr. Robert Kusiak
(formerly of the Ontario Ministry of Labour), Dr. Doug Chambers (SENES
Consultants Ltd), and Dr. Paul Villeneuve (Health Canada) regarding exposure
assessment and analysis.
xi
Abbreviation
ASIR/ASMR Age Standardized Incidence/Mortality Rate
CCO Cancer Care Ontario
CI Confidence Interval
ERR Excess Relative Risk
GI Gastrointestinal
IR Ionizing Radiation
ICD-9 International Classification of Diseases, 9th Revision
ICRP International Commission on Radiological Protection
LNT Linear no-threshold
OUMC Ontario Uranium Miners Cohort
u/mSv Micro/Milli-Sievert
MMF Mining Master File
MSF Master Study File
NDR National Dose Registry
LET Linear Energy Transfer
OCR Ontario Cancer Registry
OMD Ontario Mortality Database
OUMC Ontario Uranium Miners Cohort
ppm Parts per million
RD Radon Daughters or Radon Progeny
RR Relative Risk
U3O8 Uranium oxide
WHF Work History File
WL/M Working Level/Month
1
Chapter 1: Objectives and Review of the Literature
2
Introduction
Despite the extensive literature supporting a consistent link between
exposure to inhaled high energy alpha particles emitted from radon and its
decay products and associated increased risk of lung cancer mortality among
uranium miners [1, 5-22], there remain major knowledge gaps. The first pertains
to whether the same human carcinogenicity responsible for increased lung
cancer mortality is true as well for non-lung cancer sites, particularly for major
organs that come into direct contact with radon decay products through
ingestion. Secondly, cancer risks to date have focused primarily on mortality as
an endpoint. While this is appropriate for cancers with high fatality rates such as
lung cancer, incidence is arguably a better measure of the full impact of the
health risks associated with exposure to ionizing radiation for cancers with
relatively good survival, such as those of the colon and rectum [5]. Finally, the
renewed debate on the scientific uncertainty regarding cancer risks at low
doses requires closer examination [6, 7]. Cancer risks associated with exposure
to gamma radiation for uranium miners remain a challenge and will not be
addressed in this thesis due to lack of data on gamma exposure.
The Ontario Uranium Miners (OUM) cohort is a large cohort of men
employed to mine uranium ore in Ontario beginning in 1954. Compared to other
uranium mines elsewhere, all Ontario uranium mines were of low ore grade,
approximately 0.15% uranium oxide (U3O8) or less. Because of the low uranium
ore grade, the men employed within these mines to extract uranium oxide were
3
typically exposed to relatively lower dose rates of ionizing radiation relative to
mines operated elsewhere. Despite the low dose rate, excess in lung cancer
mortality has been well demonstrated for this cohort [8-10]. Like other cohorts,
cancer risks for non-lung cancer effects remain inconclusive. The large Ontario
Uranium Miners cohort, combined with the long follow-up, provides a unique
opportunity to address research questions regarding the potential adverse long-
term health impacts of exposures to relatively low levels of ionizing radiation, in
particular, as it relates to cancer effects on major organs along the digestive
tract where the research is still lacking.
4
Objectives
The overall aim of this study is to assess the risk of gastrointestinal cancer
amongst male workers employed in Ontario uranium mines between 1954 and
1996 and who were followed until the end of 2004. Within this cohort, the
specific objectives of this study are as follows:
1. To determine whether the risk of diagnosis (incidence) of or death
(mortality) from gastrointestinal cancers (esophageal, stomach,
and colorectal) is associated with cumulative exposures to radon
decay products; and,
2. To determine whether the duration of exposure (dose rate), years
since last exposure, and age at first exposure modify these
associations.
5
Gastrointestinal Cancers: Esophagus, Stomach, and Colorectal
Justification for Selected Cancers
Three sites within the gastrointestinal tract are targeted in this thesis; the
esophagus, stomach, and colon-rectum. These three major sites along the
digestive tract were of particular interest given the plausible hypothesis that
direct contact through ingestion of radon decay products, a known human
carcinogen [2], provides the basis for the initiation of the carcinogenic process.
In the past, mining was much less automated compared to mining
practices of today. Men worked in a harsh physical environment performing
physically demanding tasks as part of their daily work requirements. High levels
of physical exertion in dusty environments provided the medium for inhaled dust
particles laden with radon decay products to initially be trapped by the mucus
lining of the bronchial wall and lining of the chest cavity and later transported
back to the throat by mucociliary action [11]. The mucus, containing dust,
dissolved radon and its radon decay products, would invariably then be
swallowed, thus ending up in the digestive tract.
In addition to the many working hours spent underground, breaks
(including eating) were taken within the ore body [12]. As such, airborne dust
containing radon and its decay products from the mine environment would not
only be inhaled, but ingested as well. Ingestion of contaminated food or water
6
provides a direct pathway to the esophagus, stomach and other internal organs
within the digestive tract.
For ingested radon decay products, it has been shown that the burden of
the ingested radiation dose would be to the stomach [13] (Table1). In a
simulation study, Kendall and Smith showed that for an estimated annual
ingestion of water containing 1000 Bq per liter of water, an equivalent dose of 50
mSv would be directed to the stomach as compared to only 1.26 mSv directed
to the lungs [13].
Table 1: Estimated annual doses of ingested radon (222Rn) in water containing
1000 Bq per liter of water.
Organ Annual dose at 1000 Bq/L
water (mSv)
Stomach 50.40
Small intestine 2.60
Colon 0.10
Lung 1.26 Source: Kendall and Smith (2002) [13] dose to the
esophagus not evaluated.
Gastrointestinal Cancer Incidence and Mortality
For a small proportion of individuals, cancer can develop at different parts
along the gastrointestinal (GI, Figure 1) tract. In Ontario, it is estimated that
cancers of the GI for the 3 main organs (esophagus, stomach, and colorectal)
collectively accounted for 17% (n=5450) of all new cancer cases and 19%
(n=2710) of all cancer mortalities in 2008 among Ontario men [14]. However, the
7
epidemiology of these cancers differs in terms of trends, risk factors, and survival.
The following sections describe the epidemiology of these cancer sites in detail.
Figure 1: Schematic of gastrointestinal cancers of interest (ICD-9 coding) in this
study.
(Note: Diagram adapted from the American Cancer Society with permission for reproduction in
this thesis [15])
8
Cancer of the Esophagus (ICD-9: 150)
In 2008, it is expected that 450 men in Ontario will be diagnosed with
esophageal cancer. The age standardized incidence rate for esophageal
cancer is 6 per 100,000 [14] representing the 14th most common cancer
diagnosed among Ontario men. Although esophageal cancer occurs less
frequently than many other cancers, it is highly fatal since most patients with
esophageal cancer present at advanced stages of the disease [16]. According
to the Canadian Cancer Society and the National Cancer Institute of Canada,
only 14% of esophageal cancer patients are likely to be alive 5 years after
diagnosis [14]. Figure 2 (left panel) shows 3-year moving averages of age-
standardized incidence and mortality rates from 1964 to 2004 for Ontario men.
For this period, both incidence and mortality rate trends are fairly stable and the
ratios of incidence to mortality are almost at unity.
Among morphologically verified esophageal cancer cases, squamous
cell and adenocarcinoma morphologies account for 95 percent of cases
worldwide [16, 17]. Squamous cell carcinoma arises from the stratified squamous
epithelial lining of the esophagus while the adenocarcinomas develop from
columnar glandular cells that replace the squamous epithelium [18]. In Ontario,
approximately two-thirds of esophageal cancer cases are squamous cell
carcinomas, with the remainder being mainly adenocarcinomas [17]. Over the
past 10 years, however, the incidence of adenocarcinoma is increasing while
9
that for squamous cell carcinoma is on the decrease [16, 18, 19]. The reasons for
these trends are unknown.
The risk of developing esophageal cancer increases with age and is rarely
diagnosed in individuals under 40 years of age [15]. Smoking can also lead to
increased risk of developing esophageal cancer[15]. The impact of diet and
physical activity was recently reviewed by the World Cancer Research Fund
and the American Institute for Cancer Research[20]. To date, there is convincing
evidence that alcohol consumption can increase the risk of esophageal cancer
while intake of non-starchy vegetables, fruits, and food with high content of
beta-carotene and vitamin C can decrease the risk of developing cancer of
the esophagus [20] (Table 2).
Men are 3 times more likely to be diagnosed with esophageal cancer
[15]. It is possible that some of the increases in diagnosis of esophageal cancer
among men are associated with occupational related factors. In the past, men
were employed more frequently in industrial processes than women. In Ontario,
most of the miners employed in the mining industry were men. Cancer of the
esophagus has been associated with exposure to ionizing radiation in some
studies, especially for squamous cell carcinomas [18, 21].
The latent period between esophageal cancer initiations to diagnosis is
unknown. Estimates of this time window are quite variable given the small
sample size of studies conducted to date. It has been estimated that
10
progression from Barrett’s Esophagus to high grade dysplasia to
adenocarcinoma is approximately from 12 to 17 years [22].
Cancer of the Stomach (ICD-9: 151)
According to the World Health Organization, stomach cancer is the
second leading cause of cancer mortality worldwide [23]. However, incidence
and mortality rates vary tremendously throughout the world. The highest
incidence can be observed in Asia, particularly in Japan, while lower incidence
rates can be observed in Canada, the United States and other Western societies
[24]. In Ontario, approximately 700 men are expected to be diagnosed with
stomach cancer in 2008 [14]. Stomach cancer is the 10th most common cancer
diagnosed among Ontario men. Incidence and mortality have been declining
for many years (Figure 2, left Graph).
A number of dietary factors can influence the risk profile of stomach
cancer. A declining incidence and mortality trends are likely attributed to
increased consumption of fresh foods including preservative-free meats and fish,
likely influenced by availability of refrigeration [25]. High content of nitrates and
related compounds in foods has also been associated with increased risk of
stomach cancer (Table 2)[20], as well as smoking and excess alcohol
consumption [26].
Almost all morphologically verified diagnosed stomach cancers are of
the adenocarcinoma type [27]. Like esophageal cancer, the risk of developing
stomach cancer increases with age [15]. Infection with Helicobacter pylori has
11
been shown to cause acute gastric inflammation, increasing the risk of gastric
cancer [26].
The incidence of stomach cancer is much higher among men. In Ontario,
the age-standardized incidence rate for stomach cancer in men is 10 while only
5 per 100,000 for women per year [14]. Occupational factors have been
associated with increased risk of stomach cancer. Kusiak and colleagues
showed that gold mining was associated with an increase in stomach cancer
risk (SMR=1.52, 95%CI 1.25-1.85) [28]. Exposure to arsenic, chromium, diesel
emissions, and aluminum powder were implicated as possible explanations for
these miners [28]. There is some evidence that painters and individuals
employed in the rubber industry have an increased risk of stomach cancer [29].
Internal exposure to ingested radon decay products has also been implicated
for stomach cancer risk. Darby and colleagues pooled data from 11 cohorts of
uranium miners and compared it to a standard population, their analysis
showed a 33% excess risk of stomach cancer (SMR=1.33, 95% CI 1.16-1.52) [30].
Cancer of the colon and rectum (ICD-9: 153-154, 159.0)
Colorectal cancer is the second leading cause of cancer death in
Ontario. One in 14 men is expected to develop colorectal cancer during their
lifetime and one in 27 will die of it [14]. Beginning in 1968, the incidence of
colorectal cancer among men increased sharply (Figure 2, right), but appeared
to plateau by 1988. Approximately half of all colorectal cancers diagnosed
result in death. The age-standardized mortality rate peaked in 1988 at 35 deaths
12
per 100,000 in Ontario. Despite the significant burden of this disease, the causes
of colorectal cancer remain unknown. Like esophageal and stomach cancer,
colorectal cancer incidence is associated with increased age and is higher
among males than females [31].
Etiologic studies have revealed that diet can modify the risk of developing
colorectal cancer. Most common dietary factors examined include intake of
fats, fiber, fruits and vegetables. Results to date suggest that a high intake of red
meat, processed meat and alcohol increase the risk of developing colorectal
cancer. Conversely, a diet rich in foods with high dietary fiber, garlic, milk, and
calcium contributes to a decreased risk of colorectal cancer[20] (Table 2). The
risk of developing colorectal cancer has also been shown to be inversely
associated with physical activity [22].
Like the other cancers, the time window between colorectal cancer initiation to diagnosis
is unknown but it has been suggested that it can to take several decades given that initiation to
adenoma can take 5 to 20 years and adenoma to cancer another 7 to 8 years [22].
13
Table 2: Summary of risk of developing cancer of the esophagus, stomach, or colorectal cancers associated
with foods, nutrition, and level of physical activity.
Esophageal Stomach Colorectal Level of Evidence Decreased Risk Increased Risk Decreased Risk Increased Risk Decreased Risk Increased Risk
Convincing None identified Alcoholic Drinks Body Fatness
None identified None identified Physical Activity Red meat Processed meat Alcoholic drinks Body fatness Abdominal fatness Adult attained height
Probable Non-starchy foods Fruits Foods containing beta-carotene or Vitamin C
Mate (South Am. Drink)
Non-starchy vegetables Allium vegetables Fruits
Salt Salted and salty foods
Foods containing dietary fiber, garlic, milk, calcium
Limited - suggestive
Foods containing dietary fiber, folate, pyridoxine, vitamin E
Red meat Processed meat High temperature drinks
Pulses (legumes) Foods containing selenium
Chili Processed meat Smoked foods Grilled animal foods
Non-starchy foods Fruits Foods containing folate, selenium, Vitamin D Fish
Foods containing iron Cheese Foods containing animal fat or sugars
Source: World Cancer Research Fund and the American Institute for Cancer Research [20]
14
Figure 2: Three-year moving average of age-standardized incidence and mortality rate for cancer of the
esophagus and stomach (left) and colorectal (right) of Ontario men, 1964-2004
Source: SEERSTAT (Ontario) data generated 31 May 2008 [3]
0
10
20
30
40
50
60
70
19641968
19721976
19801984
19881992
19962000
2004
Ag
e-S
tan
dar
diz
ed R
ate
(per
100
,000
)
Colorectal Cancer (Incidence)
Colorectal Cancer (Mortality)
0
5
10
15
20
25
30
1964
1968
1972
1976
1980
1984
1988
1992
1996
2000
2004
Year of Diagnosis/Death
Ag
e-S
tan
dar
diz
ed R
ate
(per
100
,000
)
Esophageal Cancer (Incidence)
Esophageal Cancer (Mortality)
Stomach Cancer (Incidence)
Stomach Cancer (Mortality)
15
Table 3: Summary of descriptive epidemiology and risk factors associated with gastrointestinal cancers.
Descriptive Epidemiology Associated Risk Factors
Gastrointestinal Cancer Site
(ICD-9) ASIR (per
10^5)*
ASMR (per
10^5)*
5-Yr Relative Survival Ratio
(95% CI)**
Oc
cu
pa
tio
-
na
l
fac
tors
***
Sm
okin
g
Die
t
(Hig
h fib
er)
Mic
ro-
org
an
ism
Ag
e
Se
x
(ma
les)
Esophagus (150) 6 7 14 (13-16) ■ ▲ ▼ ■ ▲ ▲
Stomach (151) 10 6 22 (21-24) ■ ▲ ■ ▲ ▲ ▲
Colorectal (153, 154, 159.0) 60 25 62 (61-63) ■ ▲ ▼ ■ ▲ ▲
Note: *ASIR/ASMR - Age-standardized incidence/mortality rate, standardized to 1991 Canadian population, Ontario men; **Survival of Canadian men during follow-up 2001-03, excluding Quebec [14] ; ▲- Increased risk; ▼-
Decreased risk; ■- Inconclusive; *** Siemiatycki et al (2004) [29] suggestive occupations associated with stomach
cancer (Painters and rubber industry), substance or mixture suggestive associated with esophageal cancer (Soots;
tetrachloroethylene), none mentioned for esophageal cancer.
16
Ionizing Radiation
Naturally occurring uranium consists mainly of 3 different isotopes (238U,
235U, and 234U), all of which are unstable and readily break down in order to form
more stable elements. In the process of breaking down, uranium isotopes emit
ionizing radiation (IR) which are subatomic particles (alpha particles) or
electromagnetic waves that are capable of extracting electrons from atoms
and molecules as it passes through cells or tissues of living organisms [32]. The
International Agency for Research on Cancer (IARC) considers IR to be a human
carcinogen [33].
Sources of Ionizing Radiation Exposure
Naturally occurring radioactive materials are common in the
environment, and as such, all humans are exposed to some level of ionizing
radiation on a daily basis [34]. Sources of these exposures include cosmic
radiation, rocks, soil, building materials and even some foods [34]. Collectively,
the ionizing radiation from these and similar sources is referred to as background
radiation. It has been estimated that natural background radiation accounts for
approximately 82% of the general population’s total exposure [34]. The
remaining 18% is from human activities, including medical and occupational
related exposures [34].
17
Occupational Exposures to Ionizing Radiation
In Canada, occupational exposure to ionizing radiation (IR) is monitored
by the National Dose Registry (NDR). To date, the NDR contains data for over
500,000 workers with exposures to IR. These workers are typically employed in the
area of industry, research, medicine, nuclear power, and mining. Uranium
miners are among the workers monitored by the NDR. Most radiation exposures
are measured using personal dosimeters provided by the National Dosimeter
Services [35], however, because of harsh working conditions, uranium miners did
not wear dosimeters until the early 1980s when a dosimeter specially designed
for capturing radiation in the dusty mining environment was developed [35].
Among the various occupations susceptible to radiation exposure, miners
are among the highest. Figure 3 shows the relative annual effective dose
endured by workers employed in occupations susceptible to exposure to high
levels of ionizing radiation. On average, the mining occupation experiences 4.4
mSv of ionizing radiation per year. In relative terms, uranium miners, on average,
receives almost twice the level of exposure of nuclear reactor operators and
almost ten times the level of individuals working in the medical field (See Figure
3).
18
Figure 3: Average annual effective dose per monitored worker in different
occupations.
Radon Decay Products
A summary of the uranium decay chain is shown in Figure 4. Uranium-238
(238U) is by far the most abundant of the three uranium isotopes. Uranium-238 has
a half-life of approximately 4.4 billion years. Uranium-238 breaks down to
radium-226 (226Ra) then decays to radon gas (222Rn). Radon gas (222Rn) is a
noble (inert) gas with a half-life of 3.8 days [36]. It, in turn, breaks down into a
series of four short-lived decay products commonly known as ‘progeny’ or
‘radon decay products’ (RDP). The four radon decay products are polonium-
218 (218Po), lead-214 (214Pb), bismuth-214 (214Bi), and polonium-214 (214Po). The
Sources: Collated from IARC [2] and UNSCEAR [4].
4.4
2.5
0.8
0.8
0.7
0.5
0 1 2 3 4 5
Mining
Reactor operation
Fuel fabrication
Research
Military activities
Medical applications
milli-Sieverts (mSv)
Occ
upat
ion
19
combined half-life of these four radon decay products is approximately 51
minutes (Figure 4). Both polonium-218 and polonium-214 emit high energy
alpha particles as they decay [36]. Alpha particles are high-energy helium
nuclei whose energy is dissipated by transferring to host cells as they come into
contact. This ‘transfer’ of energy can cause atoms of the host cells to ionize,
leading to cellular damage. This decay chain continues until stable lead (206Pb)
is formed.
The activity of a radionuclide is determined by the rate of radioactive
decay, and it can be measured by the number of disintegrations per minute.
However, in uranium mines, it is not practical to measure individual
radionuclides; instead, the concept of working levels (WL) was developed and
used to measure the concentration of the short lived radon decay products.
Working Level measures the potential alpha energy concentration of the four
short lived radon decay products in air. One WL is defined as any combination
of radon decay products per liter of air that will result in the emission of 1.3x106
million electrons. The total dose of radon decay products is commonly
expressed in working level months (WLM) where 1 WLM is equal to the inhalation
of air concentration of 1 WL for a period of 170 hours, the approximate number
of hours worked in one month [37].
In the mining environment, radon gas and its decay products can exist in
the air as ions or attached to dust particles. As such, within the mine, the level of
ionizing radiation can be controlled by ventilation conditions of the mine where
20
increasing ventilation can drastically reduce the concentration of radon and its
decay products concentration. In fact, stricter regulatory controls implemented
in the late 1960s resulted in a dramatic decrease in the radon concentrations in
Ontario mines [38].
Carcinogenic Effects of Ionizing Radiation
Damage to cellular DNA is thought to be the initiating event leading to
the development of ionizing radiation-induced cancers. This damage, which
has been well documented in both in vivo and in vitro systems [39] includes
chromosome aberrations, reciprocal translocations, sister chromatid exchange,
DNA fragmentation in mice and other mammalian cells [40]. The mechanism of
damage occurs by both direct and indirect interactions of the ionizing particles
with the DNA double helix [39]. In direct interaction, ionizing particles can collide
with the DNA strands breaking the bonds responsible for maintaining the DNA
structure [39]. Indirect interaction can react with water to generate reactive
radicals which can subsequently break DNA bonds [39]. While cells are capable
of self-DNA repair, repeated damage to DNA strands can result in mutations
and lead to uncontrolled cell growth [41].
21
Figure 4: Simplified uranium decay chain of uranium (238-U) to radon gas (222-
Rn) and short-lived radon decay products.
Uranium
(238-U)
Radium
(226-Ra)
Radon
(222-Rn)
Radon
Daughter 1
= “Radon and its
decay products”
Working Level = Measure of Potential alpha
energy concentration from short lived radon
daughters/progeny
Radon
Daughter 2
Radon
Daughter 3
Radon
Daughter 4
Half-life = 4.4 billion years
Half-life = 1,620 years
Half-life = 3.8 days
Lead
(206-Pb)
Total half-life = 51 minutes
Radon
Gas
Radon
Daughters
22
Chromosomal aberrations have been examined by Smerhovsky and
colleagues in a cohort of radon-exposed miners located in the Czech Republic
[42]. The authors found a significant correlation between chromatid breaks and
radon exposure. [42] Furthermore, Meszaros and colleagues using blood
samples found that the frequency of aberrations for current and past uranium
miners was 2-3 times higher than that of the unexposed population [43]. Among
former uranium miners, the deletions were maintained well after mining had
ended [43].
Carcinogenic Potential of the Gastrointestinal Tract
Ingestion has been recognized as an important route of internal exposure
among workers exposed to harmful alpha emitters. As such the International
Commission for Radiological Protection (ICRP) developed a physiologically-
based GI Tract biokinetic model for describing transit times of ingested material
and weighting factors for various radio-sensitivity organs and tissues. The GI Tract
Model was first developed in the late 1970s [44] and updated in 2006 [45]. This
model is used by dosimetrists world-wide to estimate internal doses of ingested
radionuclides to different organs along the GI tract. The model was recently
updated to include new data on food transport, absorption, retention, and
secretion of nuclides [45].
According to the updated GI Tract Model (Table 4), transition time from
ingestion to excretion is approximately 41 hours. Less than one minute is spent in
23
the oral cavity and the esophagus combined. Three percent of the transition
time (approximately 1 hour) is spent in the stomach while 87 percent of the
transition time is spent traversing the colon. Within the uranium mining
environment, the most important alpha emitters are radon and its decay
products. Although radon gas has a half-life of 3.8 days, its decay products
have very short total half-lives of only 51 minutes (Figure 4). As such, the decay
products can deliver significant radiobiologic damage over a very short period
of time. Based on the GI Tract Model, more than half of the radiologic dose (first
half-life) from ingested radon decay products is expected to be delivered to the
stomach alone, while the colon receives only approximately 3% of the total
dose (Table 6).
Table 4: Transit times for ingested food along the gastrointestinal tract for human
males according to the gastrointestinal tract model.
Organ Transit Times
Mouth 12 Seconds
Esophagus 7 to 40 Seconds
Stomach 70 Minutes
Small Intestine 4 hours
Right Colon 12 hours
Left Colon 12 hours
Recto Sigmoid 12 hours
Source: The International Commission for Radiological
Protection (ICRP) [45].
24
Factors Influencing Carcinogenic Risks of Radon Decay Products
The main source of data for deriving cancer risks associated with exposure
to alpha radiation has been from epidemiological studies of uranium miners. In
total, there are 13 cohorts of uranium miners world wide. Of these, three are
located in Canada (Newfoundland, Ontario, and Saskatchewan). Historically,
uranium miners have been exposed to alpha radiation. Accordingly, these
exposures translate to high rates of lung cancer deaths. Excess lung cancer
mortality due to exposure to radon and its decay products have been well
documented [46-49].
In addition to the abundance of literature describing lung cancer risks
associated with exposure to radon decay products, studies have also been
conducted to examine modifiers of this dose-response relationship. Among the
most important of these are duration of exposure (dose rate), age at exposure,
and year since last exposure [47-49].
Duration of exposure
Most studies to date estimating cancer risks associated with exposure to
radon decay products have examined cumulative dose as the risk function. As
Hornung and others [47, 48] have noted, implicit in this examination is the
assumption that exposure to high levels of radon decay products over a short
period is etiologically equivalent to the same cumulative exposure over a longer
period of time. However, it has been shown that a protracted dose of low alpha
25
radiation doses delivered continuously over a relatively long period has a more
potent carcinogenic effect than the same dose delivered over a short period of
time[48]. Biological hypotheses for this observation suggest that cells are more
vulnerable to mutations during replication and that protracted doses increase
the likelihood that alpha energy released from radon decay directly affects
genetic material during mitosis [47]. This inverse dose rate has been shown in
animal studies as well as human studies, namely those examining lung cancer
risks among uranium miners [50-53]. The inverse dose rate, however, has not
been shown for gastrointestinal cancers.
Years Since Last Exposure
Since most uranium miners worked for a very short period of time, most of
the person years of follow-up are ‘inactive years’ where no additional exposures
to mining related radon occurred [47]. Several studies have found that as the
number of inactive years increases, the risk of developing cancer, if any
approaches background rates [47]. This inverse relationship has been well
documented for radon effects on lung cancer mortality for most uranium miner
cohorts [48]. The Committee on the Biological Effects of Ionizing Radiation [36]
has examined this issue and based on the pooled analysis of several miner
cohorts, it was concluded that the risk of lung cancer death associated with
exposure to radon decay products remained elevated for approximately 25
years after last exposure, after which, the risk remained constant for lung cancer
mortality. This inverse relationship has not been examined for GI cancers. With
26
the extended follow up of the Ontario cohort, it is possible to determine whether
years since last exposure would modify the dose-response relationship.
Age at Exposure
The relationship between the risk of developing disease and the age at
which exposure occurs has been a topic of much interest in radiation
epidemiology. It has been shown in mice that for some cancers, the most
susceptible age for neoplasm induction was from the neonatal through juvenile
period [54]. Data from the Life Span Studies of Japanese atomic bomb survivors
have shown that exposure to ionizing radiation in infancy and childhood is more
effective in inducing disease [55]. Similarly, susceptibility to thyroid cancer
appears to be higher in childhood and adolescent exposures than adulthood
[55].
The relationship between the risk of cancer and age at exposure to radon
decay products has not been consistently demonstrated across different
cohorts of uranium miners. For lung cancer, some studies have observed
increased cancer risks at younger age [56], while others did not observe any
associations [57]. The modifying effects of age at exposure for GI cancer are
not known.
Gastrointestinal Cancer Risks of Radon Decay Products
Cancer risks associated with exposure to ionizing radiation have been a
topic of regular review by several international agencies. These reviews were
27
mainly based on data collected from atomic-bomb survivors, uranium miners,
and other occupational cohorts such as nuclear workers where exposure is
higher than background [32, 36, 45].For health effects associated with exposure
to radon and its decay products, data from cohorts of uranium miners have
been the primary source used to evaluate cancer risks [36]. In fact, it has been
estimated that approximately 40% of lung cancer deaths among miners are
likely due to radon progeny exposure [36]. However, due to the long latency of
some solid tumors and lack of statistical power, the effects of exposure in terms
of other types of cancers is not well characterized. To date, knowledge
regarding the association between exposure to radon and gastrointestinal
cancer is limited. Only a few studies have examined this relationship and results
have been inconclusive [24, 34, 49, 58].
Darby and colleagues pooled data from 11 cohorts of miners that were
exposed to ionizing radiation to examine cancer mortality risks other than lung
cancer [30]. Of the 11 cohorts, 4 were from Canada and accounted for almost
50% of the men in the study (30,195 of the 64,209 men in the study). The Ontario
uranium miners’ cohort was the largest cohort included in this study followed by
China and Beaverlodge in Saskatchewan. Although the study observed
significant elevated risks for mortality due to stomach cancer (SMR=1.33, 95% CI;
1.16-1.52), the authors cautioned that these risks might not be due to radon
exposure since the increase was not proportional to their estimates of
cumulative exposure of ionizing radiation.
28
There were limitations with the Darby study. Firstly, not all miners had
worked in uranium mines [30]. For example, a cohort from Sweden worked in an
iron mine [30, 59], and those from China and Southwest England were tin miners.
It was not clear whether ionizing radiation from iron and tin mines were
measured in the same way as that in uranium mines or whether the methods of
mining iron/tin are similar to that of uranium. More importantly, a re-assessment
of the exposure information from one of the cohorts included in the Darby study
(Beaverlodge, Saskatchewan) demonstrated that exposure to ionizing radiation
had been substantially underestimated [60]. In a case-control study, Howe and
Stager re-estimated exposure for the Beaverlodge cohort by re-reviewing
employment records with respect to the location within the mine worked (e.g.,
stopings, drifting/raising, travel ways, and shaft areas) and using mine area-
specific exposure measurements. The revised cumulative exposure translated
into an increase of 20% in the magnitude of the risk estimate [60]. The change in
risk estimate was attributed to the reduction in random measurement error that
had biased estimates to the null [60].
Morrison and colleagues examined the mortality experience of a cohort
of 1,772 Newfoundland underground fluorspar miners with high exposure to
radon progeny [61] .For stomach cancer, they were expecting 16 fatal cases
based on Newfoundland mortality rates but observed 22 deaths (SMR = 1.35,
95% CI; 0.85-2.05) [61]. For death due to cancer of the large intestine (n=5) and
rectum (n=1) observed deaths were lower than expected but not statistically
29
significantly. However, these findings might be due to random variation due to
the small number of cases. This cohort was updated in 2005 and stomach
cancer risk remained elevated, but was not statistically significant [62].
Tomasek and colleagues examined the mortality experience of 4320 West
Bohemian (Czech Republic) underground uranium miners [63]. They observed
significantly higher than expected deaths for all types of cancers combined.
However, for esophageal (SMR = 1.22, 95% CI; 0.49-2.52), stomach (SMR = 1.05,
95% CI; 0.79-1.35), and rectal cancer (SMR = 1.04, 95% CI; 0.67-1.55), the ratio of
observed to expected exceeded 1, but was not statistically significant [63].
Laurier and colleagues examined the mortality experience of a cohort of
1785 French underground uranium miners [64]. They compared mortality
experience of cohort members employed for at least 2 years to that of the
general public. Overall, they observed 234 cancer deaths, but had only
expected 183 deaths due to cancer of all types (SMR = 1.3, 95% CI; 1.1-1.5). For
cause-specific cancer deaths, lower than expected deaths were observed for
esophagus cancer (SMR = 0.7, 95% CI; 0.4-1.4), while the number of deaths was
higher than expected for stomach (SMR = 1.1, 95% CI; 0.5-2.0) and colorectal
cancer (SMR = 1.4, 95% CI; 0.8-2.1), although no results is statistically significant
[64].
All of these studies suggested an increase in stomach cancer risk, but
were not statistically significant, likely due to low statistical power. Two studies
indicated non-significant elevated risks of esophageal cancer [30, 63], while one
30
study suggested a protective effect [64]. In addition, all of these studies were
based on mortality rather than incidence. Errors associated with coding of
cause of death can impact risk estimates. Furthermore, all of these studies
compared the observed to the expected numbers that are generated from
external general population. It has been shown that a bias towards
underestimating the mortality risks in occupational cohorts when the general
population is used (i.e., external comparison) as the comparator [65].
Uranium Mining in Ontario
Uranium mining in Ontario first started in 1954 when uranium deposits were
discovered in the areas of Elliot Lake, Agnew Lake, and Bancroft Township.
Mines in Ontario continued operations until 1996, employing over 28,000 men
during this period to extract uranium ores. The health effects associated with
uranium mining in Ontario have been examined previously by the Ham
Commission [66], Muller and colleagues [8-10], and the Industrial Diseases
Standards Panel [38].
Cancer risk associated with exposure to radon and its decay products
have been closely examined by Muller and colleagues. Like in other studies
conducted during this period, standardized ratios were computed for stomach
cancer on two occasions. In the first when follow-up ended in 1977, the SMR for
stomach cancer was 1.3 (95% CI 0.83-2.01), based on 21 deaths. Following the
latest update in 1981, the SMR for stomach cancer increased to 1.41 (95% CI
0.99-2.01) based on 30 deaths. These estimates excluded gold miners who are
31
known to have increased stomach cancer risks due to exposure to arsenic [67].
While the risk for stomach cancer was on an increasing trend, neither analysis
showed a statistically significant relationship with exposure to radon and its
decay products likely due to low precision.
Cancer Risks at Low Doses
Figure 5 compares average cumulative doses of uranium miners in
different cohorts. Of the 11 cohorts, the Colorado Plateau of the United States
had an average of 580 WLM of equivalent radon and its decay products at the
time of the BEIR VI review [1]. In contrast, the Ontario Uranium miners cohort had
an average of 31 WLM. Only Beaverlodge (Canada) and Radium Hill (Australia)
had lower average cumulative doses from radon and its decay products than
the Ontario cohort [1]. Also, in contrast to other cohorts, the Ontario uranium
miner cohort is by far the largest cohort reviewed by BEIR VI committee. The
advantage of having a large cohort is that it is amendable to evaluating
cancer risks at lower doses.
32
Figure 5: Average doses of radon (WLM) and number of miners in different cohorts.
Source: BEIR VI [1].
0 200 400 600
Radium Hill (Australia)Beaverlodge (Canada)
Ontario (Canada)France
Newfoundland (Canada)New Mexico (US)
Czech RepublicPort Radium (Canada)
ChinaSweden
Colorado (US)
Average Working Level Month (WLM)
Ura
niu
m M
iners
Co
ho
rt
Average Working Level Month
0 5,000 10,000 15,000 20,000 25,000
Radium Hill (Australia)Beaverlodge (Canada)
Ontario (Canada)France
Newfoundland (Canada)New Mexico (US)
Czech RepublicPort Radium (Canada)
ChinaSweden
Colorado (US)
Number of Miners Employed
Number of Miners
33
Summary of Review
In summary, the literature on the association between exposure to radon
decay products and cancer risk other than lung is limited. There is some
evidence from other uranium cohort studies that workers may be at increased
risk of gastrointestinal cancer. However, larger numbers of workers and a longer
period of follow-up are required to examine these more rare events. Although
there is a significant body of literature on the long-term consequences of
radiation exposure, for example studies involving the Atomic Bomb Survivors,
these studies focus on the health consequences of a one-time high dose
exposure, in contrast with uranium miners, who may experience relatively high
occupational radiation exposures over a period of several years. The cancer
effects from radiation exposure at lower doses spread over a long period of time
are less clear. The last update of the Ontario Uranium Miners cohort occurred
nearly 25 years ago (in 1981) [9]. The added person-years of follow-up provide
additional statistical power to detect risks associated with exposure to radon
and its decay products.
Scientific and Practical Relevance of this Research
Between 1954 and 1996, over twenty-eight thousand men were employed
to extract uranium ore from vast uranium deposits located in various parts of
Ontario, Canada. During this period, more than 300 million pounds of uranium
34
oxide (U3O8) was extracted from underground mines [68]. With recent increased
energy demands, the remaining uranium reserves in Ontario that were
previously considered to be of too low grade to be economically viable are
once again generating interest in exploration and development [69].
Furthermore, an estimated 50 percent of uranium reserves in the Elliot Lake
region alone remain un-mined [68, 69]. Despite the lucrative past and enormous
potential future economic benefits of this important commodity, the uncertainty
of the inherent adverse health effects associated with mining of uranium ore in
relation to major organs of the gastrointestinal track remain unknown.
A substantial portion of the literature regarding the relationship between
ionizing radiation and cancer focuses on lung cancer mortality. It is not clear
what risks are experienced by workers for other forms of cancer. Collective
scientific evidence from studies conducted to date is suggestive of an increase
in cancer risk of major organs along the gastro-intestinal tract, particularly for
stomach cancer, however, results are in conclusive. The major limitation of these
individual studies has been a lack of statistical power due to the low incidence
rate of gastrointestinal cancers, and for some, low exposure to radon and its
decay products. Given that Ontario uranium miners represent a large cohort
with long period of follow-up, a study of this group may be able to detect
smaller cancer risks if they exist. This is necessary to inform policies and standards
to better protect future workers in this industry.
35
Chapter 1 References
1. BEIR VI, Health Effects of Exposure to Radon. 1999, National Research Council
(USA).
2. International Agency for Research on Cancer, Monographs on the Evaluation of
Carcinogenic Risk to Humans: Ionizing Radiation, Part 1: X- and Gamma (g)-
Radiation, and Neutrons. 1988, International Agency for Research on Cancer:
Lyon. p. Vol 75.
3. SEERSTAT Version 6.3.6, Surveillance Research Program, National Cancer
Institute SEER*Stat software, Cancer Care Ontario, Editor. 2008: Toronto, ON.
4. United Nations Scientific Committee on the Effects of Atomic Radiation, Ionizing
Radiation: Sources and Biological effects, Annex D 1993.
5. Breslow, N.E. and N.E. Day, Statistical Methods in Cancer Research, Volume II -
The Design and Analysis of Cohort Studies, ed. I.A.f.R.o. Cancer. 1987. p.3.
6. Brenner, D.J., T.K. Hei, and O. Niwa, Low-dose risk assessment: We still have
much to learn. Radiat Res, 2007. 167(6): p. 744-745.
7. Tubiana, M., et al., Low-dose risk assessment. Radiat Res, 2007. 167(6): p. 742-
4; author reply 744.
8. Muller, et al., Study of Mortality of Ontario Uranium Miners 1955-1977. 1983,
Ontario Ministry of Labour, Ontario Worker's Compensation Board, Atomic
Energy Control Board of Canada: Toronto.
9. Muller, J., R.A. Kusiak, and A.C. Ritchie, Factors Modifying Lung Cancer Risk in
Ontario Uranium Miners, 1955-1981. 1989, Ontario Ministry of Labour, Workers'
Compensation Board of Ontario, Atomic Energy Control Board of Canada:
Toronto.
36
10. Muller, J., et al., The Ontario Miners Mortality Study, in Radiation Hazards In
Mining: Control, Measurement, And Medical Aspects M. Gomez, Editor. 1981. p.
Chapter 56 (p.359-362).
11. Agency for Toxic Substances and Disease Registry, Toxicological Profile for
Ionizing Radiation. 1999, US Department of Human Health and Services: Atlanta,
Georgia. p. 45.
12. Utting R.E., An Assessment of Gamma Exposure of Miners in Three Ontario
Uranium Mines. 1978, Atomic Energy Control Board (AECB-1172).
13. Kendall, G.M. and T.J. Smith, Doses to organs and tissues from radon and its
decay products. J Radiol Prot, 2002. 22(4): p. 389-406.
14. Canadian Cancer Society/National Cancer Institute of Canada:, Canadian
Cancer Statistics 2008. 2008: Toronto, Canada, 2008.
15. American Cancer Society, Cancer Facts & Figures 2007, American Cancer
Society, Editor. 2007: Atlanta.
16. Layke, J.C. and P.P. Lopez, Esophageal cancer: a review and update. Am Fam
Physician, 2006. 73(12): p. 2187-94.
17. Cancer Care Ontario, Cancer Incidence and Mortality in Ontario 1964-1996:
Esophagus (ICCD9 150). 1999, Cancer Care Ontario: Toronto, Ontario.
18. Blot J.W., McLaughlin J.K., and Fraumeni J.F., Esophageal Cancer, in Cancer
Epidemiology and Prevention, Third Edition, Schottenfeld d. and J.F. Fraumeni,
Editors. 2006, Oxford University Press: Bethesda, Maryland, US.
19. Triboulet, J.P. and C. Mariette, [Oesophageal cancer: what's new during the last
10 years?]. Bull Cancer, 2008. 95(4): p. 425-31.
20. World Cancer Research Fund and American Institute for Cancer Research,
Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global
Perspective. 2007: Washington DC: AICR.
21. United Nations Scientific Committee on the Effects of Atomic Radiation,
Biological effects at low radiation doses, Annex I. 2000. p. 312-346.
37
22. Rohan, T.E., et al., Cancer Precursors, in Cancer Epidemiology and Prevention,
D. Schottenfeld and J.F. Fraumeni, Editors. 2006.
23. World Health Organization, The World Health Report 2002. 2002, World Health
Organization: Geneva, Switzerland.
24. Parkin, D.M., et al., Cancer Incidence in Five Continents Vol. VIII. IARC Scientific
Publications No. 155, 2002.
25. Kono, S. and T. Hirohata, Nutrition and stomach cancer. Cancer Causes Control,
1996. 7(1): p. 41-55.
26. Nomura, A., Stomach Cancer, in Cancer Epidemiology and Prevention, D.
Schottenfeld and J.F. Fraumeni, Editors. 1996.
27. Cancer Care Ontario, Cancer Incidence and Mortality in Ontario 1964-1996:
Stomach (ICCD9 151). 1999, Cancer Care Ontario: Toronto, Ontario.
28. Kusiak, R.A., et al., Mortality from stomach cancer in Ontario miners. Br J Ind
Med, 1993. 50(2): p. 117-26.
29. Siemiatycki, J., et al., Listing occupational carcinogens. Environ Health Perspect,
2004. 112(15): p. 1447-59.
30. Darby, S.C., et al., Radon and cancers other than lung cancer in underground
miners: a collaborative analysis of 11 studies. J Natl Cancer Inst, 1995. 87(5): p.
378-84.
31. Cancer Care Ontario: Insight on Cancer. News and Information on Colorectal
Cancer, Toronto: Canadian Cancer Society (Ontario Division). 2004.
32. Agency for Toxic Substances and Disease Registry, Toxicological Profile for
Ionizing Radiation. 1999, US Department of Human Health and Services: Atlanta,
Georgia. p. 41.
33. U.S. Department of Health and Human Services, Public Health Service, and
National Toxicology Program, Report on Carcinogens, Eleventh Edition. 2004.
34. BEIR VII, Health Risks From Exposure to Low Levels of Ionizing Radiation
(Phase 2). 2005, National Research Council (USA).
38
35. National Dose Registry. National Dosimetry Service. Access date: Jan 2005.
http://www.hc-sc.gc.ca/hecs-sesc/nds/photo_uranium-mines.htm [cited 2005
January 2005]; Available from: http://www.hc-sc.gc.ca/hecs-
sesc/nds/photo_uranium-mines.htm.
36. BEIR VI, Health Effects of Exposure to Radon. 1999, National Research Council
(USA). p. 20-24.
37. United Nations Scientific Committee on the Effects of Atomic Radiation, Ionizing
Radiation: Sources and Biological effects, Annex D p. 143. 1982. p. 77.
38. Industrial Disease Standards Panel, Report to the Workers Compensation Board
on the Ontario Uranium Mining Industry (Report # 6). 1989: Toronto, Ontario.
39. Agency for Toxic Substances and Disease Registry, Toxicological Profile for
Ionizing Radiation. 1999, US Department of Human Health and Services: Atlanta,
Georgia. p. 138.
40. Agency for Toxic Substances and Disease Registry, Toxicological Profile for
Ionizing Radiation. 1999, US Department of Human Health and Services: Atlanta,
Georgia. p. 139.
41. United Nations Scientific Committee on the Effects of Atomic Radiation,
Biological effects at low radiation doses, Annex G. 2000. p. 77.
42. Smerhovsky, Z., et al., Increased risk of cancer in radon-exposed miners with
elevated frequency of chromosomal aberrations. Mutat Res, 2002. 514(1-2): p.
165-76.
43. Meszaros, G., G. Bognar, and G.J. Koteles, Long-term persistence of
chromosome aberrations in uranium miners. J Occup Health, 2004. 46(4): p.
310-5.
44. Innternational Commision on Radiological Protection (ICRP), Limits of Intake of
Radionuclides by Workers, IDRC Publication 30, Oxford: Pergamon Press,1979.
39
45. Innternational Commision on Radiological Protection (ICRP), Human Alimentary
Tract Model for Radiological Protection, IDRC Publication 100, . 2006, Oxford,
UK: Elsevier Ltd.
46. Archer, V.E., et al., Latency and the lung cancer epidemic among United States
uranium miners. Health Phys, 2004. 87(5): p. 480-9.
47. Hornung, R.W., J.A. Deddens, and R.J. Roscoe, Modifiers of lung cancer risk in
uranium miners from the Colorado Plateau. Health Phys, 1998. 74(1): p. 12-21.
48. Lubin, J.H., et al., Radon-exposed underground miners and inverse dose-rate
(protraction enhancement) effects. Health Phys, 1995. 69(4): p. 494-500.
49. Lubin, J.H., et al., Lung cancer in radon-exposed miners and estimation of risk
from indoor exposure. J Natl Cancer Inst, 1995. 87(11): p. 817-27.
50. Brenner, D.J. and E.J. Hall, The inverse dose-rate effect for oncogenic
transformation by neutrons and charged particles: a plausible interpretation
consistent with published data. Int J Radiat Biol, 1990. 58(5): p. 745-58.
51. Crompton, N.E., B. Barth, and J. Kiefer, Inverse dose-rate effect for the induction
of 6-thioguanine-resistant mutants in Chinese hamster V79-S cells by 60Co
gamma rays. Radiat Res, 1990. 124(3): p. 300-8.
52. Lubin, J.H., et al., Quantitative evaluation of the radon and lung cancer
association in a case control study of Chinese tin miners. Cancer Res, 1990.
50(1): p. 174-80.
53. Sevc, J., et al., A survey of the Czechoslovak follow-up of lung cancer mortality in
uranium miners. Health Phys, 1993. 64(4): p. 355-69.
54. Sasaki, S., Age-dependence of susceptibility to carcinogenesis by ionizing
radiation in mice. Radiat Environ Biophys, 1991. 30(3): p. 205-7.
55. Miller, R.W., Special susceptibility of the child to certain radiation-induced
cancers. Environ Health Perspect, 1995. 103 Suppl 6: p. 41-4.
40
56. Tomasek, L., et al., Patterns of lung cancer mortality among uranium miners in
West Bohemia with varying rates of exposure to radon and its progeny. Radiat
Res, 1994. 137(2): p. 251-61.
57. Villeneuve, P.J. and H.I. Morrison, Radon progeny exposure and lung cancer: a
mortality study of Newfoundland Fluorspar miners 1950-2001. 2005, Epistream
Consulting: Ottawa, Ontario.
58. Chovil, A., The epidemiology of primary lung cancer in uranium miners in
Ontario. J Occup Med, 1981. 23(6): p. 417-21.
59. Darby, S.C. and P.D. Inskip, Ionizing radiation: future etiologic research and
preventive strategies. Environ Health Perspect, 1995. 103 Suppl 8: p. 245-9.
60. Howe, G.R. and R.H. Stager, Risk of lung cancer mortality after exposure to
radon decay products in the Beaverlodge cohort based on revised exposure
estimates. Radiat Res, 1996. 146(1): p. 37-42.
61. Morrison, H.I., et al., Cancer mortality among a group of fluorspar miners
exposed to radon progeny. Am J Epidemiol, 1988. 128(6): p. 1266-75.
62. Villeneuve, P.J., H.I. Morrison, and R. Lane, Radon and lung cancer risk: an
extension of the mortality follow-up of the Newfoundland fluorspar cohort. Health
Phys, 2007. 92(2): p. 157-69.
63. Tomasek, L., et al., Radon exposure and cancers other than lung cancer among
uranium miners in West Bohemia. Lancet, 1993. 341(8850): p. 919-23.
64. Laurier, D., et al., An update of cancer mortality among the French cohort of
uranium miners: extended follow-up and new source of data for causes of death.
Eur J Epidemiol, 2004. 19(2): p. 139-46.
65. Card, T.R., et al., Is an internal comparison better than using national data when
estimating mortality in longitudinal studies? J Epidemiol Community Health,
2006. 60(9): p. 819-21.
66. Ham, J.M., Report of the Royal Commision on the Health and Safety of Workers
in Mines. 1974, Government of Ontario: Toronto, Canada.
41
67. Kusiak, R.A., Lung Cancer Mortality in Ontario Gold Miners. Chronic Diseases in
Canada, 1992. 13(No 6 (Suppl)): p. s23-s26.
68. Government of Ontario, Uranium in Ontario, Uranium Mineralization,, Exploration
and Mining in Ontario. 2006, Government of Ontario: Toronto, Ontario, Canada.
69. Cochrane L.B. and Roscoe W.E., Technical Report on the Elliot Lake Project,
Ontario, Canada. 2007, Scott Wilson Roscoe Postle Associates Inc.: Toronto,
Ontario, Canada.
70. Darby, S.C., E.P. Radford, and E. Whitley, Radon exposure and cancers other
than lung cancer in Swedish iron miners. Environ Health Perspect, 1995. 103
Suppl 2: p. 45-7.
Table 5: Summary of miners cohorts in which gastrointestinal cancer risks have been examined. (BEIR VI, p. 83,
131)
Study Author (Year) Population Cancer Site (ICD) SMR (95% CI)
Morrison et.al. (1988)[63]
Study Population
Newfoundland cohort of fluorspar miners (N=4320) Referent Population Mortality rates for Newfoundland by calendar year
Stomach (ICD-8) Large intestine Rectum
1.35 (0.85-2.05) 0.57 (0.18-1.34) 0.33 (0.00-1.84)
Tomasek et.al. (1993)[63]
Study Population
- West Bohemia cohort of uranium miners (N=4320) Referent Population Mortality rates for Czechoslovakia by calendar year
Stomach (ICD-9: 151) Esophagus (150) Colon (152-153) Rectum (154) Non-lung cancers
1.05 (0.79-1.35) 1.22 (0.49-2.51) 0.84 (0.50-1.34) 1.04 (0.67-1.55)
1.14 (0.98-1.33)
Darby et.al. (1995)[70]
Study Population Swedish iron miners Referent Population External rates from communities in the same area
Stomach Rectum
1.45 (1.04-1.98) 1.94 (1.03-3.31)
43
Study Author (Year) Population Cancer Site (ICD) SMR (95% CI)
Darby et.al. (1995)[30]
Study Population Joint analysis of 11 cohorts of miners from different countries Referent Population Rates from general population of respective country
Stomach (ICD-9: 151) Esophagus (150) Colon (152-153) Rectum (154) Non-lung cancers
1.33 (1.16-1.52) 1.05 (0.77-1.41) 0.77 (0.63-0.95) 0.86 (0.66-1.11)
1.01 (0.95-1.07)
Laurier et.al. (2004)[64]
Study Population French cohort of uranium miners employed for at least 2 yrs (N=1785) Referent Population National mortality rate of male population of each calendar year
Stomach (ICD-9: 151) Esophagus (150) Colon/Rectum (152-154)
1.10 (0.50-2.00) 0.70 (0.40-1.40) 1.40 (0.80-2.10)
44
Table 6: Summary of transit time and potential radon doses to the organ based
on the gastrointestinal tract model
OrganTime
(Hours)
Transit Time
(hours)*
Tissue Weighting
Factor (wT)**
# of Half Lives***
Estimated Proportion of
Doses to Organ
Proportion of Time
Oral Cavity 0 0 - 0 0,00% 0,00%Esophagus 0 0 0,05 0 0,00% 0,00%
01 54,55% 3,00%2345 42,61% 10,00%6789
1011121314151617 2,84% 29,00%181920212223242526272829 0,07% 29,00%303132333435363738394041 0,00% 29,00%
Small Intestine
Stomach 1,3
4,7
1,15
4
12
12
0,12
0,05
0,12
0,12
Note: *Transit times based on ICRP-100 updated Human Alimentary Tract Model for Radiological Protectin; **Tissue Weighting Factor based on ICRP-60 for radiosensitivity of organs; *** Number of half live was based on decay chain of short lived radon decay products of 51 mintues.
14,1
14,1
14,10,12
Right Colon
Left Colon
Sigmoid 12
45
Chapter 2: Research Methodology
Chapter 2: Research Methodology
46
Chapter 2 Table of Contents
Overview ..........................................................................................................................47
Methodology...................................................................................................................48
Overview Study Design...............................................................................................48
Data Sources................................................................................................................48
Data Source 1: Work History File ............................................................................49
Data Source 2: National Dose Registry ...............................................................55
Data Source 3: Ontario Cancer Registry and Ontario Mortality Database..64
Record Linkage............................................................................................................65
Linkage Results .........................................................................................................68
Radon Decay Product Exposure Assignment .........................................................69
Analytic Approach......................................................................................................73
Confounding and Effect Modification.....................................................................75
Latency .........................................................................................................................76
Loss to Follow-up..........................................................................................................76
Chapter 2 References....................................................................................................78
47
Overview
The overall goal of this study is to assess the risk of gastrointestinal cancer
among male workers employed in Ontario uranium mines between 1954 and
1996, and followed through December 31, 2004. Within this cohort, the specific
objectives of this study are as follows:
1) To determine whether the risk of diagnosis (incidence) of or death
(mortality) from gastrointestinal cancers (esophageal, stomach, and
colorectal) is associated with cumulative exposures to radon decay
products; and,
2) To determine whether the duration of exposure (dose rate), years since
last exposure, and age at first exposure modify these associations.
This Chapter describes the methodology needed to address the overall
objectives of this study. Specifically, this Chapter contains detailed descriptions
and/or discussions of the following:
• Rationale for choice of study design;
• Data sources;
• Record linkage results;
• General analytical strategy; and,
• Potential biases.
48
1.0 Methodology
Overview Study Design
This study uses a retrospective cohort design to address the
aforementioned objectives. This design provides the opportunity to study
multiple outcomes (e.g. esophageal, stomach, and colorectal cancers) related
to exposures to ionizing radiation emitted by radon decay products. Though
cancers are rare events, the Ontario Uranium Miners cohort consists of over
28,000 miners with a long period of follow-up, making a cohort design an
appropriate option for assessing risks for rare outcomes (such as cancer).
Furthermore, this cohort’s long follow-up period allows for the opportunity to
examine diseases with long latent periods.
In radiation epidemiology, retrospective cohort design has been the
primary tool for examining cancer risks. This is particularly evident for evaluating
cancer risks of uranium miners who have been exposed to alpha emitting radon
decay products. To date, in addition to Ontario, cancer risks derived from
retrospective cohorts have been examined for many uranium mining cohorts
located worldwide [1-7].
Data Sources
This study uses 4 different data sources to address the research objectives.
The Work History File (WHF) and the National Dose Registry (NDR) were used to
assemble the study cohort and to assess exposure, while the Ontario Cancer
49
Registry (OCR) and the Ontario Mortality Database (OMD) were used to identify
cases (cancer diagnosis and deaths) and to determine person-years at risk.
Table 1 summarizes the contents and purposes of these data sources.
Table 7: Summary of data sources and databases used in the study
Database Data Source/custodian Purpose of Database
Work History File (WHF)
Workplace Safety Insurance Board of Ontario (WSIB)
- Extract of the Mining Master File (MMF);
- Identify cohort members, and;
- Radon exposure data, work history
National Dose Registry
(NDR)
Radiation Protection, Health Canada
- Centralized national database;
- Identify cohort members, and;
- Radon and gamma exposure data, work history
Ontario Cancer Registry (OCR)
Cancer Care Ontario (CCO)
- Identify cancer diagnosis and death (outcome)
Ontario Mortality Database (OMD)
Registrar General of Ontario - Identify fact of death for calculating person-years
Data Source 1: Work History File
The Work History File (WHF) is a subset of the Mining Master File (MMF)
extracted for the purpose of investigating health risks of workers with a history of
uranium mining in Ontario. Information for this data source originated shortly
after the Ontario Mining Act came into effect in 1928. Under this act, miners who
worked in Ontario were required to attend annual chest clinics in order to be
50
certified as being fit to work in dust exposure occupations within the mining
industry [8, 9]. Part of the examination involved collecting detailed work history
of employment in mines from the time of the previous examination (hire) from
each miner. This information was later transcribed onto computer cards and still
later onto computer tapes. Data collection continued until 1986 where it was
discontinued.
Inclusion Criteria for Selecting Uranium Miners from Mining Master File
Extraction of the WHF from the MMF was conducted by one of the co-
authors (G. Suranyi) of the original Muller studies [10-12] for an earlier study of
uranium miners and risk of congenital anomalies in offspring [13]. Miners meeting
the following inclusion criteria in the MMF were extracted [14]:
• Male;
• Miner worked in a uranium mine in Ontario between 1954 to 1986
inclusive; and,
• Miner worked for at least 0.5 months in Ontario uranium mines (Ministry
of Labour's definition of a uranium miner).
The data file contains unique information about each miner (names, date
of birth, place of birth) as well as their work history information. A summary of the
key variables contained in the extracted WHF are shown in Table 2 below with
full record layout of the WHF found in Appendix I. Table 3 shows summary
statistics of the miners captured by the WHF. In total, there were 26,320 miners
51
found in the WHF. Of these miners, 92 were females, 119 had missing information
on sex, and the remaining miners were male. The median year of birth for these
miners was 1937. Of the miners employed in Ontario uranium mines, only 6,701
miners were born in Ontario. A large proportion of miners were born in Quebec
and the Maritimes (Newfoundland and Labrador, New Brunswick, and Nova
Scotia) while 5,794 miners were born outside of Canada.
52
Table 8: Description of main variables of the Work History File
Variable name Description
MCERT Unique Miner Certificate Number
Names Surname/first & second given name
Date of birth Year/Month/Day
Place of birth Place of birth codes
Data on work characteristics
YRS
Year of start of employment each employment
record
MOS
Month & day of start of each employment
record
WLMS
Radiation exposure in WLMs of each
employment record
EMOS Elapse time in months for radiation exposure
MINECD Mine code of each employment record
OREO Ore code of each employment record
ORE_Flag Flag to indicate whether miner was exposed to
other type of ore (e.g., gold mining)
OCCUPO Occupation code of each employment record
53
Table 9: Characteristics of Ontario Uranium Miners from data extracted from the
Work History File (Mining Master File), 1954-1986.
Variable name Description
Number of miners 26,320
Sex (n (%))
Males
Females
Missing
26,109 (100)
92 (0)
119
Year of Birth (n (%))
<1900
1900 - 1919
1920 - 1939
1940 - 1959
1960+
Mean
Median
Range
Missing
28 (0.1)
2,298 (8.8)
12,681 (48.6)
10,140 (38.9)
953 (3.7)
1937
1937
1887-1984
220
Place of birth (n)
Newfoundland
Prince Edward Island
Nova Scotia
New Brunswick
Quebec
Ontario
Manitoba
Saskatchewan
Alberta
British Columbia
North West Territories
Yukon
Canada (region not specified)
All of Canada
Outside of Canada
Missing
481
37
493
438
2,938
6,701
208
165
59
97
5
6
8,650
20,278
5,794
248
54
Strengths and Limitations of the Work History File
Data from the Work History File (WHF) has been used extensively in the
past for etiologic research [8, 9, 15-17] and litigation purposes. As such, the
quality of the WHF has been well scrutinized. For example, the WHF was
previously assessed, both for completeness and validity of the work history data
[18]. Employment records from 3 mining companies were randomly sampled
(n=288) and compared to the information contained in the WHF. The inclusion
rate was 99%. Of the matched files, 100 were randomly selected and the work
history information from the WHF was compared to respective company payroll
records. No significant differences were observed between company records
and information from the WHF [18].
Despite the wealth of information contained in the WHF, it has its
limitations. Though uranium mining remained active in Ontario until 1996, the
WHF was officially terminated in 1986. In fact, data for 1986 in the WHF is
relatively incomplete. Termination of the WHF resulted in a data gap for miners
employed in uranium mines between 1987 and 1996. Secondly, information on
potential confounders that would have been relevant to cancers of the
gastrointestinal tract (e.g., smoking, diet, H. pylori infection) was not collected
since the WHF was not originally designed for use in epidemiological
investigations.
55
Data Source 2: National Dose Registry
The National Dose Registry (NDR) is maintained by the Radiation
Protection Bureau of Health Canada. It is a national and centralized registry with
the mandate to monitor radiation doses of all workers employed in Canada
who are potentially exposed to ionizing radiation. Though established in 1987,
the NDR contains information dating back to the early 1950s [17]. The NDR and
its use for epidemiological studies are described in a number of publications [19-
27]. Since it is a national and centralized database, it can monitor and collect
exposure information on individual workers even if s/he moves to another
province and/or changes jobs.
Uranium miners are among the group of workers monitored by the NDR.
Radon dose records for uranium miners were in part, reconstructed,
retrospectively beginning in 1978 based on a number of different data sources.
Before 1968, radon dose (WLM) data for individual miners was obtained from
magnetic tapes provided by the Ontario Worker’s Compensation Board and the
Ontario Ministry of Labour. These records were supplemented with employment
records from Elliott Lake uranium mines. By the early 1970s, dose data was
obtained directly from mining companies. A more detailed description of the
dose data from the NDR is described in the proceeding sections of this Chapter
and Chapter 4.
56
Inclusion Criteria for Selecting Uranium Miners from National Dose Registry
In this study, data for uranium miners employed in Ontario were extracted
from the entire NDR. Miners meeting the following criteria (original letter in
Appendix 1) were extracted for analysis:
• All individuals who had ever worked in an Ontario uranium mine;
• Period between 1951 (inception of the NDR) to December 31st, 2004;
• All information on radiation exposure (e.g., radon, gamma, and
others) ; and,
• Complete work history (all job classifications including work in another
occupations with potential exposure to ionizing radiation and province
of employment).
Two data files were obtained from the National Dose Registry for analysis
in Microsoft Access format. The first data file (“Cohort File”) contained unique
identifiers1 (first and last names), date of birth, place of birth, and sex of the
miner. In total, there were 29,888 entries representing 29,888 workers identified in
the NDR. However, among these workers 23 duplicates were found resulting in
29,865 miners eligible for analysis (Table 4). The second data file (“Dose File”),
also in Microsoft Access format, contained employment and dosimetry
information. In total, 210,791 employment records were identified for the
corresponding 29,865 workers. A summary of the content of the data extracted
from the Cohort File and Dose files of the NDR are shown in Table 4.
1 Note: Due to privacy obligations, the author does not have access to unique identifier information. Only Mr Nelson Chong who needs this information for record linkage purposes were privy to personal identifiers.
57
Table 10: Description of variables extracted from the National Dose Registry.
Variable name Description
Cohort File (n=29,865 (after removing 23 duplicate miners))
Names Surname/first & second given name
Date of birth Year/Month/Day
Place of birth Place of birth codes
Dose File (n=210,791 employment records)
EXPOSURE_YEAR Calendar year of exposure (employment)
MAXJC Job class
EXTREMITY_CODE Code for type of exposure (radon or gamma)
PROVINCE Province/territory of employment
GROUP_CLASS Industry
SERVICE_TYPE Type of dosimetry service
SERIAL_NUMBER Employer code
JOB_CLASS Code for job classification
SKIN_DOSE_FIELD Alpha exposure (radon, WLM)
FROM_PERIOD First period of monitoring
TO_PERIOD Last period of monitoring
RECORD_COUNT No. of discrete dose records per year
Descriptive Statistics from the National Dose Registry
In total, the NDR contained 210,791 records describing the characteristics
of 29,865 eligible miners (Table 5). According to the NDR, 96 percent of the
miners were male miners with the remaining being either female (2 %) or
unknown (2%). The miners were born between 1887 and 1979, more than half of
the miners were born before 1940. Although some information on place of birth
58
was available in the NDR, however, most was missing (n=21,705). Among those
with known place of birth information, the majority were born in Canada
(n=7,451). As expected, Ontario was the most common known province of
birth.
Strengths and Limitations of the National Dose Registry
One of the major strengths of the NDR is the completeness of the data in
terms of the uranium mining periods in Ontario spanning from 1954 to 1996.
Secondly, the NDR being a national database in scope records doses accrued
outside of Ontario. Furthermore, the NDR also includes doses from all
occupations requiring radiation monitoring and not just uranium mining. Like the
WHF, data quality of the NDR has been well scrutinized particularly for radiation
doses. Spot checks were conducted by the NDR and the Atomic Energy Control
Board of Canada (AECB) for accuracy of the reported doses and discrepancies
investigated between different data sources.
As with most databases, there are limitations to the NDR. One of the major
limitations (from an epidemiological perspective) is the use of periods to code
start and end dates. Up until 1977, the NDR divided a calendar year into 26 two
weekly reporting periods in order to code for the time interval in which the
exposure occurred. In 1977, this was simplified to 24- semi monthly reporting
periods. For uranium miners, doses were reported on a quarterly basis (4 times
per year). The quarters were defined as follows:
• 1st quarter of the calendar year - 06
59
• 2nd quarter of the calendar year - 12
• 3rd quarter of the calendar year - 18
• 4th quarter of the calendar year - 24
Given this coding, the exact dates of exposure could not be determined.
Furthermore, start and end dates of a given year for a significant proportion of
miners could not be determined with certainty.
Like the MMF, the NDR was created for regulatory purposes. In the case of
the NDR, the objective was to collect information on radiation exposure for
workers in Canada. As such, information on potential confounders that would
have been relevant to cancers of the gastrointestinal tract (e.g., smoking, diet,
H. pylori infection) is not available.
60
Table 11: Characteristics of Ontario Uranium Miners from data extracted from
the National Dose Registry (as of December 31, 2004).
Variable name Description
Number of miners 29,865
Sex (n (%))
Males
Females
Unknown
Missing
28,786 (96)
486 (2.0)
593 (2.0)
24
Year of Birth (n (%))
<1900
1900 - 1919
1920 - 1939
1940 - 1959
1960+
Mean
Median
Range
Missing
25 (0.1)
2,178 (7.6)
12,787 (44.4)
11,818 (41.0)
1,989 (6.9)
1940
1938
1887-1979
1,068
Place of birth (n)
Newfoundland
Prince Edward Island
Nova Scotia
New Brunswick
Quebec
Ontario
Manitoba
Saskatchewan
Alberta
British Columbia
North West Territories
Yukon
Canada (region not specified)
All of Canada
Outside of Canada
Missing
230
12
117
153
692
2,780
93
70
23
34
1
1
3,245
7,451
709
21,705
61
Comparison of the Work History File and National Dose Registry
While there are many similarities between the Work History File (WHF) and
the National Dose Registry (NDR), there are some important differences in terms
of the quality and the completeness of the data. Tables 6 and 7 compare and
contrast the WHF with the NDR with respect to individual identification
information as well as work history and exposure information. Table 6 shows
information on unique identifiers of the miners, which is important for record
linkage purposes. In both data sources, names (first and given) and date of birth
were relatively complete.
Approximately 73% of place of birth were missing in the NDR while the
same information was 99% complete in the WHF. Discussions with
representatives of the NDR revealed that data entry of place of birth only
began recently. Furthermore, the NDR developed and used its own codes for
place of birth rather than using the standard coding from the Vital Statistics
Section of Statistics Canada. From the perspective of record linkage, different
coding systems create difficulties when matching different records for the same
miner.
62
Table 12: Qualitative comparison of unique identification of uranium miners
found in the Work History File and National Dose Registry
Databases
Criteria Work History
File (WHF)
National
Dose
Registries
(NDR)
Comments
Unique Identifiers of Miners
Surname √ √ Available in both databases*
Given Name 1 √ √ Available in both databases*
Given Name 2 √ √ Available in both databases*
Date of Birth (year) √ √ Available in both databases
Date of Birth (month) √ √ Available in both databases
Date of Birth (Day) √ √ Available in both databases
Place of Birth
√ ≈
WHF was more complete (99%
complete) and uses standardized
coding system. Seventy-three
percent of place of birth in the
NDR was missing.
Note: √ - Available (>90%); ≈ - Available but limited; ≠- Not Available; *-Information obtained
from N Chong
Table 7 presents a qualitative comparison of the work history and
dosimetric information found in the WHF and the NDR. In terms of coverage, the
NDR has 14 more years of information than the WHF. Given that mines operated
until 1996, the added years provided additional data for those who worked
beyond 1986 and those who started on or after 1986. Although the years of
employment are available in both data sources, the NDR lacked details in terms
of start day and month of employment.
63
Table 13: Qualitative comparison of work history and dosimetry information
uranium miners found in the Work History File and National Dose Registry
Databases
Criteria Work History
File (WHF)
National
Dose
Registries
(NDR)
Comments
Work History Information of Miners
Coverage (uranium
miners) 1954-1986 1954-2004
NDR data was more up to date
and complete relative to WHF.
Year of employment √ √ Calendarized year of employment
used in both databases.
Month and Day of start
of employment
√ ≠
Due to the quarterly reporting
mechanism of the NDR, month
and day of start of employment
cannot be determined with
certainty.
Job classification
√ ≈ Although job codes were
available in the NDR, accuracy of
the coding was questionable.
Mine employed
√ ≈
Although the NDR has a serial
number that identifies the
company (mine operator), the
exact mine (mine name) in which
the miner could not be
determined with certainty.
Flag to indicate
exposure to other types
of mining √ ≠
WHF has some information on
exposure to other types of mining
(e.g., gold, copper, nickel etc.)
Dosimetry
Radon Exposure √ √ Available in both data bases.
Gamma Exposure ≠ ≈ The NDR has gamma
measurement starting 1981.
Note: √ - Available (>90%); ≈ - Available but limited; ≠- Not Available
64
Data Source 3: Ontario Cancer Registry and Ontario Mortality Database
The Ontario Cancer Registry (OCR) is a population-based registry
containing information on all Ontario residents who have been diagnosed with
cancer (incidence) or who have died of cancer (mortality). The OCR depends
entirely on information generated for purposes other than cancer registration
and is created by record linkage and computerized medical logic. The major
data sources used to create the OCR are:
• Hospital separations data with cancer as a diagnosis;
• Pathology reports with a mention of cancer;
• Death certificates in which cancer is the underlying cause of death; and,
• Reports from specialized cancer centers throughout the province.
The Ontario Cancer Registry also uses the Ontario Mortality Database to
record fact of death for cancer cases. Relevant data holdings at the OCR
include the following:
• Deaths with cancer as cause of death (1950-2004);
• Deaths from all causes (1964-2004); and,
• Cancer diagnoses (new cases, 1964-2004).
Non-melanoma skin cancers are not captured by the OCR. The quality and
completeness of the OCR for coverage of Ontario cases has been previously
examined and is considered to be of good quality comparable to leading
cancer registries worldwide. More detailed information regarding the quality of
the OCR is available in an IARC monograph [28].
65
Data Source 4: Ontario Mortality Database
For every death in Ontario, a death certificate must be submitted to the
Office of the Registrar General (ORG) in accordance with the Vital Statistics Act.
The data are coded and entered at the ORG. A copy of this file was provided
to the Ontario Cancer Registry. This file was used to determine the fact and date
of death to permit determination of person years at risk of cancer.
Record Linkage
Record linkage refers to the process of linking records within or between
different data sources to the same entity. It is a tool commonly used for passive
follow-up of cohort members to determine health outcomes being investigated
[29]. In this study, record linkage was used to assemble a cohort of uranium
miners from the WHF and the NDR. Miners’ cancer and vital status were
determined by linkage to the OCR, and OMD databases, respectively. This was
achieved using deterministic and probabilistic linkage methods followed by
manually resolving grey areas pairs (uncertain matches). Unique identifiers used
in the linkage process were phonetically encoded names, surname and given
name(s), date of birth, and gender. Other information such as place of birth
(where available) was used to resolve grey areas. These unique identifiers were
also used to identify diagnosis and death for the OCR and OMD respectively.
Figure 1 summarizes the linkage flow. The Work History File and the National
Dose Registry were previously linked in 2003 to examine risks of congenital
66
abnormalities [13, 30]. This initial linkage was expanded for the current study to
include 1986 to 2004 in order to capture additional miners employed after 1986
to form the study cohort. The cohort was then linked to the Ontario Cancer
Registry to identify all cohort members that had been diagnosed with or died
from cancer. The same cohort was also linked to the OMD to identify deaths
from non-cancer causes.
67
Figure 6: Summary schema for record linkage of different data sources used to
establish the cohort, exposure history, outcome identification, and follow-up
data.
68
Linkage Results
To avoid potential biases, it was determined a priori that the current author
of this study was not to be involved in any work related to linking information
from different data sources or in the resolution of grey areas of the linkage
process for individual uranium miners. Instead, record linkage was conducted by
N Chong, a Research Associate at Cancer Care Ontario who had many years
of experience in conducting linkage work. It is also important to note that Mr.
Chong was also blinded to the exposure information during linkage to the
outcome databases, as well as to any information regarding linkages
conducted previously by Muller and colleagues [10, 11].
Between the Work History File and the National Dose Registry (Table 8),
30,914 workers were identified. Of these, 82 percent (n=25,271) have
employment information appearing in both the WHF and the NDR, 15 percent
(n=4,594) are only in the NDR only and 3 percent (1,049) are only in the WHF. A
higher proportion of miners found in the NDR than the WHF was expected given
that the WHF was terminated in 1986 while the NDR continued until 2004.
69
Table 14: Cross-tabulation of number of miners found in the National Dose
Registry and Work History File
Radon Decay Product Exposure Assignment
Exposure to radon decay products was measured within the mines using
equivalent units of Work Level (WL) of energy from alpha particles emitted
potential from decay of radon-222 (222Rn) in air. One WL has an equivalent
energy of 1.3 x 10^6 million electron volts per liter of air. Exposure to one WL in a
period of one month (assumed to be 170 hours) equals an exposure to radon
and its decay products of one Working Level Month (WLM). That is, if a miner is
exposed to 2.6x10^6 million electron volts (2 WL) in 170 hrs, then the miner is said
to have been exposed to an equivalent of 2 WLM for that particular month .
In Ontario, over 131,000 area measurements of radon and its decay
products were taken since mines began operation [10]. However, during the 43
years of mining in Ontario (1954-1996), methods and frequency of
measurements changed. Similar to practices around the world [31, 32],
measurements of radon and its decay products were conducted ad hoc in the
Yes No TotalYes 25.271 1.049 26.320No 4.594 0 4.594
Total 29.865 1.049 30.914
National Dose Registry
Wor
k H
isto
ry
File
70
early years and gradually became more systematic and frequent in later years.
Table 9 summarizes the different approaches used to measure radon decay
products for different periods and the associated uncertainties with these
measurements.
Although uranium mining in Ontario began in 1954, systematic monitoring
of radon levels did not begin until 1958. Prior to 1958, extrapolation methods
were developed by mine engineers, industrial hygienists, and government
officials who had intimate knowledge of mining construction, and processes of
the time [10, 11]. Beginning in 1958, radon levels were measured by mine
operations using the Kusnetz method [33] with instrumentation calibrated by
government authorities. Levels of radon and its decay products were measured
every 3 to 4 months. No individual measurements were undertaken; but rather,
measures of radon and its decay products were obtained in headings, stopes,
raises, and travelways. Exposure to radon daughters and its decay products
were calculated by the time-weighted average for the concentration of work
area (stopes, headings, raises, and travelways) with the relative time-weights of
80 percent for work areas and 20 percent for travelways [11]. These weighted
averages were used to assign individual exposures by multiplying the average
weighted concentration of radon and its decay products in the mine during the
year the miner worked by the number of months employed during that year.
These estimates were adjusted for overtime, work stoppages, strikes, and
holidays throughout the year[11].
71
Beginning in 1968, individual exposures based on a detailed work history
(location and duration of a given day) and corresponding mine measurements
of radon decay products were reported by the mine operator directly to the
Atomic Energy Control Board (AECB) of Canada. Measures of radon and its
decay products occurred much more frequently and at different locations
within the mine. Individual exposures were assigned based on miners’ daily
reports of the time spent in each workplace and most recent measurements of
the levels of radon and its decay products closest to the corresponding
workplaces. Data on radon decay products have been collated over the years
by various stakeholders, namely, Ministry of Labour, AECB and mine operators,
and are currently housed in the WHF and NDR used for this study.
72
Table 15: Overview of dosimetry practices for measurement of radon and its
decay products for Ontario Uranium Miners, 1954-1996.
Period Dosimetry Practice Qualitative
Uncertainty Level*
• 1954-1957 • No measurements, estimates by
extrapolation methods
developed by mine engineers
and other experts. Miner
exposures were assigned based
on extrapolations.
• 1958-1968 • Area measurements conducted
by mine operators using
equipment calibrated by
government authorities.
Measurements were taken
every 3 to 4 months.
• 1968+ • Starting in 1968, radon
measurements were taken on a
regular basis and in different
locations within a mine. Work
history of miners was collected
on a daily basis. Miner
exposures to radon and its
decay products were
determined based on the
closest area(s) in which the
most recent measurements
were taken.
Higher
Uncertainty
Lower
Uncertainty
Note: *Uncertainty level is a qualitative assessment of the potential for measurement error of
radon and its decay products. ‘Higher Uncertainty’ indicates higher potential for
measurement error than ‘Lower Uncertainty’.
73
Analytic Approach
Internal comparison method based Poisson regression of grouped data
(risk-set approach) is one of the primary approached used to evaluate cancer
risks in occupational epidemiology [34-36]. Person-years were tabulated using a
program developed by Pearce and Checkoway [37] and modified by
Villeneuve and colleagues [38, 39]. Person-time data was generated for each
individual starting at the date of first employment in any Ontario uranium mine
(entry date) until December 31, 2004 or date of death/diagnosis of cancer
(esophagus/stomach/colorectal) or whichever occurred first. These person-
years were cross-classified by independent variables. An example2 [40] of the
cross-tabulation (risk sets) for 3 exposure levels and three age groups is shown in
Table 10.
2 Examples adapted from course notes from Dr. Paul Corey.
74
Table 16: Cross tabulations of 3-category exposure variable by 3-category age
groups
Exposure Categories Age Group (years)
Low Medium High
< 25
c11
PY11
r11 = c11/py11
c12
PY12
r12 = c12/py12
c13
PY13
r13 = c13/py13
25-<65
C21
PY21
r21 = c21/py21
c22
PY22
r22 = c22/py22
c23
PY23
r23 = c23/py23
65+
c31
PY31
r31 = c31/py31
c32
PY32
r32 = c32/py32
c33
PY33
r33 = c33/py33
Note: C- cases (diagnosis or deaths); PY – Person years at risk; and r= rate.
75
As in studies conducted recently [39, 41], a Poisson regression model was
used to conduct an internal cohort comparison. Poisson regression models the
logarithm of either the incidence and mortality rates of GI cancers as a
regression of the independent variables. Relative risks were estimated by
exponentiation of the regression coefficients for the independent variables. The
general form of the Poisson regression model is:
λ /λo = exp (β1X1, β2X2, …, βkXk), (3)
where X1, X2, …,Xk, are predictor variables;
λ is the incidence/mortality rate for persons with specified values X1, X2, …,Xk;
λo is the baseline mortality/incidence rate; and,
β1, β2, …, βk are parameters to be estimated from the data.
Cumulative dose (WLM) for each miner was treated as a time-dependent
variable in the internal comparison. The goodness of fit of the model was
assessed with the ratio of the deviance to the number of degrees of freedom.
Confounding and Effect Modification
In the modeling process, the potential influence of confounding factors
are typically explored by the change of 10% in the risk estimate as proposed by
Greenland [42]. However, the ability to fully assess and adjust for confounding
effects was limited in this study due to the lack of data on smoking, diet,
physical activity and medical history (e.g., H. pylori infection, stomach ulcers,
Barrett’s esophagus, etc).
76
In lung cancer mortality analyses, duration of exposure (dose rate), years
since last exposure, and age at first exposure have been shown to modify the
dose response relationship. In this study, potential effect modification of these
factors will also be explored. The strategy to be used is by stratification rather
than including it as an interaction term since it is more practical given the
grouped data approach of data analysis.
Latency
Rothman (1981) [43] defined latency as the period between disease
initiation and manifestation. For cancer outcomes, this period can be anywhere
from 5 years for leukemia to 30-40 years for mesothelioma. Given that there is no
consensus on the exact period between initiation and detection, the current
study addresses the issue of latency by lagging the cumulative dose for each
individual in a risk set to the dose received 0, 5, 10, 15, and 20 years before the
event (diagnosis or death due to GI cancer).
Loss to Follow-up
One major limitation of cohort studies in general, is the loss-to follow-up (or
misclassification of disease status) of cohort members. For example, Woodward
and colleagues conducted a retrospective cohort study of uranium miners
employed at Radium Hill in Australia to examine the risk of lung cancer mortality
associated with exposure to radon decay products [7]. Although they found a
significant excess risk of lung cancer mortality (SMR=1.94, 95% CI 1.42-2.45), when
77
the analysis was restricted to those with cumulative exposure greater than 40
WLM, the risk increased by 5-fold (SMR 5.2, 95% 1.8-15.1). Despite the positive
findings, this cohort experienced a loss-to-follow-up of 36%. One of the main
reasons cited for this loss was emigration of migrant workers returning to their
native countries post-war [7].
The Ontario cohort is not immune to loss of follow-up. In fact some loss was
expected given that outcome data (e.g., cancer diagnoses, deaths) were
ascertained from provincial rather than national databases. However, logistical
(time required) and cost considerations made linkage to the national database
prohibitive. The extent of the loss was expected to be approximately 15% given
the experiences of other occupational linkage studies recently conducted in
Canada. For example, Villeneuve conducted a record linkage of the
Newfoundland fluorspar miners to the Canadian Mortality Database in 2005 [41].
Newfoundland is a relatively small province (1.5 % of the population of Canada)
with a highly mobile workforce. Results from their linkage showed that 16% of
deaths due to lung cancer occurred outside of the province of Newfoundland.
The potential biases associated with loss in this study are addressed in the next
Chapter (Chapter 3).
78
Chapter 2 References 1. Lubin, J.H., et al., Lung cancer in radon-exposed miners and estimation of risk
from indoor exposure. J Natl Cancer Inst, 1995. 87(11): p. 817-27.
2. Morrison, H.I., et al., Cancer mortality among a group of fluorspar miners
exposed to radon progeny. Am J Epidemiol, 1988. 128(6): p. 1266-75.
3. Rogel, A., et al., Lung cancer risk in the French cohort of uranium miners. J
Radiol Prot, 2002. 22(3A): p. A101-6.
4. Roscoe, R.J., An update of mortality from all causes among white uranium
miners from the Colorado Plateau Study Group. Am J Ind Med, 1997. 31(2): p.
211-22.
5. Tirmarche, M., et al., Mortality of a cohort of French uranium miners exposed to
relatively low radon concentrations. Br J Cancer, 1993. 67(5): p. 1090-7.
6. Tomasek, L., et al., Patterns of lung cancer mortality among uranium miners in
West Bohemia with varying rates of exposure to radon and its progeny. Radiat
Res, 1994. 137(2): p. 251-61.
7. Woodward, A., et al., Radon daughter exposures at the Radium Hill uranium
mine and lung cancer rates among former workers, 1952-87. Cancer Causes
Control, 1991. 2(4): p. 213-20.
8. Kusiak, R.A., et al., Mortality from lung cancer in Ontario uranium miners. Br J
Ind Med, 1993. 50(10): p. 920-8.
9. Kusiak, R.A., et al., Carcinoma of the lung in Ontario gold miners: possible
aetiological factors. Br J Ind Med, 1991. 48(12): p. 808-17.
79
10. Muller, e.a., Study of Mortality of Ontario Uranium Miners 1955-1977. 1983,
Ontario Ministry of Labour, Ontario Worker's Compensation Board, Atomic
Energy Control Board of Canada: Toronto.
11. Muller, J., R.A. Kusiak, and A.C. Ritchie, Factors Modifying Lung Cancer Risk in
Ontario Uranium Miners, 1955-1981. 1989, Ontario Ministry of Labour, Workers'
Compensation Board of Ontario, Atomic Energy Control Board of Canada:
Toronto.
12. Muller, J., et al., The Ontario Miners Mortality Study, in Radiation Hazards In
Mining: Control, Measurement, And Medical Aspects M. Gomez, Editor. 1981. p.
Chapter 56 (p.359-362).
13. Nahm, S., Paternal Exposure to Ionizing Radiation in Ontario Uranium Miners
and Risk of Congenital Anomaly in Offspring: A Record Linkage Case-Control
Study. 2003, University of Toronto: Toronto.
14. Nahm, S., Inclusion Criteria for Mining Master File (Perconal communication-
Email). 2006: Toronto.
15. Kusiak, R.A., Lung Cancer Mortality in Ontario Gold Miners. Chronic Diseases in
Canada, 1992. 13(No 6 (Suppl)): p. s23-s26.
16. Kusiak, R.A., et al., Mortality from stomach cancer in Ontario miners. Br J Ind
Med, 1993. 50(2): p. 117-26.
17. National Dose Registry. National Dosimetry Service. Access date: Jan 2005.
http://www.hc-sc.gc.ca/hecs-sesc/nds/photo_uranium-mines.htm [cited 2005
January 2005]; Available from: http://www.hc-sc.gc.ca/hecs-
sesc/nds/photo_uranium-mines.htm.
80
18. Industrial Disease Standard's Panel, Report to the Workers Compensation Board
on the Ontario Gold Mining Industry. 1987: Toronto, Ontario. p. (Section 2:
Validity of the Mining Master File).
19. Ashmore, J.P., The Design of National Dose Registries. European Journal of
Cancer, 1997. 33(Suppl.): p. S44-S47.
20. Ashmore, J.P. and D. Grogan, Record Keeping in the Canadian National Dose
Registry. Health Phys, 1977. 33(6): p. 673.
21. Ashmore, J.P. and D. Grogan, Record Keeping in the Canadian National Dose
Registry. Radiation Protection Dosimetry, 1985. 11(2): p. 95-100.
22. Ashmore, J.P., et al., First analysis of mortality and occupational radiation
exposure based on the National Dose Registry of Canada. Am J Epidemiol,
1998. 148(6): p. 564-74.
23. Hazelton, W.D., et al., Biologically based analysis of lung cancer incidence in a
large Canadian occupational cohort with low-dose ionizing radiation exposure,
and comparison with Japanese atomic bomb survivors. J Toxicol Environ Health
A, 2006. 69(11): p. 1013-38.
24. Sont, W.N., et al., First analysis of cancer incidence and occupational radiation
exposure based on the National Dose Registry of Canada. Am J Epidemiol,
2001. 153(4): p. 309-18.
25. Teschke, K., et al., Estimating nurses' exposures to ionizing radiation: the elusive
gold standard. J Occup Environ Hyg, 2008. 5(2): p. 75-84.
81
26. Zablotska, L.B., J.P. Ashmore, and G.R. Howe, Analysis of mortality among
Canadian nuclear power industry workers after chronic low-dose exposure to
ionizing radiation. Radiat Res, 2004. 161(6): p. 633-41.
27. Zielinski, J.M., et al., Decreases in occupational exposure to ionizing radiation
among Canadian dental workers. J Can Dent Assoc, 2005. 71(1): p. 29-33.
28. Black, R.J., L. Simonato, and H. Storm, Automated Data Collection in Cancer
Registration. IARC Technical Publication No. 32. 1998, International Agency for
Research on Cancer: Lyon.
29. Howe, G.R., Use of computerized record linkage in cohort studies. Epidemiol
Rev, 1998. 20(1): p. 112-21.
30. Marrett, L. and S. Nahm, Ontario Miners Database Feasibility Study. 2001,
Canadian Nuclear Safety Commission: Ottawa.
31. BEIR VI, Health Effects of Exposure to Radon. 1999, National Research Council
(USA). p. 20-24.
32. Puskin, J.S. and A.C. James, Radon exposure assessment and dosimetry
applied to epidemiology and risk estimation. Radiat Res, 2006. 166(1 Pt 2): p.
193-208.
33. Kusnetz, H.L., Radon daughters in mine atmospheres; a field method for
determining concentrations. Am Ind Hyg Assoc Q, 1956. 17(1): p. 85-8.
34. Breslow, N.E. and N.E. Day, Statistical Methods in Cancer Research, Volume II -
The Design and Analysis of Cohort Studies, ed. I.A.f.R.o. Cancer. 1987. p.3.
35. Checkoway, H., N. Pearce, and D. Kriebel, Research Methods in Occupational
Epidemiology, 2nd Edition. 2004, New York: Oxford University Press. p.91.
82
36. Frome, E.L. and H. Checkoway, Epidemiologic programs for computers and
calculators. Use of Poisson regression models in estimating incidence rates and
ratios. Am J Epidemiol, 1985. 121(2): p. 309-23.
37. Pearce, N. and H. Checkoway, A simple computer program for generating
person-time data in cohort studies involving time-related factors. Am J Epidemiol,
1987. 125(6): p. 1085-91.
38. Villeneuve, P.J., R.S. Lane, and H.I. Morrison, Coronary heart disease mortality
and radon exposure in the Newfoundland fluorspar miners' cohort, 1950-2001.
Radiat Environ Biophys, 2007. 46(3): p. 291-6.
39. Villeneuve, P.J., H.I. Morrison, and R. Lane, Radon and lung cancer risk: an
extension of the mortality follow-up of the Newfoundland fluorspar cohort. Health
Phys, 2007. 92(2): p. 157-69.
40. Corey, P., Random Counts and the Poisson Probablity Model. 2004, University of
Toronto: Toronto.
41. Villeneuve, P.J. and H.I. Morrison, Radon progeny exposure and lung cancer: a
mortality study of Newfoundland Fluorspar miners 1950-2001. 2005, Epistream
Consulting: Ottawa, Ontario.
42. Greenland, S., Modeling and variable selection in epidemiologic analysis. Am J
Public Health, 1989. 79(3): p. 340-9.
43. Rothman, K.J., Induction and latent periods. Am J Epidemiol, 1981. 114(2): p.
253-9.
83
Appendix 1: Letter Sent to the National Dose Registry to Request Data
Dr. Willem Sont Head, Analysis Unit National Dose Registry Radiation Protection Bureau 775 Brookfield Road, AL 6302C2 Ottawa, ON, K1A 1C1 08 May 2006 Re: Access to National Dose Registry for funded study “Radiation Exposure and Risk of Cancer among Ontario Uranium Miners: a Case-Cohort Study” Dear Dr. Sont: I am requesting access to data held by the National Dose Registry (NDR) to complete a study jointly funded by the Canadian Institutes for Health Research and Workplace Safety & Insurance Board, entitled, “Radiation Exposure and Risk of Cancer among Ontario Uranium Miners: a Case-Cohort Study”. The purpose of this study is to examine cancer risks associated with exposure to ionizing radiation among a cohort of Ontario uranium miners. NDR data will be used to identify potential eligible cohort members and to assess exposure. We have received approval from Health Canada’s REB Secretariat for access to the data contained in the NDR for this study. (See letter attached) This study involves linkage of NDR to the Mining Master File (MMF) for the period of 1950s to the present. The linkage is necessary for the following reasons:
• To identify all individuals who have ever worked in Ontario as a uranium miner; and, • To obtain exposure information (ionizing radiation and work history) for these individuals.
It has come to our attention that previous work for a study of the Eldorado Uranium Miners in Saskatchewan resulted in identification of duplicates of nominal rolls and improvements in exposure information, that these improved data were incorporated into the NDR (personal communication with Rachel Lane, CNSC). We request that these data be included in the version of the NDR provided, if at all possible, as these will improve the quality and accuracy of both our cohort and exposure estimates. Could you please let us know whether the file provided includes these data? Thank you in advance for your attention to this data request. If you have questions, please do not hesitate to contact me at anytime. Sincerely, Loraine D. Marrett, PhD Senior Scientist, Division of Preventive Oncology, Cancer Care Ontario
84
Inclusion Criteria 1. All individuals who have ever worked in an Ontario uranium mine 2. Period between 1951 (inception of the NDR) to the present 3. All information on radiation exposure (e.g., radon, gamma, and others) 4. Complete work history (even if the miner employed in another occupation) 5. All geographical locations of other work (including those outside of Ontario)
Data elements: Identifying variables
1. Social Insurance Number: (9 digit numeric series) 2. Last Name: 3. Given Name1(s): (complete, no initials) 4. Given Name2 (s): (complete, no initials) 5. Sex: 6. Job: (title of the individual’s job, e.g., underground miner) 7. Job class: NDR job classification code 8. Date of Birth: 9. Place of Birth: (province within Canada or Country outside Canada)
Data elements: Dosimetric variables
1. Enroll year: (1st year of radiation exposure) 2. Employment data: (For each job held by miner: job titles/classifications, by date,
employer, location, mine etc) 3. All Extremities: (Whole Body/Torso Head/Collar), Left Hand or Arm (below elbow),
Right Hand or arm (below elbow), Left Foot or Leg (below knee), Right Foot or Leg (below knee))
4. grp-no: geographic, organization & employer code a. prov-cd: province code b. grp-cls: organization code c. groupno: employer code d. svc-type: radiation badge service type e. ser-no: name of the employer
5. frst cont period: First radiation badge wearing period 6. last cont period: Last radiation badge wearing period 7. complete exposure-yr: exposure year to radiation 8. complete dose count: # of radiation records/year 9. complete skin dose: radon dose (WLM) (Note: finest breakdown available
(weekly/monthly/quarterly/yearly)) 10. complete body dose: gamma dose (mSv) (Note: finest breakdown available
(weekly/monthly/quarterly/yearly))
Additional data from the Eldorado Miners of Saskatchewan As available
85
Chapter 3: Assessment of the Impact of loss to Follow-up
Chapter 3: Comparison of Current AND Muller Linkage:
Assessment of Impact loss to Follow-up (1964 -1981)
86
Chapter 3 Table of Contents Assessment of Impact loss to Follow-up (1964 -1981)................................................85
Abstract ............................................................................................................................87
Objectives ........................................................................................................................91
Methodology...................................................................................................................92
Overview.......................................................................................................................92
Definition of Mechanisms of Loss to Follow-up........................................................93
Data Sources................................................................................................................95
Study population .........................................................................................................96
Study Period..................................................................................................................96
Outcomes of Interest ..................................................................................................96
Exposures of Interest....................................................................................................98
Statistical Analysis ........................................................................................................98
Results..............................................................................................................................101
Part 1: Comparison of Current and Muller Record Linkage Results...................101
Part 2: Determination of Potential Biases: Current Study vs. Combine Linkage
......................................................................................................................................108
Chapter 3 References..................................................................................................115
87
Abstract
Background
Loss to follow-up is a methodological challenge for any cohort study. This
is particularly true for computerized record linkage cohort studies where status of
cohort members is determined passively by linking to existing databases. For
example, the Current Study relies on the Ontario Cancer Registry and the
Mortality Database to identify cancer deaths and other causes of death.
Cohort members leaving Ontario represents a loss to follow up due to out-
migration since their health status can no longer be monitored. It has been
shown that if this loss occurs at random, then the resulting risk estimates remains
unbiased. However, if the loss does not occur at random, the resulting risk
estimate will be biased. Since the Current Study uses provincial rather than
national databases to identify events of interest, loss due to out-migration is
expected. As such, the impact on the risk estimate must be explored for this
study.
Objective
The objective of this Chapter is to assess the impact of loss to follow-up by
determining the changes the relative risk of death due to gastrointestinal cancer
based on results of linkage conducted using provincial (Ontario) outcome data
from the risk estimates derived using current linkage results supplemented with
data from national linkage.
88
Methodology
Results of the linkage from the Current Study with provincial cancer and
mortality (fact of death) databases were supplemented with the Muller linkage
which was previously linked to the Canadian Mortality Database for the period
between 1954 and 1981. The impact of the loss was examined by the
magnitude of the differences in the proportion of loss between exposure strata
(exposed vs. non-exposed) and corresponding relative risks were computed for
the Current Study and the Combined analysis (Current deaths + deaths missed
from Muller linkage) for the period between 1954 and 1981.
Results
Between 1954 and 1981, 25,834 miners were employed to extract uranium
ore in Ontario. Of these, 1,227 deaths (all causes) were identified in the Current
Study while 1,947 deaths were identified in the Muller Study. The Combined
Linkage (Current + Muller linkage combined) yielded 2,097 deaths.
For cancer outcomes, there were 297 deaths identified in the Current
Study compared to 415 identified in the Muller Study, a 40% loss in follow-up.
Proportionally, more deaths occurred in the early years than recent years.
Missing deaths occurred more frequently in the lower exposed group
(cumulative radon decay and duration of employment) than higher exposure
group.
Conclusion
89
Linking to the provincial rather than national outcome database resulted
in a loss of follow-up of 40% of deaths from all causes. Deaths appeared to
occur more frequently in the lower exposure group.
Introduction
Occupational cohorts constructed by linking existing administrative
databases have been invaluable in addressing research questions related to
the potential adverse health impacts associated with exposure to occupational
and environmental hazards [1-7]. Since first introduced in 1959 by Newcombe
and colleagues [3], the practice of Computerized Record Linkage (CRL) based
on probabilistic principles has became increasingly popular for a number of
reasons. From a methodological perspective, refinement of linkage algorithms
has improved the sensitivity and specificity of matches between different data
sources [1, 2] reducing the number of potential errors and thereby improving the
validity of linkage studies. From a statistical perspective, CRL can be used to link
large databases which provide the necessary statistical power to detect small
increases (or decreases) in relative risks associated with low level exposures to
environmental or occupational hazards. Finally, from a practical perspective,
CRL studies relying on existing data result in lower costs than studies involving
data collection from large numbers of individuals.
Despite the many advantages, CRL studies have limitations. One major
limitation of CRL studies is the reliance of passive follow-up to identify events of
interest (e.g., cancer deaths) and those remaining at risk of developing the
90
event. In passive follow-up, events of interest are determined indirectly through
administrative databases such as cancer registries or vital statistics databases.
Individuals who do not appear in these databases are assumed to remain free
of the event and at continuing risk of developing the event. This assumption can
be invalid if individual(s) have left the population at risk through migration to
regions or countries not covered by databases being used to monitor the events
of interest [1, 8]. Out-migration represents a special type of loss to follow-up in
many CRL studies and is often ignored due to a lack of ability to characterize
the impact of the loss on study results.
It is well recognized that loss to follow-up in cohort studies is problematic
since it can lead to biases in the risk estimation [9-13] . In the case of out-
migration in CRL studies, loss to follow-up would lead to under-counting of the
numerator (number of events of interest) and over-counting of the person-years
at risk. When comparing to external cancer rates, losses result in artifactually
reduced risk ratios [1, 8].
For within cohort comparisons (e.g., using Poisson regression), the impact
of out-migration on the risk estimate depends on the mechanism of loss to
follow-up. Greenland [11], and more recently, Kristman and colleagues [12]
showed that no important biases were observed with levels of loss to follow-up
between 5 to 60% when the losses were missing completely at random (MCAR)
or missing at random (MAR). However, this does not hold true when the loss
occurs not at random (MNAR).
91
The current study employs CRL methodology to re-construct an
occupational cohort of uranium miners employed in Ontario in order to
investigate cancer risks associated with exposure to ionizing radiation caused by
radon decay products. Cohort members were assembled using the Work History
File and the National Dose Registry databases for the period between 1954 and
1996 and followed passively using cancer registry and death files through
December 31, 2004. Although exposure data were available at the national
level (i.e., wherever an Ontario miner worked within Canada), outcome data
(cancer incidence/mortality and fact of death) were available only provincially.
As such, the current study is susceptible to loss to follow-up due to migration of
cohort members to geographical locations outside of Ontario. If the problem of
out-migration is ignored, then computation of standardized incidence/mortality
ratios would result in reduced risk estimates. Therefore, the methodological issue
of interest in this Chapter is whether in this situation, risk estimates based on
within cohort comparisons are unbiased.
Objectives
The overall objective of this Chapter is to assess the impact of the loss to
follow-up by determining whether estimates of the relative risk of death due to
gastrointestinal cancer differed depending on whether provincial or national
outcome databases were employed for a cohort of Ontario miners employed
between 1954 and 1981. The specific objectives are as follows:
92
1. To describe the results of record linkage of the Current Study that relied
solely on Ontario mortality database to identify deaths in comparison to
those of the earlier Muller Study [14] that had used the Canadian
(national) mortality database to identify deaths for the same cohort;
2. To derive and compare the relative risks of gastrointestinal, lung, and all
cancers deaths from the Current Study to those based on the Combine
Linkage (cancer deaths identified from Current Study and deaths found in
the Muller Study that were not found in the Current Study) scenario;
Methodology
Overview
Muller and colleagues linked the Ontario uranium miners cohort to the
Canadian Mortality Database (CMDB) on two occasions, in 1977 and 1981 [14,
15]. The results (deaths) from the most recent linkage (1981) were available for
comparative analysis. Deaths identified outside of Ontario in the Muller studies
represent an estimate of the loss-to-follow-up (out-migration) of cohort members
of the Current Study.
The Current linkage was conducted completely independent of the
Muller linkages. Considering the results of the Muller study together with those of
the Current Linkage (i.e., deaths identified within Ontario), a combined mortality
data file was created representing a “Combine Linkage” of the same cohort
93
with cancer deaths identified from both linkages. Specifically, the two groups
are defined as follows:
• Current Study = Deaths from Current Linkage (i.e., restricted to
Ontario outcomes files)
• Combine Linkage =Deaths from Current Linkage + Deaths from
Muller Linkage not found by the Current Study
Deaths occurring outside of Canada would not be captured by either
linkage so their impact could not be evaluated; the number of such deaths is
expected to be relatively small. To characterize the impact of loss-to-follow-up,
changes in the proportion of deaths and relative risk (and 95% confidence
intervals, CI) between the Current Study and the Complete Linkage were
computed.
Definition of Mechanisms of Loss to Follow-up
Missing data are commonly classified in one of three categories based on
the mechanism of the loss: i) missing completely at random (MCAR), ii) missing at
random (MAR), and iii) missing not at random (MNAR) [12, 16]. Specifically,
these are defined as follows:
Missing Completely At Random (MCAR) occurs when the probability
that a subject remains in the study is not related to the exposure or
disease status. The remaining sample in the cohort therefore may be
considered to be a random subsample of the original cohort.
94
Missing At Random (MAR) occurs when the probability of the subject
remaining in the study is related to the exposure and confounders but
not to the outcome of interest.
Missing Not At Random (MNAR) occurs when the probability of loss
relates directly to the outcome of interest and cannot be completely
explained by the other covariates. The probability of loss may also be
related to exposure status and should not be ignored in the analysis
due to possible biases in risk estimation.
The relationship between mechanism of loss and the impact on risk
estimates has been demonstrated by Greenland [11] and Kristman [12] . Both
simulation studies showed that if the proportions of loss are constant across
exposure strata, then the resulting risk estimates are unbiased. However, if these
proportions are not constant with respect to the exposures, the resulting risk
estimates would be biased. The extent of the bias depends on the magnitude
and direction of the loss.
Algebraically, Kristman and colleagues have shown (Figure 1a to 1c were
reproduced from Kristman et al. 2004 [12]) that if the loss is equally distributed
across exposure groups (i.e., MCAR, Figure 1b), then the magnitude of the odds
ratio (OR), an estimate of the relative risk, is the same as in a theoretical
complete cohort with no loss to follow-up. Similarly, it can be shown that when
the loss follows the MAR mechanism (Figure 1c) then the loss occurred
95
proportionally to the exposure groups and the magnitude of the risk estimate
remains the same as the original cohort.
The situation in the Current Study is shown in Figure 1d where some
outcomes (deaths) are missing, in particular deaths that occurred outside
Ontario as identified in the Muller linkage. In this scenario, following Kristman and
colleague’s rationale [12], it can also be shown algebraically (Figure 1d) that an
unbiased risk estimate will be obtained if the loss of the deaths occurs in the
same proportion in the exposed group as in the non-exposed group (i.e.,
proportionally constant). In this case the magnitude of the risk estimate would
be the same as that for the complete cohort.
Data Sources
Two data sources were used in this analysis:
i) Current Study linkage deaths to December 31 2004, and,
ii) Muller linkage deaths up to 1981.
The Current Study contained the unique mining certificate number
(‘mcert’), date of birth, year of death, cancer death (by cancer types), and
fact of death coded to ICD-9. Cancer deaths were determined by
computerized record linkage to the Ontario Mortality Database.
The Muller death file also contained information on cause of death (ICD-
9), date of death, and place of death for those uranium miners who died up to
1981. Vital status in the Muller study was determined by record linkage to the
Canadian Mortality Database. The Muller death file also contained the same
96
unique mining certificate number (‘mcert’) that enabled merging with the
Current Study file to create the Combined Linkage file.
Study population
The study population consisted of men who worked in uranium mines in
Ontario between 1954 and 1981. Miners who started work after December 31,
1981 were not included in this analysis. Miners who started work before 1981 and
died after December 31, 1981 were considered to be alive as of December 31,
1981.
Study Period
Although the Current Study extended the period of follow-up to
December 31, 2004, this analysis (Chapter 3) was restricted to a comparison up
to 1981 to match the study period used for the Muller analysis. Therefore, in this
Chapter, the study period is 1954-1981.
Outcomes of Interest
The primary cancer causes of deaths of interest were: i) esophageal
cancer (ICD-9: 150), ii) stomach cancer (ICD-9: 151), and iii) colorectal cancer
(ICD-9: 153, 154). Due to the small sample size of the first 2 cancer causes of
death, lung cancer (ICD-9: 162) and all cancer causes of death (ICD-9: 140-208)
were also examined.
97
Figure 7: Algebraic illustration of the impact of loss to follow-up on the odds ratio
for the complete cohort, missing completely at random, and missing of case
group in the Current Study.
Figure 1a. Complete Cohort (no loss to follow-
up)
Case Non-case Total Exposed pn* (1-p)n n Non-exp pn (1-p)n n
Total 2pn 2n-2pn 2n
The OR for a theoretical
complete cohort (with no loss to
follow-up) is equal to 1.0.
Odds ratio = OR = pn(1-p)n / pn(1-p)n = 1.0
Figure 1b. Missing Completely At Random
(MCAR) Case Non-case Total Exposed rpn r(1-p)n rn Non-exp rpn r(1-p)n rn
Total 2rpn 2rn-2rpn 2rn
Although the cohort is not
complete, the proportion of
missing subjects is equally
distributed throughout the cell. In
the case of MCAR, the OR
remains at 1.0.
Odds ratio = OR = rpn(1-p)nr / rpn(1-p)nr = 1.0.
Figure 1c. Missing At Random (MAR) Case Non-case Total Exposed rpn r(1-p)n rn
Non-exp pn (1-p)n n
Total rpn+pn n-np+rn-
rnp
n(r+1)
Odds ratio = OR = rpn(1-p)n / rpn(1-p)r = 1.0.
In the case of MAR, the loss
occurred proportionally in the
exposed group. Despite the loss,
the risk estimate remained the
same as the complete cohort at
1.0.
Figure 1d. Misclassification of disease status Case Non-case Total Exposed pn+x (1-p)n-x n Non-exp pn+x (1-p)n-x n
Total 2pn+2x 2n-2pn-2x 2n
Cu
rre
nt
Stu
dy
Odds ratio = OR = (Pn+x )(1-p)n-x / (Pn+x )(1-p)n-x =
1.0.
Given that only death file is
available from the Muller
linkage, only missing cases are
added to the case group. If the
proportion of missing is the same
in the exposure categories within
the case group, then the OR
remains unchanged at 1.0.
Note: *p-proportion of subjects with the outcome; n-number of subjects; r-proportion of subjects
remaining in the cell. (Figure 1a to 1c adopted from Kristman et al 2004 [12])
98
Exposures of Interest
Exposure variables of interest were cumulative radon exposure, and
duration of employment. The median value was used to create a binary
variable (exposed and non-exposed). A binary rather than multi-category was
used to ensure adequate number of deaths in each category. Table 1
summarizes the cut-points used to generate the binary values for the respective
exposure variables needed for the 2x2 table.
Table 17: Exposure variables of interest and median cut-points used to create
dichotomous exposure groups.
Statistical Analysis
Part 1 of this Chapter used descriptive statistics to compare results from
the Current Study where outcome information was determined using provincial
outcome databases with results of the Muller Study where outcomes were
determined using national databases. The difference represent estimated loss to
follow-up for the current study.
Exposure Status for 2x2 Contingency Table
Exposure Variable Median
Exposed Non-
exposed
Cumulative radon (WLM) 7.39 WLM > 7.39 WLM <=7.39
WLM
Duration of Employment 3.00 years > 3.00 years <= 3.00
years
99
Part 2 of this Chapter aims to determine the mechanism of loss, relative risk
estimates and 95% confidence intervals. The relative risks were estimated for the
Current Study linkage as well as for the Combine Linkage where Current Study
results were ‘supplemented’ with those from the Muller linkage. The Combined
Linkage represents the ‘Gold Standard’ since it contains deaths that were
missed by the Current Study as well as deaths that were missed in the Muller
Study.
For the relative risks, 2x2 contingency tables (Table 2) were calculated for
column 1 risks as follows [17]:
Table 18: Theoretical 2x2 contingency table
The column 1 relative risk (RR1) is defined as risk of row 1 relative to row 2 and
was calculated as follows:
Column 1 Column 2 Total
Row 1 n11 n12 n1 ·
Row 2 n21 n22 n2 ·
Total n·1 n·2 n
)1(.2
212|1
.1
111|1
2|1
1|11 n
npand
n
npwhere
p
pRR ===
100
The 95% confidence limits for RR1 are:
where
and Z is the 100(1 - α/2) percentile of the standard normal distribution.
)2()exp(*),exp(* 11 vZRRvZRR −
)3(11
)(lnvar21
2|1
11
1|11 n
p
n
pRRv
−+
−==
101
Results
Part 1: Comparison of Current and Muller Record Linkage Results
Table 3 provides summary characteristics for the 25,834 cohort members
who were ever employed in an Ontario uranium mine between 1954 and 1981.
The median age at which these miners started uranium mining was 23 years.
Over this period, on average they accumulated 24 WLM of radon exposure,
however, the variability in exposure is quite large, ranging from zero (non-
detectable) to almost 400 WLM. The majority of miners worked only for a short
period of time, the median duration of employment being less 3 years, with the
mean being 4.2 (SD 4.1) years.
Table 4 shows the number of deaths for all cancer causes of deaths as
well as deaths due to cancers of the esophagus, stomach, colorectal, lung
cancer, as well as non-cancer deaths. Between 1954 and 1981, the Current
Study identified 297 cancer deaths compared to 415 cancer deaths identified in
the Muller Study. The same number of deaths due to esophageal cancer was
identified in both studies. However, 11 more deaths due to stomach cancer and
10 more deaths due to colorectal cancer were identified in the Muller study as
compared to the current study. In total, 1,227 deaths were identified in the
Current Study based on the provincial linkage, while Muller’s linkage to the
Canadian Mortality Database yielded 1,947 deaths, a difference of 720 deaths.
102
The Combine Linkage of the two studies provided 2,097 deaths at the end of
follow-up in 1981.
Table 19: Employment Characteristics of the Ontario cohort of uranium miners
(1954-1981)
First employed as an Ontario
uranium miner
1954-1981
Number of miners 25,834
Cumulative exposure to Radon* (n) 25,556
Mean (SD) 23.9 (44.46)
Range 0-399
Median
Missing (n)
7.38
278
Duration of employment (n) 25,766
Mean (SD) 4.2 (4.1)
Range 0-33
Median
Missing
3.0
68
Note: * Radon daughters measured in Working Level Months (WLM); SD-
Standard Deviation
103
Table 20: Summary of number of deaths found in the Current Study, Muller study,
and Combined Linkage (both Current and Muller linkages (1954-1981))
Table 5 compares the number of cancer deaths detected by the Current
Study and those of the national linkage conducted by Muller by year of death.
The absolute and proportional differences in the number of deaths detected
were much larger for earlier years than more recent years. For example,
between 1954 and 1963, the Current Study found 17 deaths compared to 29
cancer deaths found in the Muller linkage, a difference of 12 cases or 71% more
deaths detected in the Muller study. Differences were larger in earlier years than
in later years. Overall, for the comparison period between 1954 and 1981, there
were 40% more cancer deaths identified in the Muller linkage using national
Cause of Death (ICD-9)
Current Study (n)
Muller 1981 (n)
Combine Linkage (n)
All Cancer Causes
(140-208)
297 415 438
Esophageal (150) 4 4 6
Stomach (151) 22 33 33
Colorectal (153,
154)*
30 40 40
Lung (162) 144 172 209
Non-cancer 930 1310
1424
Total 1,227 1,947 2,097 Note: *ICD-9 159.0 was not used to be consistent with Muller study Colorectal = 153 and
154 only); ** One death had missing code, assumed to be death due to non-cancer
causes.
104
data sources compared to the current linkage conducted using provincial data
sources.
Table 21: Comparison of number of cancer death found in the Current study
and Muller linkage based on the number of cases (all cancer causes) of death
between Current and Muller Study (1954-1981).
Figure 2 shows the frequencies of cancer deaths by calendar year for deaths
between 1954 and 1981 for both the Current Study (black bars) and the Muller
linkage (white bars). In both linkages, the number of deaths increased as the
years progressed. As the miners aged, deaths due to cancer became more
frequent. In every calendar year, there were more deaths found in the Muller
study than in the Current Study.
Period Current (A) Muller (B)Absolute Difference
(B-A)Proportion
((B-A)/ A)(%)
1954-1963 17 29 12 711964-1968 32 49 17 531969-1973 54 79 25 461974-1978 100 140 40 401979-1981 94 118 24 26
Total 297 415 118 40
105
Figure 8: Comparison of numbers of cancer deaths for the Current Linkage to
Muller linkage (1954-1981) by year of death.
0102030405060
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
Curr
ent (
n)0
00
01
32
43
45
010
107
314
1212
1326
1916
1821
2440
30
Mul
ler (
n)0
00
21
44
66
66
413
1511
1115
1718
1835
2524
3125
3050
38
Number of Deaths (All Cancers)
Year
of D
eath
106
Table 6 depicts a cross-tabulation of the linkage results of the Current
Study with the Muller Study for all cancer deaths and demonstrates that neither
linkage was perfect. There were 23 Ontario cancer deaths identified in the
Current Study that were not identified in the Muller Study. Conversely, there were
141 cancer deaths found in the Muller linkage that were not identified in the
Current Study. In the two studies combined (i.e., Combine Linkage), a total of
438 died of cancer.
Deaths occurring outside of Ontario represent out migration of the Ontario
uranium miners cohort. Table 7 shows place of deaths for the 141 miners whose
deaths were not captured in the Current Study. Of these, 78% occurred outside
of Ontario with nearly 38% died in Quebec and another 11% died in the
neighboring province of Manitoba. Thirty-one Ontario deaths were not
detected by the Current Linkage. Even though Saskatchewan has active
uranium mining operations, only 2% of deaths were found in this province. This
suggests that employment was not the primary motivator for the out migration.
107
Table 22: Comparison of linkages of all cancer causes of deaths between
Current and Muller Study (1954-1981)
Table 23: Place of death of miners found to have died from cancer in Muller
Study but not in the Current Study (1954-1981)
Place of Death Number of
Miners Percent
Prince Edward Island 1 0.71
Nova Scotia 3 2.13
New Brunswick 2 1.42
Quebec 53 37.56
Ontario 31 21.99
Manitoba 15 10.64
Saskatchewan 3 2.13
Alberta 7 4.96
British Columbia 22 15.60
Yukon 1 0.71
Newfoundland 3 2.13
Total 141 100%
Current Study
Dead Alive Total Dead 274 141 415
Alive 23 0 23
Mu
ller
‘81
Total 297 141 438
108
Part 2: Determination of Potential Biases: Current Study vs. Combine Linkage
Figure 3 shows the relative risks for the exposed group with a cumulative
radon dose of more than 7.39 WLM compared to those with cumulative dose of
7.39 WLM or less for the Combined Linkage and the Current Study.
Results for esophageal cancer (Figure 3A) are difficult to interpret due to
random variation of small numbers.
For stomach cancer (Figure 3B) there were 22 deaths identified in the
Current Study. An additional 11 stomach cancer deaths were added from the
Muller study to form the Combined Linkage. These 11 deaths would have been
misclassified in the Current Study as being still alive at the end of follow-up.
Proportionally, there were more stomach cancer deaths missed in the non-
exposed group (42%) as compared to the exposed group (29%), a net
difference of 13% between the two groups. Since the net difference is not 0, it
suggests that the loss-to-follow up deviates away from missing at random (MAR)
shifting towards missing not at random (MNAR). The differential loss is shown in
the change in the relative risk. The confidence interval of the two risk estimates
overlaps, the RR increased from 2.14 (95%CI; 1.04-5.23) for the Current Study to
1.75 (95%; 0.86-3.55) for the Combined analysis respectively. Similar trends were
observed for colorectal cancer deaths.
For all cancers combined, the proportion of the loss in the exposed group
compared to the non-exposed group is quite similar leading to similar risk
109
estimates for the Current study (RR= 2.64, 95%; CI 2,05-3.42) and the Combine
Linkage (RR=2.45, 95%CI; 2.05-3.42).
Figure 4 shows the relative risks associated with duration of employment
for the Current Study and the Combine Linkage analyses for esophageal,
stomach, colorectal, lung, and all cancers combined. The median duration was
used to determine the exposed (>3 years) and non-exposed group (<= 3 years).
As in analyses using cumulative exposure to radon decay products, comparison
using duration of employment also suggests an overestimation of the RR in the
Current study relative to the Combine Linkage.
110
Figure 9: Comparison of changes to the unadjusted relative risks and proportions
of deaths in the exposed and non-exposed groups to radon gas (WLM) for
Combine linkage relative to the Current Study (1954-1981).
Dead Alive Total Dead Alive TotalExposed 3 12.778 12.781 Exposed 1 12.780 12.781 66,67%Non-Exp 3 12.772 12.775 Non-Exp 3 12.772 12.775 0,00%
Total 6 25.550 25.556 Total 4 25.552 25.556 ?p 66,67%
Dead Alive Total Dead Alive TotalExposed 21 12.760 12.781 Exposed 15 12.766 12.781 28,57%Non-Exp 12 12.763 12.775 Non-Exp 7 12.768 12.775 41,67%
Total 33 25.523 25.556 Total 22 25.534 25.556 ?p -13,10%
Dead Alive Total Dead Alive TotalExposed 28 12.753 12.781 Exposed 22 12.759 12.781 21,43%Non-Exp 12 12.763 12.775 Non-Exp 8 12.767 12.775 33,33%
Total 40 25.516 25.556 Total 30 25526 25.556 ?p -11,90%
Dead Alive Total Dead Alive TotalExposed 163 12.618 12.781 Exposed 119 12.662 12.781 26,99%Non-Exp 46 12.729 12.775 Non-Exp 25 12.750 12.775 45,65%
Total 209 25.347 25.556 Total 144 25.412 25.556 ?p -18,66%
Dead Alive Total Dead Alive TotalExposed 310 12.471 12.781 Exposed 215 12.566 12.781 30,65%Non-Exp 128 12.647 12.775 Non-Exp 82 12.693 12.775 35,94%
Total 438 25.118 25.556 Total 297 25.259 25.556 ?p -5,29%
RR =2.33 (95% CI: 1.19-4.59) RR = 2.75 (95% CI: 1.22-6.18)
Figure D: Death due to lung cancer (ICD-9: 162)Combine (Current + Muller deaths) Current Study
Notes: ICD-9 - International Classification of Diseases, 9th Revision; WLM - Cummulative Working Level Months; Exposed - > 7.39 WLM; Non-Exposed <= 7.39 WLM; RR - Relative Risk; CI - Confidence Interval; r-proportion of original subjects lost; ?p - change in the proportion of original subjects lost from the exposed group vs. non-exposed (Non-exp) group. Fisher´s exact p-value > 0.05.
RR =2.45 (95% CI: 2.00-3.02) RR = 2.64 (95% CI: 2.05-3.42)
RR =3.56 (95% CI: 2.57-4.96) RR =4.79 (95% CI: 3.11-7.38)
Figure E: All Cancer Mortality (ICD-9: 140-208)
Combine (Current + Muller deaths) Current Study
WL
M
Proportion (%)
Proportion (%)
Figure A: Death due to cancer of the esophagus (ICD-9: 150)
WL
M
RR = 1.00 (95% CI:0.20-4.95) RR = 0.33(95% CI:0.03-3.21)
Combine (Current + Muller deaths) Current Study
RR = 1.75 (95% CI:0.86-3.55) RR = 2.14 (95% CI: 1.04-5.23)
Proportion (%)
Proportion (%)
WL
M
Proportion (%)Figure C: Death due to colorectal cancer (ICD-9: 153, 154)
Combine (Current + Muller deaths) Current Study
WL
M
Figure B: Death due to stomach (ICD-9: 151)Combine (Current + Muller deaths) Current Study
WL
M
111
Figure 10: Comparison of crude relative risks and changes in proportion of
deaths in the exposed and non-exposed groups to as measure by duration of
employment for Combine Linkage and deaths identified in the Current Study
(1954-1981).
Dead Alive Total Dead Alive TotalExposed 2 10.477 10.479 Exposed 1 10.478 10.479 50,00%Non-Exp 4 15.283 15.287 Non-Exp 3 15.284 15.287 25,00%
Total 6 25.760 25.766 4 25.762 25.766 ?p 25,00%
Dead Alive Total Dead Alive TotalExposed 8 10.471 10.479 Exposed 5 10.474 10.479 37,50%Non-Exp 25 15.262 15.287 Non-Exp 17 15.270 15.287 32,00%
Total 33 25.733 25.766 22 25.744 25.766 ?p 5,50%
Dead Alive Total Dead Alive TotalExposed 20 10.459 10.479 Exposed 17 10.462 10.479 15,00%Non-Exp 20 15.267 15.287 Non-Exp 13 15.274 15.287 35,00%
Total 40 25.726 25.766 30 25736 25.766 ?p -20,00%
Dead Alive Total Dead Alive TotalExposed 113 10.366 10.479 Exposed 65 10.394 10.459 42,48%Non-Exp 96 15.191 15.287 Non-Exp 59 15.228 15.287 38,54%
Total 209 25557 25.766 124 25622 25.746 ?p 3,94%
Dead Alive Total Dead Alive TotalExposed 208 10.271 10.479 Exposed 149 10.330 10.479 28,37%Non-Exp 230 15.057 15.287 Non-Exp 148 15.139 15.287 35,65%
Total 438 25328 25.766 297 25469 25.766 ?p -7,29%
Dur
(Yrs
)
RR =1.47 (95% CI: 0.79-2.71) RR = 1.91 (95% CI: 0.93-3.93 )
Figure D: Death due to lung cancer (ICD-9: 162)Combine (Current + Muller deaths) Current Study
Notes: ICD-9 - International Classification of Diseases, 9th Revision; Exposed - > 3.00 years, Non-Exposed - <3.00 years; RR - Relative Risk; CI - Confidence Interval; r-proportion of original subjects lost; ?p - change in the proportion of original subjects lost from the exposed group vs. non-exposed (Non-exp) group; Fisher´s exact p-value > 0.05.
RR =1.32 (95% CI: 1.10-1.60 RR = 1.47 (95% CI: 1.17-1.85)
RR =1.72 (95% CI: 1.31-2.67) RR = 2.10 (95% CI: 1.51-2.95 )
Figure E: All Cancer Mortality (ICD-9: 140-208)Combine (Current + Muller deaths) Current Study
Dur
(Yrs
)
Proportion (%)
Proportion (%)
Figure A: Death due to cancer of the esophagus (ICD-9: 150)Combine (Current + Muller deaths) Current Study
Dur
(Yrs
)
RR = 0.73(95% CI:0.13-3.98) RR = 0.49 (95% CI:0.05-4.67)
RR = 0.47 (95% CI:0.21-1.03) RR = 0.43 (95% CI: 0.16-1.16)
Proportion (%)
Proportion (%)
Dur
(Yrs
)
Proportion (%)Figure C: Death due to colorectal cancer (ICD-9: 153, 154)
Combine (Current + Muller deaths) Current Study
Figure B: Death due to stomach (ICD-9: 151)Combine (Current + Muller deaths) Current Study
Dur
(Yrs
)
112
Discussion
Results from this chapter indicate that approximately 40% of deaths were
missed by the Current Study. The loss occurred more frequently in earlier years
than in recent years. Overall, the missed deaths appear to be occurring not at
random (MNAR). Proportionally, more deaths were lost in the non-exposed
group than the exposed group. As a result, the estimate of the relative risks was
modestly higher in the Current Study as compared to the Complete Linkage.
The high loss to follow-up was somewhat surprising for the following
reasons:
• A long latency of exposure and disease relationship makes it unlikely that
workers selectively leave Ontario based on disease status;
• Duration of employment was relatively short, making decision about
leaving Ontario due to mining experiences unlikely; and,
• Miners were not informed about their exposure levels; therefore, it is
unlikely that differential loss occurred due to knowledge about exposure
levels.
Given the high lost to follow-up, a number of options were examined that
could potentially minimize any potential biases; however, none were particularly
effective due to limited statistical power to detect an association. These options
included the following:
• Examine only miners who started work after 1968 where the proportion of
loss appeared to be smaller;
113
• Restrict analysis to those born in Ontario;
While loss to follow-up is a methodological challenge that is frequently
acknowledged in cohort studies, its impact on the risk estimates are rarely
quantified in practice, likely due to the lack of data to determine the extend of
the loss. While the loss to follow-up in this study is high, similar losses have been
observed in other uranium miners cohorts. For example, Radium Hill cohort in
Australia experienced a loss of 36% [18] . Like the Australians, higher proportions
of the loss to follow up occurred in the lower exposure group. The German
uranium miners cohort had also indicated significant losses to follow-up. Kreuzer
and colleagues [19] used a ‘correction’ factor to inflate the number of
detected deaths to account for undetected deaths. However, this would
require assumptions about disease rate and registry error rate. Since both of
these factors have changed over time, making such assumptions would
introduce additional sources of uncertainty.
While the loss to follow-up suggests a bias in this study, the absolute
difference in the risk estimate of the Current Study compared to the Combine
Linkage is modest. For example, when comparing the risk estimates for
cumulative dose of radon decay products (Figure 3c), the Current Study
provided a risk estimate of 2.75 (95%CI; 1.22-6.18) compared to 2.33 in the
Complete linkage (95%CI; 1.19-4.59), a risk difference of only 0.42 with the
confidence interval overlapping. The differences are even smaller for the all
cancer deaths analysis (Figure 3e). For the Current Study, the risk estimate was
114
2.64 (95% CI; 2.05-3.42) compared to the risk estimate for the Combined Linkage
of 2.45 (95%CI; 2.00-3.02) representing a risk difference of only 0.19 with almost
identical confidence intervals.
Conclusion
Results from this Chapter confirm that loss to follow-up did occur. The loss
was greatest in earlier years than in more recent years. Overall, there was a 40%
loss to follow up when linking the Ontario Uranium Miners Cohort to the
provincial rather than national outcome databases. The results also indicate
that the loss occurred more frequently in the lower exposed group suggesting a
loss occurring not at random. As a result, risk estimates in the Currently Linkage
are modestly overestimated.
115
Chapter 3 References
1. Howe, G.R., Use of computerized record linkage in cohort studies. Epidemiol
Rev, 1998. 20(1): p. 112-21.
2. Krewski, D., et al., The Effect of Record Linkage Errors on Risk Estimates in
Cohort Mortality Studies. 2005, Statistics Canada, Catalogue No. 12-001:
Ottawa,. p. 13-21.
3. Newcombe, H.B., et al., Automatic linkage of vital records. Science, 1959. 130: p.
954-9.
4. Smith, M.E., The present state of automated follow-up in Canada--Part I:
methodology and files. J Clin Comput, 1980. 9(2): p. 1-18.
5. Smith, M.E. and H.B. Newcombe, Automated follow-up facilities in Canada for
monitoring delayed health effects. Am J Public Health, 1980. 70(12): p. 1261-8.
6. Smith, M.E. and H.B. Newcombe, Use of the Canadian Mortality Data Base for
epidemiological follow-up. Can J Public Health, 1982. 73(1): p. 39-46.
7. Smith, M.E., J. Silins, and J.P. Lindsay, The present state of automated follow-up
in Canada--Part II: the products. J Clin Comput, 1980. 9(2): p. 19-30.
8. Breslow, N.E. and N.E. Day, Statistical Methods in Cancer Research, Volume II -
The Design and Analysis of Cohort Studies, ed. I.A.f.R.o. Cancer. 1987. p.3.
9. Altman, D.G. and J.M. Bland, Missing data. Bmj, 2007. 334(7590): p. 424.
10. Burton, A. and D.G. Altman, Missing covariate data within cancer prognostic
studies: a review of current reporting and proposed guidelines. Br J Cancer,
2004. 91(1): p. 4-8.
11. Greenland, S., Response and follow-up bias in cohort studies. Am J Epidemiol,
1977. 106(3): p. 184-7.
116
12. Kristman, V., M. Manno, and P. Cote, Loss to follow-up in cohort studies: how
much is too much? Eur J Epidemiol, 2004. 19(8): p. 751-60.
13. Kristman, V.L., M. Manno, and P. Cote, Methods to account for attrition in
longitudinal data: do they work? A simulation study. Eur J Epidemiol, 2005. 20(8):
p. 657-62.
14. Muller, J., R.A. Kusiak, and A.C. Ritchie, Factors Modifying Lung Cancer Risk in
Ontario Uranium Miners, 1955-1981. 1989, Ontario Ministry of Labour, Workers'
Compensation Board of Ontario, Atomic Energy Control Board of Canada:
Toronto.
15. Muller, e.a., Study of Mortality of Ontario Uranium Miners 1955-1977. 1983,
Ontario Ministry of Labour, Ontario Worker's Compensation Board, Atomic
Energy Control Board of Canada: Toronto.
16. Twisk, J. and W. de Vente, Attrition in longitudinal studies. How to deal with
missing data. J Clin Epidemiol, 2002. 55(4): p. 329-37.
17. SAS Institute Inc., SAS OnlineDoc® 9.1.3. . 2008., Cary, NC:SAS Institute Inc.
18. Woodward, A., et al., Radon daughter exposures at the Radium Hill uranium
mine and lung cancer rates among former workers, 1952-87. Cancer Causes
Control, 1991. 2(4): p. 213-20.
19. Kreuzer, M., et al., Radon and risk of extrapulmonary cancers: results of the
German uranium miners' cohort study, 1960-2003. Br J Cancer, 2008. 99(11): p.
1946-53.
117
Chapter 4: Gastrointestinal Cancer Risks Associated
with Exposure to Radon Decay Products
118
Chapter 4 Table of Contents
Introduction....................................................................................................................123
Objectives ......................................................................................................................127
Method...........................................................................................................................128
Study Design...............................................................................................................128
Study Cohort ..............................................................................................................128
Cancer Incidence and Mortality Ascertainments ...............................................135
Study Variables ..........................................................................................................136
Hierarchy of Data Assignment.............................................................................136
Outcome Variables...............................................................................................137
Radon Exposure.....................................................................................................138
Description of Study Covariates and Derived Variables.................................139
Statistical Methods ....................................................................................................143
Data Mining............................................................................................................143
Poisson Regression Model ....................................................................................145
Linear Test for Trend...............................................................................................145
Results..............................................................................................................................147
Discussion .......................................................................................................................152
Strengths and Limitations......................................................................................152
Interpretations of Study Findings .........................................................................154
I) Esophageal Cancer...........................................................................................154
II) Stomach Cancer...............................................................................................156
III) Colorectal Cancers..........................................................................................159
IV) Lung Cancer.....................................................................................................160
V) Record Linkage.................................................................................................162
VII) Risk Modeling...................................................................................................166
VIII) Poisson Regression: Grouped vs. Ungrouped Data..................................171
Conclusions....................................................................................................................172
Chapter 4 References..................................................................................................173
Chapter 4 Tables and Figures .....................................................................................178
119
Abstract
Objectives
This objective of this Chapter is to present the results of analyses examining
the risks for diagnoses (incidence) and deaths (mortality) due to cancers of the
gastrointestinal tract (esophagus, stomach, and colorectal cancers) for a cohort
of Ontario uranium miners who have been exposed to alpha ionizing radiation,
namely, radon decay products.
Methods
The analyses were based on a dynamic cohort of men who were ever
employed as uranium miners in Ontario at anytime between 1954 and 1996. This
cohort was retrospectively constructed using data from the Work History File and
the National Dose Registry. Cohort members were followed from entry until the
event of interest (diagnosis or death due to cancer of the esophagus, stomach,
or colorectal) was observed. Otherwise, date of death from other causes or the
end of follow-up (December 31, 2004) was noted to determine the person years
at risk. For each miner, cancer status was determined by record linkage of
unique identifiers of each miner with the Ontario Cancer Registry. Fact of death
for non-cancer deaths were obtained from the Ontario Mortality Database.
Exposure to radon decay products were previously estimated and recorded in
units of Working Level Month (WLM). Internal comparisons based on the Poisson
regression technique for grouped data was used to derive the relative risks
associated with exposure to radon decay products.
120
Combined analyses (gastrointestinal cancer (GI) = esophagus, stomach,
and colorectal) were also conducted to increase statistical power. In addition,
lung cancer risks were also computed to facilitate comparison of results with
previous analyses of this cohort and other cohorts published in the literature.
Results
The final cohort consisted of 28,273 male uranium miners who were
employed in an Ontario uranium mine between 1954 and 1996. In total, these
miners contributed over 900,000 person-years of observation. For the period
between 1964 and 2004, 34 miners were diagnosed with esophageal cancer, 86
miners developed stomach cancer, and 359 miners were diagnosed with
colorectal cancer. For the period between 1954 and 2004, there were 40
deaths due to esophageal cancer, 69 from stomach cancer, and 176 from
colorectal cancer identified in the Ontario Cancer Registry. Approximately half
(51%) of the miners were first employed in the uranium mines prior to 1968. As
with other cohorts elsewhere, Ontario uranium miners only worked for a short
period of time. The median duration of employment was only 3 years. On
average, the cumulative exposure was 18.2 WLM with a wide range of 0 WLM to
1169 WLM. Miners who were employed before 1968 where ventilation was poor
experienced much higher doses of radon than those employed on or after 1968.
For example, for miners who were employed less than 2 years, the cumulative
dose experienced by miners who were first employed before 1958 was 6.62
WLM. For the same duration, miners employed after 1978 had a cumulative
121
dose of only 0.26 WLM, a 25-fold decrease in exposure for recent workers. Age
at first employment did not appear to be a significant factor in determining the
cumulative dose received.
For both cancer incidence and mortality, significant increases in cancer
risks associated with cumulative exposure to ionizing radiation were observed for
stomach and colorectal but not for esophageal cancer. When comparing the
highest cumulative exposure group (> 40 WLM) to the referent group (0 WLM),
the relative risk was 2.30 (95%CI: 1.02-5.17) and 1.56 (95%CI: 1.07-2.27) for
diagnosis of stomach and colorectal cancers respectively. For the same
comparison, significant increases in cancer deaths were also observed for
stomach (RR=2.90, 95%CI: 1.11-7.63) and colorectal cancer (RR=1.74, 95%CI:
1.01-2.99) mortality. For colorectal cancer, the increase in cancer risk with
increasing dose was significant (P trend < 0.05).
The results from this study provided suggestive evidence of modifying
effects of duration of exposure (dose rate) and years since exposure for
colorectal cancer incidence and mortality. Modifying effects of age at first
exposure was not evident. Results from the current study also support the inverse
dose rate observed in lung cancer mortality studies among uranium miners. For
example, among those with cumulative exposures of between 20 to 40 WLM,
those with duration of at most 3 years of employment were at a much lower risk
(RR= 1.31, 95% CI: 0.67-2.56) than those with more than 3 years of employment
(RR= 2.74, 95% CI: 1.12-6.69) for the same cumulative exposure. Modification by
122
duration (dose rate) was confirmed in analysis for lung cancer diagnoses and
death.
Conclusions
Analysis of the data showed statistically significant increases in diagnosis
(incidence) and mortality of stomach and colorectal cancers associated with
exposure to cumulative radon decay products. No significant increases were
observed for esophageal cancer likely due to lack of statistical power.
123
Introduction
Major epidemiologic studies conducted to date examining the
associated adverse health effects on uranium miners have largely focused on
the effects of inhaled radionuclides and risk of lung cancer mortality [1-7]. While
it has been shown that direct exposure to alpha particles emitted from radon
and its short lived decay products (222radon) through ingestion also contribute a
significant burden of ionizing radiation exposure to the major organs lining the
digestive tract [8], very little attention has been given to the possibility that
ingested radionuclides may also cause damage to major organs that come into
direct contact with the high energy transfer of alpha particles emitted from
radon decay products. Of the few studies conducted to date, collective
scientific evidence appears to be suggestive of a relationship between
exposure to ionizing radiation and increased risk of cancers along the
gastrointestinal tract, particularly those of the stomach and colorectal.
However, most of these studies lack the precision needed to demonstrate a
significant increase in risk association with exposure to radon decay products.
Morrison and colleagues first examined the mortality experience of a
cohort of 1,772 Newfoundland underground fluorspar miners with high exposure
to radon progeny [9]. For stomach cancer, they were expecting 16 fatal cases
based on general male Newfoundland mortality rates but observed 22 deaths.
124
Although an elevated risk ratio was observed, it was not statistically significant
(SMR = 1.35, 95% CI; 0.85-2.05) [9]. For death due to cancer of the large intestine
(n=5) and rectum (n=1) observed deaths were non-statistically lower than
expected. However, these findings might be due to random variation due to
small numbers. Although colorectal cancers have relatively good survival,
incidence was not examined. This study was recently updated to extend the
follow-up by 11 years to end of 2001 adding 6 more stomach cancer cases,
however, the increase in stomach cancer risk remained statistically non-
significant [10]. Similarly, Tomasek and colleagues examined the mortality
experience of 4,320 West Bohemian (Czech Republic) underground uranium
miners [11]. They observed significantly higher than expected deaths for all types
of cancers combined. However, none of the GI cancers assessed in this study
was statistically significant. For esophageal (SMR = 1.22, 95% CI; 0.49-2.52),
stomach (SMR = 1.05, 95% CI; 0.79-1.35), and rectal cancer (SMR = 1.04, 95% CI;
0.67-1.55), the ratio of observed to expected were higher but not statistically
significant [11]. Laurier and colleagues examined the mortality experience of a
cohort of 1785 French underground uranium miners [12]. Comparing mortality
experience of cohort members employed for at least 2 years to that of the
general public. Overall, they observed 234 deaths from all causes but had only
expected 183 deaths due to cancer of all types (SMR = 1.3, 95% CI; 1.1-1.5). For
cause specific cancer deaths, lower than expected deaths were observed for
esophageal cancer (SMR = 0.7, 95% CI; 0.4-1.4) but higher than expected for
125
stomach (SMR = 1.1, 95% CI; 0.5-2.0) and colorectal cancer (SMR = 1.4, 95% CI;
0.8-2.1) [12] .
To address the issue of poor statistical power of individual studies, Darby
and colleagues pooled data from 11 cohorts of miners that had been exposed
to ionizing radiation to examine cancer mortality risks other than lung
cancer[13]. Of the 11 cohorts, 4 were from Canada and accounted for almost
50% of men in the study (30,195 of 64,209 men in study). The Ontario uranium
miners’ cohort was the largest cohort included in this study followed by China
and Beaverlodge cohort in Saskatchewan. Darby and colleagues used indirect
standardization (external comparison) to derive the risk estimates [13]. In the
pooled analysis, significantly elevated risks for mortality due to stomach cancer
were observed(SMR=1.33, 95% CI; 1.16-1.52); however, the authors cautioned
that these risks might not be due to radon exposure since the increase was not
proportional to cumulative exposure of ionizing radiation. This study was also not
without its limitations. Although external comparisons have been used
extensively in the past, more recent studies have questioned the effectiveness of
indirect standardization in deriving unbiased risk estimates [14]. In occupational
epidemiological studies, internal comparison is viewed as being superior since it
can minimize biases caused by the healthy worker effect (e.g., diabetes,
cardiovascular diseases) and control for potential confounding factors
associated with the working environment [10]. Furthermore, exposure
information from one of the cohorts included in the Darby study (Beaverlodge,
126
Saskatchewan) was recently revised and found that exposure to ionizing
radiation was substantially underestimated [4]. Howe and Stager re-estimated
exposure for the Beaverlodge cohort by re-reviewing employment records with
respect to the location within the mine worked (e.g., stopings, drifting/raising,
travel ways, and shaft areas) and mine area-specific measurements. As a result,
the revised cumulative exposure demonstrated that controlling for these errors
resulted in significant increases in the risk estimate by 20% [4]. The increase in risk
estimate was attributed to the reduction in random measurement error that had
biased estimates to the null [4]. The impact of the revised exposure estimates of
the Beaverlodge cohort on the pooled analysis is not known. Finally, there is
significant heterogeneity in the studies that were pooled in terms of the level of
exposure experienced by miners in different cohorts. For example, because of
the low uranium ore grade in Ontario, miners employed in Ontario were typically
exposed to significantly lower doses than other cohorts such as the Colorado
miners that were also pooled in the study. While cancer risk at high doses is
better established, risks associated at low doses remain a topic of much debate
[15, 16].
In Ontario, over 28,000 men were employed to extract uranium from deep
underground mines beginning in 1954. As in the aforementioned studies,
gastrointestinal cancer risks have been previously examined [17, 18], however,
non-statistically significant risk estimates were observed at the last update in
1981. The long follow-up of this cohort of uranium miners provides a unique
127
opportunity to contribute to the current body of knowledge regarding the
relationship between exposure to ionizing radiation and risk of gastrointestinal
cancers. Ingestion of high energy alpha particles emitted from radon decay
products provides a direct route of exposure and forms a biologically-based
hypothesis of a potential relationship between exposure to ionizing radiation
and carcinogenic development of the major organs lining the gastro-intestinal
tract.
Objectives
The overall aim of this study is to assess the risk of gastrointestinal
cancer among male workers employed in Ontario uranium mines between 1954
and 1996 and who were followed until the end of 2004. Within this cohort, the
specific objectives of this study are as follows:
1. To determine whether the risk of diagnosis (incidence) of or death
(mortality) from gastrointestinal cancers (esophageal, stomach, and
colorectal) is associated with cumulative exposures to radon decay
products; and,
2. To determine whether the duration of exposure (dose rate), years since
last exposure, and age at first exposure modify these associations.
128
Method
Study Design
This study uses a retrospective cohort design of male uranium miners who
worked in Ontario between 1954 and 1996. The cohort was followed passively
until December 31, 2004. Their cancer status was monitored until December 31,
2004. Once entered into the cohort, the men were considered to be at risk of
developing the event of interest (diagnosis of or death from cancers of the
esophagus, stomach, or colorectal), or death from non-cancer causes, or end
of follow-up, which ever occurred first. Individual exposure to radon decay
products was estimated based on different methodologies that have evolved
over the years (Please refer to Chapter 2 for detailed discussion of radon
exposure assignment). The completeness and accuracy of these measurements
were closely scrutinized and have been used in previous epidemiological
investigations [17-20].
Study Cohort
The Ontario Uranium Miners (OUM) cohort was created by linkage of the
Work History File (WHF) and the National Dose Registry (NDR). Both of these data
sources contained personal information about the miner (e.g., names, date of
birth), their work history (e.g., date of employment), and their exposure
information (e.g., radon decay products).
129
The WHF is a provincial (Ontario) database containing information on all
miners of all ore types (e.g., gold, copper, nickel etc) employed in Ontario up to
1986. Male miners with at least 2 weeks of uranium mining history were extracted
from the full database for analysis in this study. In total, information on 26,367
miners with a history of uranium mining was extracted for analysis from the WHF
(See also Chapter 2 for more details on inclusion criteria). The WHF was
terminated in 1986 and therefore, information for miners who worked (or started
after 1986) were not captured in the WHF.
The second database used to create the cohort was the National Dose
Registry (NDR). The NDR is a centralized national database which monitors
ionizing radiation doses of over 500,000 radiation workers in Canada [21]
including those employed in the uranium mining industry from 1954 until the
present day. Thus, although uranium mining ceased in Ontario in 1996,
exposures of miners employed post-closure (for decommissioning, or other
occupations with radiation exposure) are still being collated by the NDR. In
addition, the NDR being national in scope includes exposures to ionizing
radiation for those Ontario miners who have also worked elsewhere in Canada.
Any worker in the NDR who has ever worked as a uranium miner in Ontario was
considered potentially eligible for cohort membership (see also Chapter 2 for
more details on inclusion criteria). In total, 210,791 employment records for
29,865 miners for the period of up to 2004 were extracted from the NDR for
analysis. Table 1 shows the distribution by province of the employment records
130
for these miners. As expected, most of the employment records were for work
conducted in Ontario (96%); however, 4% of the records were for work
conducted by the same miners in Saskatchewan.
Table 24: Distribution of employment records according to provinces and
territories of employment in Canada from 29,912 miners identified from the
National Dose Registry.
Using both the WHF and NDR, 30,914 uranium miners were identified. There
were 1,049 miners (3%) that were found in the WHF but not in the NDR.
Conversely, there were 4,594 miners that were in the NDR but not in the WHF. The
higher proportion of miners in the NDR is expected since it includes workers
employed after the WHF was terminated in 1986.
Of the 30,914 miners identified from the WHF and NDR, not all were
included in the analysis. Six exclusion criteria were applied to the entire cohort
Province or Territory
Newfoundland 24 (0.01)Prince Edward Island 1 (0)Nova Scotia 40 (0.02)New Brunswick 167 (0.08)Quebec 82 (0.04)Ontario 201,851 (95.76)Manitoba 20 (0.01)Saskatchewan 7,849 (3.72)Alberta 318 (0.15)British Columbia 51 (0.02)Northwest Territories 358 (0.17)Yukon 30 (0.01)
Total 210,791
Number of employment records (% of total)
131
as described in Table 2. Women (n=486, 1.6%) were excluded from analysis since
their small numbers would have limited any statistical inferences based on sex.
Miners with missing dates of birth were also excluded since date of birth is
required for appropriate allocation of person-years at risk and to calculate
derived variables such as age at first employment. Similarly, those with
inappropriate age at first employment were excluded. Miners under the age of
16 were excluded since they were likely too young to be employed as
underground uranium miners. Miners who were identified from the NDR with
employment history containing ‘spanner records’ were also excluded. Spanner
records were used by the NDR to assign known doses of radon to miners without
known dates of exposure. For example, a spanner of ‘190096’ indicates that the
exposure occurred anywhere between 1900 and 1996. Without specific dates of
exposure, derived variables such as duration of exposure cannot be calculated.
More importantly, date of entry into the cohort could not be established with
certainty. Miners identified from the NDR without at least one record indicating
job classification as a uranium miner (i.e., job code 601 or 610) were also
excluded to ensure that the worker was in fact at one point a uranium miner.
Finally, miners with invalid entries (e.g., exit date occurred before entry date)
were also excluded.
Figure 1 describes the exclusion process and the number of miners that
remained after the exclusion criteria were applied in sequence. In total, 2,661
miners were excluded from analysis, including 15 incidence cases and 7 deaths
132
due to cancer of the esophagus, stomach, or colorectal (Table 3). Following
exclusion, analysis was performed to explore the effect of radon decay
products for 28,273 Ontario uranium miners.
133
Table 25: Exclusion criteria applied to the Ontario Uranium Miners cohort, 1954-
2004.
Exclusion Criteria Rationale for Exclusion
• Women • Less than 1% of uranium miners were
women, therefore, insufficient statistical
power to detect any cancer effects for
female uranium miners.
• Missing date of birth • This information was needed to calculate
age (e.g., age at first employment) as a
potential confounder and person-years
• Spanner records • Spanner records were used by the NDR to
assign doses of radon to miners without
known dates of exposure. Without specific
dates of exposure, derived variables such as
duration of exposure cannot be calculated.
• Invalid age at first
employment
(<= 15)
• If calculated age at first employment
(based on Date of birth and date at first
employment) was less than or equal to 15
years, the miner was excluded. This criterion
has been used previously by Howe and
colleagues [2, 3].
• Earliest date of
employment > 1996
• Since the last mine operated in Ontario was
1996 (Stanleigh Mines), therefore, individuals
who started work after 1996 were not likely
to be true uranium miners.
• Not having at least
one record as a
uranium mining
• To ensure that the miner was indeed a
uranium miner
• Invalid entry and exit
dates
• Example of an invalid entry and exit dates
includes exit date occurring before entry
date
134
Figure 11: Summary of exclusion criteria.
Exclusion Criteria
Exclude females/unknown/
missing information on sex:
(Females: n = 486)
Master Analysis File(n= 28,273)
n = 486
Remaining
n = 30,428
Master Study File
Yes No Total
Yes 25,271 1,049 26,320
No 4,594 0 4,594
29,865 1,049Total
Exclude those with missing
date of birth:
(n = 1,142)
n = 1,142
Remaining
n = 29,286
Exclude those who’s start date is
after December 31, 1996 after the
last uranium mine in Ontario
Closed
(n= 59)
n = 59
Remaining
n = 28,910
Exclude invalid age
(e.g., <= 15 yrs at first
employment)
(n = 43)
n = 376
Remaining
n = 28,851
Delete NDR “Spanner Records”
(n = 467)
n = 133
Remaining
n = 28,718
Exclude those without at least
one uranium mining record in
work history
(n = 445)
n = 445
135
Table 26: Summary of cases and deaths lost after applying the exclusion criteria.
Incidence Cases (n) Deaths (n) Cancer Site (ICD-9) Pre-
exclusion
Post-
exclusion
Total
Excluded
Pre-
exclusion
Post-
exclusion
Total
Excluded
Esophagus (150)
36 34 2 42 40 2
Stomach (151)
90 86 4 71 69 2
Colorectal (153,154,159.0) 368 359 9 179 176 3
Cancer Incidence and Mortality Ascertainments
The cohort was linked to the Ontario Cancer Registry (OCR) following
death clearance up to December 31, 2004 to identify diagnosis and deaths due
cancer. The OCR is managed by Cancer Care Ontario and at the time of this
linkage, it held data on all deaths in Ontario due to all malignant cancers (all
sites except for non-melanoma skin cancer) for the period between 1950 and
2004. For incidence, cancer diagnosis is available for the period between 1964
and 2004. The quality and completeness of the OCR for coverage of Ontario
cases was previously examined and found to be of good quality and
comparable to leading cancer registries worldwide. More detailed information
about the OCR is available in a recent IARC monograph [22]. Cases and death
occurring outside of Ontario cannot be detected and therefore miners not
known to have died in Ontario were assumed to be alive until end of follow-up.
136
In addition to cancer death and diagnosis data, the OCR also has data on all
non-cancer causes of death (fact of death) beginning 1964. Dates of non-
cancer deaths for cohort members were also extracted to conduct person-
years allocation.
All linkages used a combination of deterministic and probabilistic
methodologies with AUTOMATCH computer software. Linkages were
conducted by a researcher at Cancer Care Ontario (N. Chong) who was
blinded to exposure status of cohort members. The current linkage was
conducted blinded from any of the previous Muller linkages. Details of the
mechanism and results of the linkages are discussed in Chapter 2.
Study Variables
Hierarchy of Data Assignment
Work history and exposure information on uranium miners were obtained
from two different data sources: NDR and WHF. These two data sources at times
overlap (e.g., WLM estimates for a given year) and agreement between these
two data sources is not always perfect, creating discrepant information
regarding work history and exposure information for a given miner. It was
therefore decided a priori that NDR data prevailed since it was the most up to
date and complete data source.
137
Outcome Variables
The primary outcome variables in this study are diagnosis (incidence) of or
death (mortality) from cancers of the esophagus, stomach, and colorectal
cancers among Ontario uranium miners.
Analysis of incidence data was restricted to first primary diagnosis of
cancer. Secondary and subsequent diagnoses of cancer were not considered.
Less than 10 percent of miners had multiple cancer diagnoses (multiple
primaries). Two approaches could have been taken: 1) use only the first
recorded diagnosis, or 2) use any cancer diagnosis by an individual that is
primary. With the second choice, one individual can contribute to more than
one outcome. In this study, it was decided a priori that the former approach
(first option) should be taken since it eliminates any doubts about
interrelatedness of the two cancer sites.
In addition to the three individual cancer sites of primary interest, analysis
of all three sites combined was also examined to increase statistical power. Lung
cancers were also examined for external validation of analytic methodology
only and are not discussed in detail in this report. These outcomes were coded
according to the International Disease Classification (9th Revision) as follows:
• Primary Outcome Variables:
o Esophageal Cancer (ICD-9: 150);
o Stomach Cancer (ICD-9: 151); and,
o Colorectal Cancer (ICD-9: 153, 154, 159.0);
138
• Secondary Outcome Variables:
o Gastrointestinal (GI) Cancers (ICD-9: 150, 151, 153, 154, 159.0); and
o Lung Cancer (ICD-9: 162).
Radon Exposure
Cumulative exposure to radon decay products measured in Working
Level Month (WLM) is the primary exposure of interest in this study. Radon doses
were calculated using data from WHF and/or NDR. Given that two databases
were used (WHF and NDR) both contained estimates of radon, discrepancies in
radon doses were expected as no data base is perfect. As such, a ‘Best
Estimates’ approach was used to resolve discrepant reported doses of the two
data sources using the following dose metric applied to each dose record:
• When a radon dose estimate is available only in the WHF, it is
considered as the “Best Estimate”;
• When a radon dose estimate is available only in the NDR, it is
considered as the “Best Estimate”; and,
• When dose is available in both the NDR and WHF, the NDR dose is
considered the “Best Estimate”.
Doses were then accumulated across years as illustrated in Table 4. In this
scenario, miner John Doe worked from 1956 to 1960. During this time, dose
records were found in both the WHF and NDR with a missing dose in the WHF in
1957 and a missing dose in the NDR in 1959. The cumulative dose based on the
arithmetic sum for Mr. Doe was 5.5 and 4.5 based on the WHF and NDR
139
respectively. Applying the algorithm above, the ‘Best Estimate’ of the
cumulative dose was 5.0 WLM.
Table 27: Example of calculation of cumulative doses based on ‘Best Estimate’
approach for a hypothetical miner employed from 1956 to 1960.
Calendar Year of Employment Data Source
1956 1957 1958 1959 1960
Cumulative Dose (WLM)
WHF 2.5 ≠ 2.0 0.5 0.5 5.5
NDR 1.5 0.5 1.5 ≠ 1.0 4.5
‘Best Estimate’ 1.5 0.5 1.5 0.5 1.0 5.0 Note: WLM – Working Level Month; WHF – Work History File; NDR-National Dose Registry; ≠ - Dose
not available
Description of Study Covariates and Derived Variables
Cumulative Dose of radon decay products is the main exposure of interest
for this study. For the descriptive statistics, cumulative radon doses were
presented as the sum of all exposure records, as illustrated above. In the
modeling, radon dose was considered as a time dependent variable with doses
accumulated for each risk set until the event of interest or end of follow-up. In
order to account for different induction and/or latency periods, cumulative
doses were lagged by 10 years. Sensitivity analyses with lagging of 0, 5, 15, and
20 years were also conducted with results summarized in Appendix V. Lagging
was achieved by excluding the doses received 0, 5, 10, 15, and 20 years
immediately prior to diagnosis or death. This concept was described in detail in
140
Chapter 2 and applied in this analysis based on the methods described in
Pearce and Checkoway [23, 24].
Cumulative exposure was categorized into four groups; the lowest with
a cumulative radon exposure of 0 WLM the others in 20 WLM increments so the
highest exposed group is greater than 40 WLM. Since health effects associated
with a given dose are not well established in relation to GI cancer, there are no
acceptable biologically-based cut-points.
Sex was used as an inclusion/exclusion criterion for this study. Females
were excluded from analysis due to small numbers of female uranium miners.
Those with unknown (n=593) and missing sex codes (n=143) were assumed to be
males and were included. This assumption was based on a random sample of
unknown/missing sex codes which were manually examined using given names
to determine whether the miner was male or female. Of those given names
examined, all were indicative of male miners (e.g., first name = John).
Calendar Year of Employment was available in both the NDR and WHF.
However, approaches used to assign exposure to a calendar year were slightly
different for each data source. For the NDR, the exposure year was defined as
the year in which monitoring of the exposure started. For example, if the
dosimeter was issued to a uranium miner in December of 1980, the dose of a
dosimeter would be included in 1980 even though the badge may have
accumulated some doses in parts of 1981. Since uranium miners are required to
report doses on a quarterly basis, such overlap was assumed to be insignificant
141
in this study. For the WHF, exposure assignment in early years was based on
employment information collected at annual chest examination clinics. Given
that these examinations did not always occur on the first day of each calendar
year, it was possible that a miner worked more than 12 months between
examinations. As such, the year of exposure has been ‘calendarized’ to
allocate appropriate months to a given year. In this study, the variables ‘yrs’ in
the WHF and ‘exposure_year’ from the NDR were taken to be the year in which
employment (exposure) had occurred.
Age at first Employment (exposure) was included in the analysis as a
potential effect modifier. It is a derived variable based on date of birth and
date of first employment. To examine the modifying effects of age at first
exposure, separate risk estimates were examined for two strata. Cut-points for
the strata was based on the median age at first employment distribution.
Duration of Employment has been identified as an important modifier of
the dose response relationship in lung cancer mortality studies of uranium miners
for several cohorts [25]. To date, the inverse dose rate has not been examined
for non-lung cancers.
Duration is a derived variable. The best data source used to do this would
have been the WHF. However, data were not available for miners employed
after 1986 in the WHF. Instead, multiple other approaches were used to derive
this variable, some with limited success. Three main approaches are described
below with the third approach used in this study.
142
1. Initially, duration was determined based on the first and last dates of
employment. However, closer investigation showed that this
approach greatly overestimated the duration of employment since
there were gaps in employment history. Results from this approach
were compared to external reports (BEIR VI) [26] and confirm that this
approach overestimates the duration of employment.
2. The second main strategy was to calculate duration using information
from the NDR (variables: from_period and to_period) for coding
dosimetry wearing periods in the NDR. Again, this did not prove to be
fruitful for a few reasons. Specific dates could not be determined
using this coding. The coding mechanism was designed to identify
quarterly reporting of dosimetry badge readings for uranium miners, as
such, the exact dates were not available in the database.
“Guestimates” (e.g., mid-point of the quarter) were attempted,
however, total duration did not agree with WHF data.
3. In the third approach, duration was determined based on the number
of radon readings for the miner. Although crude, this approach
agreed best with calculations for duration of employment conducted
in previous published reports [26, 27].
Date of entry (first employment) was determined using data from both the
NDR and WHF with NDR being the default value since its data was more
complete. If NDR date of entry was missing, then WHF values were used.
143
Date of Termination or End of Follow-up was calculated differently for
incidence and mortality analyses. For incidence analysis, miners contribute
person years until their date of diagnosis of first cancer (any site), or date of
death, or date of end of follow-up (December 31st, 2004), which ever occurred
first. Only the first primary cancer was considered. For analysis of mortality,
miners contribute person years until their date of death from any cause;
otherwise the date of end of follow-up constituted the termination date.
Statistical Methods
Data Mining
The final data set was examined for range of values and internal
consistencies between variables. Examples of consistency checking include
comparing date of birth relative to date at first employment and calculated
age at first employment to determine whether it is reasonable within a working
age range.
Missing values were also examined. One of the most common missing
values was day and month of dates (birth, first employment, and last
employment). In these situations, mid-month/year was used (i.e., 30 June).
144
Figure 12: Overview of analytical approach
Inci
dence
= T
able
13
Mort
ality
= T
able
14
Inci
dence
= T
able
15
Incidence & M
ortality
(Esophagus, Stomach, and Colorectal)
(10 year lag)
Results = Table 12
Mort
ality
= T
able
16
Inci
dence
= T
able
17
Mort
ality
= T
able
18
145
Poisson Regression Model
Poisson regression using the SAS GENMOD procedure (Version 9.1) was
used to model cancer risks as a function of covariate levels. The general form of
the Poisson regression model is:
λ /λo = exp (β1X1, β2X2, …, βkXk),
where X1, X2, …,Xk, are independent variables, λ is the incidence/mortality rate
for persons with specified values X1, X2, …,Xk, λo is the baseline
mortality/incidence rate, and β1, β2, …, βk are parameters estimated from the
data. Exponentiation of the regression coefficients provides an estimate of the
relative risk controlling for the independent variables (e.g., age at risk, period
employment).
Cross tabulations of data consisting of lung cancer deaths, person-years
of follow-up, and summary variables were entered into the regression models.
Person-years were calculated using a program adapted from that first
presented by Pearce and Checkoway and Villeneuve and Colleagues [24, 28] .
Data were cross-classified by attained age (<60, 60-<65, 65–<70,70+), calendar
period (< 1975, 1975-84, 1985–1994, 1995+), and cumulative RDP exposure (0, >0-
20, >20-40, >40 WLM).
Linear Test for Trend
The χ2 test for linear trend was used to determine the dose response
relationship between cumulative exposure to radon decay products and
146
cancer outcomes. Given that the exposure variable in this study was
categorized into four groups (0, >0-20, >20-40, and >40 WLM), the linear test for
trend was conducted by substituting the mean dose for level of each dose
category.
147
Results
The analysis was based on 28,273 male uranium miners (Table 7).
Collectively, these miners contributed 961,210 and 974,687 person-years to the
incidence and mortality analyses respectively. The average age at first
employment was 29 years; however, the age distribution is positively skewed
with the most frequent (mode) age at first employment being 21 years.
Approximately half (51%) of the miners began working in uranium mines before
1968. These workers were not employed as uranium miners for very long. Fifty-six
percent of the miners were employed for no more than 3 years (Table 9), the
average duration of employment being 5 years with a range of 0.5 to 22.5 years.
Short duration of employment is a common characteristic of uranium miners. For
example, the average duration of the Colorado Plateau uranium miners cohort
was 4 years [25].
Of the 28,273 Ontario uranium miners, 34 were diagnosed with
esophageal cancer, 86 were diagnosed with stomach cancer, and another 359
were diagnosed with colorectal cancer (Table 8). Some of these diagnoses also
resulted in death. For esophageal cancer, there were actually more deaths
(n=40) than there were diagnoses (n=34). This is due to the longer period of data
available for death (1954-2004) compared to diagnosis (1964-2004). That is,
incident cases of esophageal cancer (and all other cancers) diagnosed prior to
1964 would not be captured. The high death to diagnosis ratio also reflects the
148
seriousness of esophageal cancer. In addition to esophageal cancer, 69 miners
died from stomach cancer and another 176 miners died from colorectal
cancer. Of the three cancers investigated, colorectal cancer has the best
survival as indicated by the smaller death to diagnosis ratio of 0.5 (176 deaths:
359 diagnoses).
Overall, the Ontario uranium miners were exposed to relatively lower
levels of radon decay products than other uranium miner cohorts. The
distribution is positively skewed with very few miners with a cumulative dose
above 100 WLM. The average cumulative exposure to radon decay products
was 18.2 WLM (SD 38.1). Table 10 shows the average cumulative dose for
different age groups at first employment by periods of first employment. Age at
first employment was not a major factor in accrued doses; however, period of
employment was a major contributor to accrued higher doses. For those who
began mining before 1958, the average level of exposure was between 36.5
and 47.14 WLM. While the level of cumulative radon exposure decreased
between 1958 and 1967 it still remained relative high at between 19.47 and
24.35 WLM. With the introduction of stricter ventilation regulations, the average
cumulative radon dose decreased to below 5 WLM for those miners who began
mining in 1978 or later. Similarly, Table 11 shows the relationship between
cumulative dose across age at first employment and duration of employment.
As expected, cumulative dose increases with increasing duration.
149
Table 12 examines the average cumulative exposure to radon decay
products taking into account year of first employment and duration of
employment. For a given duration of employment, level of exposure was
dependent on the year the miner was first employed. For example, those miners
who worked for 2 to 3 years before 1958 had an average cumulative dose of
19.95 WLM. Those miners who worked for the same duration, but started in 1978
or later, have an average cumulative exposure of only 1.19 WLM.
Cancer Incidence and Mortality
Tables 13 to 19 present the main findings of the study. Adjusted risk
estimates for cancer incidence and mortality are shown in Table 13. For cancer
incidence, significant increases in risks were observed for stomach and
colorectal cancers when comparing the highest exposed group to the referent
group. Similar trends were observed for cancer mortality. Men with more than
40 WLM of cumulative exposure were 2.3 times (95% CI; 1.02-5.17) more likely to
be diagnosed with stomach cancer. Similarly, the risk of dying from stomach
cancer was also elevated with higher levels of exposure (RR=2.90, 95% CI; 1.11-
7.63). Although the risk for diagnosis or death from colorectal cancer was lower
than for stomach cancer, it was statistically elevated. Those with more than 40
WLM of cumulative exposure were 1.56 (95% CI; 1.078-2.27) and 1.74 (95% CI;
1.01-2.99) times more likely to be diagnosed with or die from colorectal cancer.
There were very few cases of esophageal cancer available for analysis, and no
significant associations were observed.
150
Duration of Employment and Inverse Dose Rate
The inverse dose rate effect was observed in this study for both cancer
incidence and mortality (Tables 14 and 15 respectively). For the same
cumulative dose, higher risk estimates were observed for those with more than 3
years of employment compared to those with less than 3 years of employment.
This effect was most evident for combined gastrointestinal and lung cancer
incidence and mortality where the larger number of cases provided more
uniform risk estimation. For example, for diagnosis (incidence) of combined GI
cancers, for those with cumulative dose of more than 40 WLM, the effect
increased significantly from 0.84 (95% CI; 0.36-2.00) to 2.12 (95% CI; 1.26-3.54).
Years Since Last Exposure
The added years of follow-up allow for evaluation of the modifying effects
of years since last exposure. This was assessed by comparing the risks for those
with at most 26 years since last employment to those with more than 26 years.
Results for incidence and mortality are presented in Tables 16 and 17
respectively. Although no modifying effects were evident for esophageal and
stomach cancers, the inverse effect was observed for colorectal cancer,
combined GI cancers, and lung cancer.
151
Age at First Exposure
Results from this analysis showed little evidence of a modifying effect for
risks associated with age at exposure. For example, for stomach cancer
incidence (Table 18 and 19), those who started employment at 28 years of age
or older are at almost the same risk (RR=2.43, 95% CI; 1.03-5.70) as compared to
those who began mining at a younger age (RR=2.33, 95% CI; 0.17-31.0).
152
Discussion
Strengths and Limitations
This study was based on a large cohort of 28,273 uranium miners that were
followed from 1954 until 2004. Given the large cohort combined with a long
follow-up period, this study is able to investigate cancer risks associated with
exposure to radon decay products, addressing an important knowledge gap in
the literature. Of particular interest are cancers of the esophagus, stomach, and
colon-rectum since these organs come into direct contact with alpha energy
emitted from ingested radon decay products. In addition to assessing cancer
risks for mortality associated with exposure to cumulative radon levels, this study
was able to assess cancer risks associated with diagnosis (incidence), thus
addressing another important knowledge gap in the literature for radon
exposure. Furthermore, while the modifying effects of duration (dose-rate), years
since last employment, and age at first exposure have been documented in the
literature for lung cancer mortality, there is currently no literature on the effects
of these modifiers other cancer sites.
Despite these strengths, there are also some important limitations to
consider when interpreting this study’s results, in particular, the potential biases
associated with loss to follow-up (or misclassification of disease status) of a large
proportion of miners. Given that national outcome data were not available for
153
this analysis, the cancer and vital status of miners included in this study were
determined by record linkage to provincial cancer registry and vital status
databases. As such, cancer and vital status of miners who have left Ontario
could not be determined. As discussed in Chapter 3, the impact of the loss to
follow-up is likely to be overestimation of relative risk. However, the degree of
overestimation could not be determined with any certainty without making
assumptions (e.g., constant error rate in cancer registration over time) that may
or may not be valid.
Calculations of radon exposure were previously conducted by mine
operators, engineers, and various regulatory bodies. As indicated in Chapter 2,
the concentration of radon daughters is measured in units of working level (WL)
which is a measure of the potential alpha particles energy per litre of air. This
represents an additional source of uncertainty in the exposure assessment in this
study since radon doses from ingestion was assumed to be proportional to
radon concentration in the air. Although the validity of this assumption needs to
be demonstrated among uranium miners, ad hoc biomonitoring of some mine
workers confirms that significant uranium significant amount of uranium had
been ingested and was ingested and excreted through the urine. While it is
conceivable that not all radon activity in air will be ingested, there is no
evidence to suggest that the amount consumed, albeit less than the
concentration found in the air, is not correlated with concentration in the air.
154
Interpretations of Study Findings
Results of this study’s analyses show significant increases in incidence and
mortality associated with cumulative exposure to radon decay products for
cancers of the stomach, colorectal, and combined GI cancers. Excess risks
remained after adjustment for age and period effects. Despite extending the
period of follow up by 23 years compared to the Muller study [18], there was
limited power to characterize the risk for esophageal cancer. Comparing the
current study’s results with those of other studies is also limited to results of
mortality analyses given that cancer risks for diagnosis (incidence) has not been
addressed in other studies to date.
I) Esophageal Cancer
Very few studies to date have examined the relationship between
exposure to radon decay products and risk of esophageal cancer. This can
likely be attributed in part to esophageal cancer being a very rare type of
cancer. In Ontario, the age-standardized incidence rate for esophageal cancer
is only 6 per 10^5 [29] compared to other cancers such as colorectal which has
an ASIR of 35 per 10^5 [29]. In order to examine the radiation effects of
esophageal cancer, one would need a larger cohort with longer follow-up
periods to have sufficient power to determine associated cancer risks.
Of those who have examined the effects of radon exposure and
esophageal cancer, the results have been inconsistent. Laurier and colleagues
observed a non-significant reduction in risk of esophageal cancer (SMR=0.70,
155
95%CI 0.40-1.40) among a cohort of 1,785 French uranium miners [12]. Tomasek
and colleagues found an increase in esophageal cancer among 4,320 West
Bohemia uranium miners (SMR=1.22, 95% CI 0.49-2.51) [30]. Darby and
colleagues [13] pooled and analyzed data from 11 cohorts and found an
increased cancer risk based on 45 deaths, but the risk estimate was not
statistically significant (SMR=1.04, 95% CI 0.77-1.41). More recently, a non-
significant increase was observed from the German cohort (SMR=1.10, 95% CI:
0.92-1.31) [31]. Results from the current study also show non-significant increases
in esophageal cancer risks (RR=1.51, 95%CI: 0.42-5.48) when comparing those
with cumulative exposure of more the 40 WLM to the referent group (0 WLM).
Though the magnitude is larger than that of other studies, the confidence
interval overlaps all studies published to date.
The current study results do not provide evidence of an association
between cumulative doses of radon decay products and risk of diagnosis or
death of oesophageal cancer. Although the lack of the association is in part
due to low statistical power, biological based rationale would also indicate that
this association would be unlikely. According to the ICRP GI Tract model, any
ingested radon and its decay products would not affect the oesophagus since
ingested material spend very little time at the oesophagus, not enough to
experience any significant doses from radon decay products where the half life
is 51 minutes. Other risk factors such as alcohol consumption [32], tobacco
156
smoke [32], and diet [32] are likely to play a more important role in the aetiology
of oesophageal cancer than ionizing radiation from radon decay products.
II) Stomach Cancer
The current study results show significant excess stomach cancer risk for
both incidence and mortality when comparing those with cumulative exposure
to radon decay products with more than 40 WLM relative to the referent group.
These findings are consistent with those of larger studies conducted to date.
Smaller studies have shown non-statistically significant excess risks[10-12].
Among larger studies, significant excess in stomach cancer mortality has
been observed in Sweden and Germany. For example, results from the Swedish
miners showed a 45% increase in stomach cancer mortality (95% CI: 1.04-1.98)
[33]. The joint analysis of 11 cohorts showed a 33% increase in stomach cancer
mortality risk (95% CI 1.16-1.52) [13]. Results for the recently published German
study also show significant excesses in stomach cancer mortality among their
miners (SMR=1.15, 95% CI: 1.05-1.25).
All studies to date are in agreement in terms of the direction of the risks
associated with exposure to radon decay products (i.e., increased risk).
However, the magnitude of the risks appears to vary from cohort to cohort.
Differences in the magnitude of the risks may be due to the analytical strategies
applied. In previous studies, risk estimates for stomach cancer were derived by
comparing the observed versus the expected number of cases (i.e., indirect
standardization) without considering dose. In this study, internal analysis was
157
used to determine the risk of stomach cancer for different cumulative doses
relative to the referent category (lowest dose group). As the difference in the
cumulative dose of radon decay products increases, the magnitude of the risk
estimates also increase.
Another factor that could also explain differences observed in the
magnitude of the risks include lagging of exposure and adjustment of potential
confounders. In some studies, no lagging of exposures immediately prior to
diagnosis were applied. The rationale being that doses incurred just prior to
diagnosis are not likely to be responsible for disease initiation. Including irrelevant
doses can ‘dilute’ the risk estimate. Differences in adjustment of confounders
can also potentially affect the size of the risk estimates. Miners are exposed to a
whole host of other agents including diesel fumes, aluminum powder, chromium
and other chemicals that could not be taken into consideration in these risk
estimates. Some of the Ontario uranium miners had a history of mining gold, and
exposure to arsenic in the gold mining process has been shown to increase
stomach mortality [34]. Sensitivity analysis was conducted to exclude miners
who had a history of gold mining. Results are presented in Appendixes VI.
Although not statistically significant, stomach cancer risks remain elevated.
Biologically, the stomach is expected to incur the highest dose from
ingested radon decay products. Based on the linear dose response relationship,
the stomach would expect to have the largest impact of all internal organs
lining the digestive tract. The current study supports this biological explanation
158
where risk estimates for stomach cancer is much larger in magnitude as
compared to colorectal cancer (Chapter 4, Table 13). However, no clear dose-
response relationship was observed suggesting the increased risk was not solely
due to radon decay products.
The lack of a clear dose-response relationship suggests that other factors
that are correlated with radon exposure may also play an important role in the
aetiology of stomach cancer. Of particular interest are gamma radiation
emitted from uranium ore bodies can potentially contribute to stomach cancer
risks. Lifespan studies from atomic bomb survivors supports a linear increase in
stomach cancer risk with increasing external dose [35]. However, Cardis and
colleagues found no statistically significant trend in stomach cancer risk with
external dose nuclear workers [36].
Stomach cancer has also been shown to be associated with exposure to
arsenic in gold mining [37]. The Mining Master File contains flags to indicate
exposure to gold mining. Using these flag, sensitivity analysis was conducted to
exclude all gold miners. Although not the risk estimate remained elevated after
excluding known gold miners, the risk estimate was not statistically significant
due to low statistical power. The precision could not be improved since the MMF
was terminated in 1986 although gold mining is still being conducted in Ontario
[38].
159
III) Colorectal Cancers
Comparing this study’s findings for colorectal cancer with other studies is
difficult due to inconsistencies in grouping of this cancer. For example, Tomasek
et al and Darby et al combined ICD-9: 152 (small intestine) with ICD-9: 153
(colon) together while analyzing rectum, rectosigmoid junction, and anus (ICD-
9: 154) as a separate site [11, 33]. Differences in classification may also explain
some of the heterogeneity in risk estimates. In the current study, significant
increases were observed for risks of diagnosis (incidence) and mortality due to
colorectal cancer.
Like stomach cancer, significant increases in colorectal cancer diagnosis
and deaths were associated with cumulative doses of radon decay products.
However, unlike stomach, the expected dose to the colon and rectum would
be much smaller since it is located further down the digestive tract (Chapter 1,
Table 6). Therefore, the increases in risk observed are likely to be one of a
number of reasons. Because of the large number of colorectal cancer cases,
there was sufficient statistical power to detect a smaller effect size at lower
doses. When comparing risk estimates and corresponding confidence intervals
for stomach and colorectal cancer, the risk estimates for colorectal cancer is
much smaller with greater precision (Chapter 4, Table 13). Secondly, according
to the ICRP GI Tract Model, radon decay products would spend significantly
longer period of time in the colon (~36 hours) compared to the stomach (~1
hour). Although the dose endured by the colon would be much smaller than the
160
stomach, the inverse dose rate due to the longer duration would translate into a
larger impact. Finally, the increased risk might be attributed to other factors such
as exposure to gamma radiation. Since gamma radiation can penetrate to
deep inner tissues, internal organs such as the colon would just as susceptible to
exposure to gamma radiation as organs at the surface.
IV) Lung Cancer
Although not the primary focus of this study, lung cancer risks associated
with exposure to radon decay products were computed for comparison with
other studies and serves as an indirect approach of validating current study
methods. Results from the current analysis are similar to those of other studies. Of
the different cohorts, the one that is most comparable to the Ontario uranium
miners cohort in terms of Working Level (WL) is the Radium Hill Cohort from
Australia, with the average WL being 0.9 and 0.7 respectively [26]. It is
important to note that both studies had significant loss to follow-up. In the
Australian study, information for 36% of cohort members could not be traced [7].
The results of these two studies are shown in Table 5. Both studies had similar cut-
points for categories of cumulative exposure to radon decay products and the
risk estimates appear to be in agreement with each other. As expected, the
highest risk estimates were found when comparing the cumulative dose of the
highest exposed group to the referent group. In the current study, a 4-fold
increase in lung cancer mortality was observed (RR=4.22, 95% CI; 3.19-5.61) while
161
the Australian study observed a 5-fold increase in risk (RR=5.2, 95% CI: 1.8-15.1).
The confidence intervals of these two studies overlap.
162
Table 28: Comparison of risk estimates obtained from the current study based on
data from the Ontario Uranium Miners and the Australian study based on data
from the Radium Hill cohort.
Source
Cumulative Radon
Decay Products
(WLM)
Crude Risk
Estimate
Current Study
0
> 0 – 20
>20 – 40
> 40
-
1.89 (1.44-2.47)
2.47 (1.74-3.39)
4.22 (3.19-5.61)
Woodward et al. [7] 0
0 < 10
11 - 40
>40
-
0.9 (0.5- 1.8)
2.2 (1.0- 4.7)
5.2 (1.8-15.1)
Note: Adjusted risk estimates (and lag information) was not available for the
Australian study.
V) Record Linkage
In this study, diagnosis of and death from GI cancer as well as death from
all causes were identified by linking personal identifying information to Ontario
outcome databases. Linkage of the miner cohort with Ontario cancer
incidence and mortality files produced fewer links than expected. This
prompted further investigation of potential bias in order to assess whether these
miss-links would affect study results. In Chapter 3, risk estimates were made
based on the Current Study and that of the Complete Linkage (Current Study
supplemented with results from the national linkage). The results showed that
163
missing deaths did not occur at random with more missing deaths occurring in
the lower exposed groups. However, the impact was modest with the
confidence intervals largely overlapped the two risk estimates.
Additional analyses were also conducted (not shown here) and miners who
were greater than 85 years of age (< 5%) and greater than 100 years of age (<
1%) at the end of follow up were systematically excluded. These were assumed
to be loss to follow-up given that these ages are well above the life expectancy
of the time. Excluding these individuals based on age at end of follow-up did
not affect study results. In order to adequately mitigate the problem of loss-to
follow-up (or misclassification of disease status), record linkage would need to
be conducted using national level incidence and mortality data files.
As shown in Table 7 of the results section, there were 31 cancer deaths
occurring in Ontario according to the Muller linkage but not in the Current
Study. The reasons for this are not clear and are likely due to a number of
factors. As indicated in Chapter 3, there were a number of cases that were
missed. Some of the missed cases died while living in Ontario while others died
outside of Ontario. Within Ontario, missed cases were likely a result of a number
of factors. Brenner and colleagues [39] described errors in record linkage as
being one of two types: homonym and synonym errors. Homonym errors occur
when two records from two different people are very similar and thus
erroneously assumed to be for the same person. In this study, homonym errors
are likely to be minimal given that multiple identifiers (e.g., first and last names,
164
phonetic encoding, date of birth, etc) were used. Increasing the number of
unique identifiers reduces the amount of homonym errors due to increasing the
discriminating power of the links. Synonym errors refer to errors in reporting or
coding of personal identifiers or changes in these data [39]. In this study, only
male miners were used in the analysis, therefore, surname changes due to
marriage are unlikely. Errors in coding are possible but these errors are unlikely to
be related to exposure and therefore would not bias study results.
VI) Lagging and Latency
Although it is well known that solid tumours have long latent periods
between disease initiation and detection, the exact period is not known and
largely dependent on the agent and individual characteristics. The
methodological implication is that including irrelevant exposures in the analyses
can dilute the risk estimate. A common approach taken in epidemiological
investigations are ‘trial and error’ approach by lagging the exposure in order to
discount the exposures that are thought not to relate to the etiology of the
disease [40, 41]. Rothman has argued that the lag duration resulting in the
highest risk estimate should be used since it is mostly likely to have the least
amount of non-differential misclassification [40].
Although some studies in the past have used a 5-year lag [10], such a
short latency is probably more relevant for blood cancers where the period
between initial exposure and induction is relatively short. Since solid tumours
generally require many more years between disease initiation and detection, it
165
is likely that lags of more than 5-years would be more relevant for solid tumours.
Lag-years have not been consistently applied in studies conducted to date.
Most did not apply lag years while others lagged the exposure for 5-years. This
inconsistency makes it difficult to compare the current study results with previous
studies. In radiation epidemiology, the BEIR VII used a 5 year lag [42] while the
Industrial Disease Panel in Ontario used a 10 year lag in assigning exposure [43].
In this study, the main results were presented using a 10 year lag of the
exposure. This choice was based in part on examination of the magnitude of risk
estimates based on different lagging intervals (0, 10, 15, and 20 years)
summarized in Table 6. The grey shaded and bolded cells indicated the highest
risk estimates for the different cancer sites. With the exception of esophageal
cancer, where very few cases were available for analysis, the highest risk
appears to be between 10 and 15 years. For all combined GI cancers
(esophagus, stomach, colorectal cancers), the highest was based on the 10
year lag. Therefore, all risk estimates were presented in this chapter were based
on a 10 year lag.
Table 29: Magnitude of the relative risk by lag years by cancer sites
Lag years
Cancer Site 0 5 10 15 20
Esophageal Cancer * 1.08 1.13 1.51 1.82 1.91 Stomach 2.41 2.54 2.90 1.80 1.62
Colorectal 1.19 1.70 1.74 1.78 1.64
Gastrointestinal 1.33 1.77 1.95 1.80 1.66
166
Lung 2.24 3.53 4.22 4.28 3.20 Notes: * Based on very few numbers of cases; Relative Risks obtained from Appendix V; Highest
risk estimate bolded and shaded in grey boxes.
VII) Risk Modeling
Although most studies published in this area use external comparison
based on indirect standardized methods (SMR) [44], this technique was not used
in the main analysis of this study. Instead the analytical strategy to estimate
cancer risks associated with exposure to radon decay products is based on the
internal comparison method, namely, the Poisson regression technique. This
approach was adopted to minimize the potential biases caused by loss to
follow-up due to out-migration of cohort members which would produce an
artifact of significantly reduced risk (See Chapter 3 on loss to follow-up).
Choice of Model
In this study, statistical models were constructed to examine the effects of radon
decay products on GI cancer risks. Two modelling approaches that could have
been used to assess cancer risk: 1) external comparison (e.g., SMR), and 2)
internal comparison (e.g., Poisson regression). Traditionally, external comparison
is used in radiation epidemiology, in part because this approach requires little
computational power to derive risk estimates. Using the external comparison
approach however has its limitations. Comparison of SMRs between studies must
be done with care since each area's population profile weights the age specific
rates are different for different populations. In addition, for some health
167
conditions such as diabetes and cardiovascular diseases, the SMRs would be
prone to the healthy worker effect. When assessing cancer risks however, the
internal (within cohort) comparison is arguably a more appropriate statistical
model given that potential biases caused by the healthy worker effects are
unlikely since comparisons are made within the cohort population and not to
the general population. Furthermore, biases caused by potential confounders
(measured or otherwise) are less likely when using the internal (within cohort)
compared to the external comparison since male miners within the cohort are
expected to be more similar to each other than to males of the general
population.
Despite the many advantages of the internal comparison approach, it
too has limitations. Internal comparisons such as the Poisson regression are more
complex and require an understanding of how variables may influence or
modify cancer risk.
Confounding:
A confounding factor is correlated with both the disease under study and
the exposure of primary interest. It is a form of bias that needs to be accounted
for in the risk estimate. In this study, age at risk and period of effect are both
considered confounders and therefore are adjusted in all analyses. As with the
BEIR analyses of lung cancer risks [45], age is considered to be a confounder
since it is associated with lung mortality. Since the main exposure of interest in
the Current Study is the cumulative exposure of radon decay products, age of
168
the miner also has a strong association with a total exposure since younger
workers are likely to work longer therefore accumulating more radiation
exposure [46].
Period (year of exposure) is also a strong confounder in the Current Study
since it is related to both the exposure and cancers of interest. In the early years
of mining (prior to 1968) poor ventilation practices resulted in high exposure to
radon decay products for miners. Regulatory changes implemented in later
years, however, dramatically reduced radon exposures for workers. As discussed
in Chapter 1, GI cancer trends have changed over time. For example, the
mortality rates for stomach cancer (Figure 2, Chapter 1) have decreased from
approximately 21 (per 100,000 populations) in 1964 to 6 (per 100,000
populations) in 2004.
Furthermore, period is also a proxy measure for many other factors such as
level of measurement errors. For example, before 1958 radon measurements
were not conducted in uranium mines, but rather estimates of exposure were
based on mine architecture and work conditions as determined by mine
engineers and other experts. Adjusting for period would take these errors into
consideration.
Other factors can also affect cancer risk. For example, a review of the literature
as discussed in Chapter 1 reveals that smoking, alcohol consumption, diet and
physical activity are known risk factors for GI cancers. Although the current study
does not have the data required to consider these factors, there is no evidence
169
to suggest that such factors would be strongly correlated with radiation dose,
although weak associations might arise by chance. Internal comparison
approach would have taken some of these variations into account.
Effect Modification:
Analysis of lung cancer mortality among uranium miners has shown that
the level of radon induced risk is dependent not only on the magnitude of the
radiation dose but that the association can be modified by duration of
employment [5, 25, 47], years since last employment [5, 25, 47], and in some
instances, age at first employment [5]. Since the same carcinogenic agents
(alpha particles emitted from radon decay products) are being assessed for GI
cancer as for lung cancer, modifying effects by these three factors were also
assessed in this study.
In this study, effect modification was determined through stratification.
Separate risk estimates were derived for each strata of the presumed modifier.
Results from this study are suggestive that effect modification did occur for
duration of employment and years since last exposure. For example, the risk for
diagnosis of colorectal cancer were much higher among those with a
cumulative dose of 20-40 WLM distributed 3 or more years of employment
(RR=1.92, 95% CI 1.058-3.52) than those who experienced the same dose over a
shorter duration (RR=0.89, 95%CI 0.47-1.70). This inverse dose rate was also
observed in the literature for lung cancer mortality [5, 25, 47].
170
Presentation of stratum-specific risk estimates provides an intuitive
assessment of effect modification; however, there are limitations to the
stratification approach. Using this approach is hampered by the relatively small
numbers of cancer cases observed for certain GI cancer sites. The lack of
statistical power prevents some modifying effects from being discerned.
Secondly, stratified approach does not provide a test of statistical significance
of the different risk estimates across strata. To address this issue, an interaction
term was created for duration of employment and cumulative radon dose in a
Poisson regression model. The results (Appendix VIII) confirm the stratified
regression approach showing a significant negative inverse relationship
between dose and duration of exposure for colorectal cancer.
171
VIII) Poisson Regression: Grouped vs. Ungrouped Data
Poisson regression is routinely used for analysis of epidemiological data
from studies of large occupational cohorts [44]. It is traditionally implemented as
a grouped method of data analysis in which all exposure and covariate
information is categorized and person-time and events are tabulated for the
entire follow-up period. Grouped data can facilitate examination of trends
according to ordered categories of age, calendar time, and exposure level,
and increases the probability of models converging. From a practical
perspective, ungrouped data can be extremely intensive computationally for
large cohorts such as the Ontario Uranium Miners, even with today’s
computational capabilities. One major drawback of group data as noted by
Loomis and colleagues [48] is that for the purpose of estimating quantitative
exposure-response relations, information is lost in the categorization of exposure
data. Given that most studies to date used grouped data with established cut-
points, the current study also used the grouped data approach to facilitate
comparison.
As a sensitivity analysis, ungrouped data was also conducted for
colorectal and lung cancer. Results for ungrouped data shown in Appendix VIII
confirm grouped data used in the current study. Beta coefficient shows a
significant increase in cancer risks for colorectal and lung cancer with increase
in cumulative dose.
172
Conclusions
The current study expanded the original study to include workers who
began employment since the last update in 1981 and extended the period of
follow-up to the end of 2004. Analysis of the data showed statistically significant
increases in diagnosis (incidence) and mortality of stomach and colorectal
cancers.
173
Chapter 4 References
1. Howe, G.R., Lung cancer mortality between 1950 and 1987 after exposure to
fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy
cohort study and a comparison with lung cancer mortality in the Atomic Bomb
survivors study. Radiat Res, 1995. 142(3): p. 295-304.
2. Howe, G.R., et al., Lung cancer mortality (1950-80) in relation to radon daughter
exposure in a cohort of workers at the Eldorado Beaverlodge uranium mine. J
Natl Cancer Inst, 1986. 77(2): p. 357-62.
3. Howe, G.R., et al., Lung cancer mortality (1950-80) in relation to radon daughter
exposure in a cohort of workers at the Eldorado Port Radium uranium mine:
possible modification of risk by exposure rate. J Natl Cancer Inst, 1987. 79(6): p.
1255-60.
4. Howe, G.R. and R.H. Stager, Risk of lung cancer mortality after exposure to
radon decay products in the Beaverlodge cohort based on revised exposure
estimates. Radiat Res, 1996. 146(1): p. 37-42.
5. Lubin, J.H., et al., Lung cancer in radon-exposed miners and estimation of risk
from indoor exposure. J Natl Cancer Inst, 1995. 87(11): p. 817-27.
6. Tomasek, L., et al., Lung cancer in French and Czech uranium miners: Radon-
associated risk at low exposure rates and modifying effects of time since
exposure and age at exposure. Radiat Res, 2008. 169(2): p. 125-37.
7. Woodward, A., et al., Radon daughter exposures at the Radium Hill uranium
mine and lung cancer rates among former workers, 1952-87. Cancer Causes
Control, 1991. 2(4): p. 213-20.
8. Kendall, G.M. and T.J. Smith, Doses to organs and tissues from radon and its
decay products. J Radiol Prot, 2002. 22(4): p. 389-406.
9. Morrison, H.I., et al., Cancer mortality among a group of fluorspar miners
exposed to radon progeny. Am J Epidemiol, 1988. 128(6): p. 1266-75.
174
10. Villeneuve, P.J., H.I. Morrison, and R. Lane, Radon and lung cancer risk: an
extension of the mortality follow-up of the Newfoundland fluorspar cohort. Health
Phys, 2007. 92(2): p. 157-69.
11. Tomasek, L., et al., Radon exposure and cancers other than lung cancer among
uranium miners in West Bohemia. Lancet, 1993. 341(8850): p. 919-23.
12. Laurier, D., et al., An update of cancer mortality among the French cohort of
uranium miners: extended follow-up and new source of data for causes of death.
Eur J Epidemiol, 2004. 19(2): p. 139-46.
13. Darby, S.C., et al., Radon and cancers other than lung cancer in underground
miners: a collaborative analysis of 11 studies. J Natl Cancer Inst, 1995. 87(5): p.
378-84.
14. Card, T.R., et al., Is an internal comparison better than using national data when
estimating mortality in longitudinal studies? J Epidemiol Community Health,
2006. 60(9): p. 819-21.
15. Brenner, D.J., T.K. Hei, and O. Niwa, Low-dose risk assessment: We still have
much to learn. Radiat Res, 2007. 167(6): p. 744-745.
16. Tubiana, M., et al., Low-dose risk assessment. Radiat Res, 2007. 167(6): p. 742-
4; author reply 744.
17. Muller, e.a., Study of Mortality of Ontario Uranium Miners 1955-1977. 1983,
Ontario Ministry of Labour, Ontario Worker's Compensation Board, Atomic
Energy Control Board of Canada: Toronto.
18. Muller, J., R.A. Kusiak, and A.C. Ritchie, Factors Modifying Lung Cancer Risk in
Ontario Uranium Miners, 1955-1981. 1989, Ontario Ministry of Labour, Workers'
Compensation Board of Ontario, Atomic Energy Control Board of Canada:
Toronto.
19. Ham, J.M., Report of the Royal Commision on the Health and Safety of Workers
in Mines. 1974, Government of Ontario: Toronto, Canada.
175
20. Industrial Disease Standard's Panel, Report to the Workers Compensation Board
on the Ontario Gold Mining Industry. 1987: Toronto, Ontario. p. (Section 2:
Validity of the Mining Master File).
21. National Dose Registry. National Dosimetry Service. Access date: Jan 2005.
http://www.hc-sc.gc.ca/hecs-sesc/nds/photo_uranium-mines.htm [cited 2005
January 2005]; Available from: http://www.hc-sc.gc.ca/hecs-
sesc/nds/photo_uranium-mines.htm.
22. Black, R.J., L. Simonato, and H. Storm, Automated Data Collection in Cancer
Registration. IARC Technical Publication No. 32. 1998, International Agency for
Research on Cancer: Lyon.
23. Frome, E.L. and H. Checkoway, Epidemiologic programs for computers and
calculators. Use of Poisson regression models in estimating incidence rates and
ratios. Am J Epidemiol, 1985. 121(2): p. 309-23.
24. Pearce, N. and H. Checkoway, A simple computer program for generating
person-time data in cohort studies involving time-related factors. Am J Epidemiol,
1987. 125(6): p. 1085-91.
25. Hornung, R.W., J.A. Deddens, and R.J. Roscoe, Modifiers of lung cancer risk in
uranium miners from the Colorado Plateau. Health Phys, 1998. 74(1): p. 12-21.
26. BEIR VI, Health Effects of Exposure to Radon. 1999, National Research Council
(USA).
27. Kusiak, R.A., et al., Mortality from lung cancer in Ontario uranium miners. Br J
Ind Med, 1993. 50(10): p. 920-8.
28. Villeneuve, P.J. and H.I. Morrison, Radon progeny exposure and lung cancer: a
mortality study of Newfoundland Fluorspar miners 1950-2001. 2005, Epistream
Consulting: Ottawa, Ontario.
29. Canadian Cancer Society/National Cancer Institute of Canada:, Canadian
Cancer Statistics 2008. 2008: Toronto, Canada, 2008.
176
30. Tomasek, L., et al., Patterns of lung cancer mortality among uranium miners in
West Bohemia with varying rates of exposure to radon and its progeny. Radiat
Res, 1994. 137(2): p. 251-61.
31. Kreuzer, M., et al., Radon and risk of extrapulmonary cancers: results of the
German uranium miners' cohort study, 1960-2003. Br J Cancer, 2008. 99(11): p.
1946-53.
32. World Cancer Research Fund and American Institute for Cancer Research,
Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global
Perspective. 2007: Washington DC: AICR.
33. Darby, S.C., E.P. Radford, and E. Whitley, Radon exposure and cancers other
than lung cancer in Swedish iron miners. Environ Health Perspect, 1995. 103
Suppl 2: p. 45-7.
34. Kusiak, R.A., et al., Mortality from stomach cancer in Ontario miners. Br J Ind
Med, 1993. 50(2): p. 117-26.
35. United Nations Scientific Committee on the Effects of Atomic Radiation,
Biological effects at low radiation doses, Annex I. 2000. p. 312-346.
36. Cardis, E., et al., Effects of low doses and low dose rates of external ionizing
radiation: cancer mortality among nuclear industry workers in three countries.
Radiat Res, 1995. 142(2): p. 117-32.
37. Kusiak, R.A., et al., Carcinoma of the lung in Ontario gold miners: possible
aetiological factors. Br J Ind Med, 1991. 48(12): p. 808-17.
38. Goldcorp Inc. Musselwhite Gold Mine, Ontario, Canada. 2009 [cited 2009 May
2009]; Available from: http://www.mining-technology.com/projects/musselwhite/.
39. Brenner, H., I. Schmidtmann, and C. Stegmaier, Effects of record linkage errors
on registry-based follow-up studies. Stat Med, 1997. 16(23): p. 2633-43.
40. Rothman, K.J., Induction and latent periods. Am J Epidemiol, 1981. 114(2): p.
253-9.
177
41. Salvan, A., et al., Selecting an exposure lag period. Epidemiology, 1995. 6(4): p.
387-90.
42. BEIR VII, Health Risks From Exposure to Low Levels of Ionizing Radiation
(Phase 2). 2005, National Research Council (USA).
43. Industrial Disease Standard's Panel, Report to the Workers Compensation Board
on the Ontario Uranium Mining Industry (Report # 6). 1989: Toronto, Ontario.
44. Callas, P.W., H. Pastides, and D.W. Hosmer, Survey of methods and statistical
models used in the analysis of occupational cohort studies. Occup Environ Med,
1994. 51(10): p. 649-55.
45. BEIR VI, Health Effects of Exposure to Radon. 1999, National Research Council
(USA). p. 20-24.
46. Consonni, D., P.A. Bertazzi, and C. Zocchetti, Why and how to control for age in
occupational epidemiology. Occup Environ Med, 1997. 54(11): p. 772-6.
47. Lubin, J.H., et al., Radon-exposed underground miners and inverse dose-rate
(protraction enhancement) effects. Health Phys, 1995. 69(4): p. 494-500.
48. Loomis, D., D.B. Richardson, and L. Elliott, Poisson regression analysis of
ungrouped data. Occup Environ Med, 2005. 62(5): p. 325-9.
178
Chapter 4 Tables and Figures
Table 30: Characteristics of the Ontario Uranium Miners study cohort.
Characteristics of cohort Characteristics
Cohort size 28,273
Follow-up period 1954-2004
Person-years of follow-up (incidence) 961,210
Person-years of follow-up (mortality) 974,687
Year of Birth (n (%))
<1900
1900 - 1919
1920 - 1939
1940 - 1959
1960+
Median
Range
28 (0.1)
2,310 (8.2)
13,006 (46.0)
11,288 (39.9)
1,641 (5.8)
1938
1887-1974
Age (years) at First Employment (n (%))
<22
22 - < 27
27 - < 34
34+
Median
Mean (SD)
6,073 (22)
7,691 (27)
7,262 (26)
7,247 (26)
27
28.9 (8.7)
179
Table 31: Incidence and mortality due to gastrointestinal cancer by age and
calendar period for a cohort (n=28,273) of Ontario uranium miners.
Esophageal* (ICD9-150)
Stomach* (ICD9-151)
Colorectal* (ICD9-153, 154, 159.0)
Characteristics Incidence
(n) Mortality (n)
Incidence (n)
Mortality (n)
Incidence (n)
Mortality (n)
Age at diagnosis/death
< 30 30 - < 40 40 - < 50 50 - < 60 60 - < 70 70- < 80 80+
Mean (SD) Year of diagnosis/death
1955-1959 1960-1969 1970-1979 1980-1989 1990-1999 2000-2004
Total
0 0 1 9 17 5 2
64.1 (8.6) ** 0 2 6 13 13 34
0 0 1 7 19 9 4
66.2 (8.6) 0 0 2 9 16 13 40
1 11 15 41 15 3
62.5 (9.9) ** 5 15 27 27 12 86
0 1 7 9 32 18 2
64.0 (9.6) 1 4 14 19 18 13 69
1 7 21 110 135 74 11
61.9 (9.6) ** 11 33 84 146 85 359
1 1 14 26 68 55 11
65.4 (10.6) 0 6 15 39 65 51 176
Note: * - First primary; **- Data from the Ontario Cancer Registry not available; SD- Standard
Deviation; ICD9-International Classification of Diseases, 9th Revision.
180
Table 32: Employment characteristics of the Ontario Uranium Miners study cohort
(as of December 31st, 2004)
Employment Characteristics Measures
Year at First Employment (n (%)) < 1958 1958-1967 1968-1978 1978+
5,953 (21.0) 8,451 (29.9) 6,039 (21.3) 7,829 (27.7)
Duration of Employment (n (%)) <2.0 yrs 2.0 - 3.0 yrs > 3.0 -< 7.0 yrs 7+ yrs Median Mean (SD)
Range
5,908 (20.9) 10,299 (36.4) 4,978 (17.61) 7,088 (25.1)
3.00 5.19 (5.8) 0.5 -22.5
Cumulative Radon (WLM) Exposure (n (%)) 0 >0 - 20 > 20 – 40 < 40 Mean (SD) Range
2,446 (8.7)
19,591 (69.3) 2,829 (10.0) 3,407 (12.0) 18.2 (38.1)
0-1169
181
Table 33: Average cumulative exposure to radon decay products (WLM) of Ontario Uranium Miners by age and
year at first employment, 1954-2004
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
< 22 868 36.50 1444 19.47 1723 5.97 2038 4.13
22 - < 27 1449 39.51 2491 25.12 1700 5.58 2051 3.97
27 -< 34 1750 43.28 2305 24.77 1396 5.44 1811 3.51
34+ 1886 47.14 2211 24.35 1220 4.00 1930 2.60
Total 5953 8451 6039 7830
Year of First EmploymentAge at First Employment
(years)<1958 1958-1967 1968-1977 1978+
182
Table 34: Average cumulative exposure to radon decay products (WLM) of Ontario Uranium Miners by age at
first employment by duration of employment, 1954-2004
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
< 22 1413 1.81 2082 6.61 940 19.03 1638 27.05
22 - < 27 1597 2.19 2904 8.58 1265 27.72 1925 38.43
27 -< 34 1413 2.34 2709 9.59 1351 29.21 1789 43.62
34+ 1485 2.43 2604 9.88 1422 29.90 1736 46.53
Total 5908 10299 4978 7088
Age at First Employment
(years)
Duration of Employment
< 2 years 2 - 3 years > 3 - < 7 years 7+ years
183
Table 35: Average cumulative exposure to radon decay products (WLM) of Ontario Uranium Miners by year at
first employment by duration of employment, 1954-2004
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
n Mean Cum WLM
<1958 809 6.62 2268 19.95 1662 43.66 1214 107.42
1958-1967 1978 3.16 3888 10.15 1284 43.08 1301 77.32
1968-1977 1144 0.73 1919 1.58 955 3.90 2021 12.20
1978+ 1977 0.26 2224 1.19 1077 3.09 2552 8.40
Total 5908 10299 4978 7088
Year at First Employment
Duration of Employment
< 2 years 2 - 3 years > 3 - < 7 years 7+ years
184
Table 36: Age and period adjusted relative risks of diagnoses (1964-2004) and deaths (1954-2004) of
esophageal, stomach, colorectal, gastrointestinal, and lung cancer associated with cumulative exposure to
radon decay products (Working Level Months, 10-year lag) for Ontario Uranium Miners.
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 2 335,778 - 4 337,470 -> 0 - 20 18 454,983 2.59 (0.57-11.8) 20 461,812 1.44 (0.47-4.43)> 20 - 40 9 77,334 6.37 (1.30-31.2) 9 79,272 2.71 (0.79-9.30)
> 40 5 93,115 2.72 (0.50-14.9) 7 96,133 1.51 (0.42-5.48)Total 34 961,210 P trend = 0.59 40 974,687 P trend = 0.74
0 11 335,778 - 7 337,470 -> 0 - 20 43 454,983 1.94 (0.94-3.96) 37 461,812 2.65 (1.11-6.32)> 20 - 40 14 77,334 2.51 (1.08-5.80) 10 79,272 2.74 (0.99-7.63)
> 40 18 93,115 2.30 (1.02-5.17) 15 96,133 2.90 (1.11-7.63)Total 86 961,210 P trend = 0.22 69 974,687 P trend = 0.33
0 57 335,778 - 24 337,470 -> 0 - 20 186 454,983 1.15 (0.84-1.58) 89 461,812 1.19 (0.73-1.93)> 20 - 40 47 77,334 1.42 (0.94-2.12) 21 79,272 1.20 (0.65-2.22)
> 40 69 93,115 1.56 (1.07-2.27) 42 96,133 1.74 (1.01-2.99)Total 359 961,210 P trend = 0.01 176 974,687 P trend = 0.02
0 70 335,778 - 35 337,470 -> 0 - 20 247 454,983 1.33 (0.99-1.77) 146 461,812 1.49 (1.00-2.23)> 20 - 40 70 77,334 1.76 (1.24-2.49) 40 79,272 1.69 (1.05-2.73)
> 40 92 93,115 1.73 (1.23-2.40) 64 96,133 1.95 (1.25-3.04)Total 479 961,210 P trend = 0.01 285 974,687 P trend = 0.02
0 78 335,778 - 73 337,470 -> 0 - 20 386 454,983 2.25 (1.74-2.90) 331 461,812 1.89 (1.44-2.47)> 20 - 40 120 77,334 3.18 (2.36-4.29) 98 79,272 2.47 (1.74-3.39)
> 40 263 93,115 5.16 (3.94-6.75) 230 96,133 4.22 (3.19-5.61)Total 847 961,210 P trend < 0.01 732 974,687 P trend < 0.01
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years.
Incidence (1964-2004) Mortality (1954-2004)
Sto
mac
h
(151
)
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Colo
rect
al
(153
, 154
,
159.
0)
Eso
phag
us
(1
50)
Gas
tro-
inte
stin
al
Lung
(162
)
185
Table 37: Age and period adjusted relative risks of diagnoses (1964-2004) of esophageal, stomach, colorectal,
gastrointestinal, and lung cancer associated with cumulative exposure to radon decay products (Working
Level Months, 10-year lag) stratified by duration of employment for Ontario Uranium Miners, 1954-2004
Cases P Y RR (95% CI)* C ases PY RR (95% CI) *
0 1 203.994 - 1 131.784 -> 0 - 20 16 320.416 4.01 (0 .50-32.2) 2 134.565 1 .07 (0 .8-13.2)
> 20 - 40 4 29.402 10.5 (1 .01-100) 5 47.932 3 .91 (0 .38-39.7)> 40 1 11.203 6.75 (0 .40-114) 4 81.912 1 .55 (0 .14-16.6)T o tal 22 565.015 P tren d = 0 .11 12 396.193 P t ren d = 0.91
0 9 203.994 - 2 131.784 -> 0 - 20 32 320.416 1.48 (0 .66-3 .33) 11 134.565 4 .78 (0 .92-21.7)
> 20 - 40 8 29.402 3.00 (1 .09-8 .24) 6 47.932 3 .16 (0 .54-17.0)> 40 1 11.203 0.83 (0 .10-6 .74) 17 81.912 4 .41 (0 .91-21.1)T o tal 50 565.015 P tren d = 0 .51 36 396.193 P t ren d = 0.32
0 38 203.994 - 19 131.784 -> 0 - 20 123 320.416 0.91 (0 .62-1 .35) 63 134.565 1 .88 (1 .08-3 .27)
> 20 - 40 13 29.402 0.89 (0 .47-1 .70) 34 47.932 1 .92 (1 .05-3 .52)> 40 4 11.203 0.67 (0 .23-1 .91) 65 81.912 1 .89 (1 .08-3 .32)T o tal 178 565.015 P tren d = 0 .49 181 396.193 P t ren d = 0.37
0 48 203.994 - 22 131.784 -> 0 - 20 171 320.416 1.10 (0 .78-1 .55) 76 134.565 2 .10 (1 .27-3 .49)
> 20 - 40 25 29.402 1.45 (0 .87-2 .39) 45 47.932 2 .17 (1 .26-3 .77)> 40 6 11.203 0.84 (0 .36-2 .00) 86 81.912 2 .12 (1 .26-3 .54)T o tal 250 565.015 P tren d = 0 .82 229 396.193 P t ren d = 0.25
0 51 203.994 - 27 131.784 -> 0 - 20 291 320.416 1.91 (1 .39-2 .62) 95 134.565 2 .80 (1 .79-4 .37)
> 20 - 40 33 29.402 1.90 (1 .21-2 .99) 87 47.932 4 .61 (2 .93-7 .23)> 40 11 11.203 1.50 (0 .77-2 .90) 252 81.912 6 .89 (4 .52-10.5)T o tal 386 565.015 P tren d = 0 .62 461 396.193 P t ren d < 0.01
N otes:* - A djusted for a tta ined age and per iod; W LM – W orking Leve l M onth , RR - Re la tive R isk ; CI-C onfidence In te rva l; and, ICD -9-In te rnational C las sifica tion o f D iseases, 9th Revision; G I - G astroin testina l C ancer ( IC D-9: 150, 151, 153 , 154, 159.0); and PY- P erson Years;
Sto
mac
h
(151
)
Gas
tro
-
inte
stin
al> 3 years o f em plo ym ent
Lu
ng
(162
)
Eso
pha
gu
s
(150
)C ancer
Site ( ICD-9)
Cum ulative Radon D ose
(WLM)
< = 3 years of emp lo ym en t C
olo
rect
al
(153
, 154
,
159
.0)
186
Table 38: Age and period adjusted relative risks of deaths (1954-2004) due to esophageal, stomach, colorectal,
gastrointestinal, and lung cancer associated with cumulative exposure to radon decay products (Working
Level Months, 10-year lag) stratified by duration of employment for Ontario Uranium Miners, 1954-2004
Deaths PY RR (95% CI)* Deaths PY RR (95% CI)*
0 2 205,049 - 2 132,421 -> 0 - 20 15 324,903 2.22 (0.48-10.3) 5 136,909 0.77 (0.14-4.39)> 20 - 40 5 30,034 6.50 (1.19-35.7) 4 49,238 0.70 (0.11-4.29)
> 40 1 11,391 3.20 (0.28-36.9) 6 84,742 0.51 (0.09-2.83)Total 23 571,377 P trend = 0.11 17 403,310 P trend = 0.39
0 7 205,049 - 0 132,421 -> 0 - 20 29 324,903 1.76 (0.71-4.33) 8 136,909 Non-est> 20 - 40 6 30,034 2.87 (0.90-9.07) 4 49,238 Non-est
> 40 1 11,391 1.00 (0.11-8.47) 14 84,742 Non-estTotal 43 571,377 P trend = 0.69 26 403,310 P trend = NA
0 19 205,049 - 5 132,421 -> 0 - 20 64 324,903 0.89 (0.51-1.54) 25 136,909 2.77 (1.00-7.66)> 20 - 40 3 30,034 0.36 (0.10-1.23) 18 49,238 2.79 (0.97-8.04)
> 40 1 11,391 0.29 (0.04-2.16) 41 84,742 3.17 (1.16-8.67)Total 87 571,377 P trend = 0.07 89 403,310 P trend = 0.18
0 28 205,049 - 7 132,421 -> 0 - 20 108 324,903 1.21 (0.77-1.90) 38 136,909 3.01 (1.28-7.07)> 20 - 40 14 30,034 1.31 (0.67-2.56) 26 49,238 2.74 (1.12-6.69)
> 40 3 11,391 0.65 (0.20-2.18) 61 84,742 3.19 (1.37-7.44)Total 153 571,377 P trend = 0.59 132 403,310 P trend = 0.16
0 48 205,049 - 25 132,421 -> 0 - 20 258 324,903 1.62 (1.17-2.25) 73 136,909 2.21 (1.37-3.57)> 20 - 40 27 30,034 1.47 (0.90-2.38) 71 49,238 3.61 (2.23-5.85)
> 40 10 11,391 1.30 (0.65-2.59) 220 84,742 5.75 (3.67-8.98)Total 343 571,377 P trend = 0.99 389 403,310 P trend < 0.01
Cancer Site (ICD-9)
Cumulative Radon Dose
(WLM)
< = 3 years of employment > 3 years of employment
Notes:* - Adjusted for attained age and period; 'Non-est.' - risk estimate could not be estimated; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years
Colo
rect
al
(153
, 154
,
159.
0)
Eso
phag
us
(1
50)
Sto
mac
h
(151
)
Gas
tro-
inte
stin
al
Lung
(162
)
187
Table 39: Age and period adjusted relative risks of diagnoses (1964-2004) of esophageal, stomach, colorectal,
gastrointestinal, and lung cancer associated with cumulative exposure to radon decay products (Working
Level Months, 10-year lag) stratified by years since last employment for Ontario Uranium Miners, 1954-2004
Cases PY RR (95% CI)* C ases PY RR (95% CI)*
0 2 168.502 - 0 167.276 -> 0 - 20 5 185.702 1,64 (0,28-10,0) 13 269.281 Non-est
> 20 - 40 3 13.512 6,47 (0,96-43,2) 6 63.822 Non-est> 40 3 21.220 2,34 (0,34-16,2) 2 71.895 Non-estTotal 13 388.936 P tren d = 0.55 21 572.274 P tren d = NA
0 11 168.502 - 0 167.276 -> 0 - 20 28 185.702 3,30 (1,54-7,07) 15 269.281 Non-est
> 20 - 40 8 13.512 4,85 (1,88-12,6) 6 63.822 Non-est> 40 12 21.220 2,91 (1,20-7,05) 6 71.895 Non-estTotal 59 388.936 P tren d = 0.36 27 572.274 P tren d = NA
0 40 168.502 - 17 167.276 -> 0 - 20 112 185.702 2,49 (1,67-3,71) 74 269.281 0,60 (0,35-1,01)
> 20 - 40 26 13.512 5,29 (3,17-8,83) 21 63.822 0,65 (0,34-1,23)> 40 42 21.220 3,36 (2,10-5,37) 27 71.895 0,68 (0,37-1,25)Total 220 388.936 P tren d < 0.01 139 572.274 P t ren d = 0.90
0 53 168.502 - 17 167.276 -> 0 - 20 145 185.702 2,66 (1,87-3,76) 102 269.281 0,82 (0,49-1,36)
> 20 - 40 37 13.512 5,38 (3,48-8,33) 33 63.822 1,01 (0,56-1,82)> 40 57 21.220 3,24 (2,16-4,87) 35 71.895 0,88 (0,49-1,57)Total 292 388.936 P tren d < 0.01 187 572.274 P t ren d = 0.80
0 57 168.502 - 21 167.276 -> 0 - 20 203 185.702 4,39 (3,21-6,00) 183 269.281 1,20 (0,76-1,88)
> 20 - 40 74 13.512 12,04 (8,44-17,2) 46 63.822 1,12 (0,67-1,89)> 40 186 21.220 12,73 (9,28-17,5) 77 71.895 1,53 (0,94-2,48)Total 520 388.936 P tren d < 0.01 327 572.274 P t ren d = 0.04
N otes:* - A djusted for a tta ined age and period; 'Non-est.' - r isk estim ate could not be estim ated; W LM – W orking Level M onth, RR - R elative Risk; CI-Confidence In terva l; and, ICD-9-International C las sification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and P Y- P erson Years;
> 26 Years
Eso
pha
gu
s
(150
)
Sto
mac
h
(151
)
Col
ore
ct
al (
153
,
154
, 15
9.0)
Gas
tro
-
inte
stin
al
Lu
ng
(162
)
C ancer Site
( ICD-9)
Cumulative Radon D ose
(WLM)
< = 26 Y ears
188
Table 40: Age and period adjusted relative risks for deaths (1954-2004) due to esophageal, stomach,
colorectal, gastrointestinal, and lung cancer associated with cumulative exposure to radon decay products
(Working Level Months, 10-year lag) stratified by years since last employment for Ontario Uranium Miners, 1954-
2004
Deaths PY RR (95% CI)* Deaths PY RR (95% CI)*
0 4 166,244 - 0 171,226 -> 0 - 20 9 186,124 1.61 (0.44-5.90) 11 275,688 Non-est> 20 - 40 2 12,877 2.08 (0.35-12.2) 7 66,395 Non-est
> 40 4 20,967 1.34 (0.30-5.96) 3 75,166 Non-estTotal 19 386,212 P trend = 0.97 21 588,475 P trend = NA
0 6 166,244 - 0 171,226 -> 0 - 20 25 186,124 6.02 (2.30-15.7) 13 275,688 Non-est> 20 - 40 5 12,877 5.79 (1.70-19.7) 5 66,395 Non-est
> 40 9 20,967 4.15 (1.38-12.5) 6 75,166 Non-estTotal 45 386,212 P trend = 0.54 24 588,475 P trend = NA
0 15 166,244 - 9 171,226 -> 0 - 20 44 186,124 2.71 (1.42-5.13) 45 275,688 0.69 (0.33-1.40)> 20 - 40 12 12,877 5.66 (2.57-12.5) 9 66,395 0.49 (0.20-1.24)
> 40 23 20,967 3.80 (1.87-7.73) 19 75,166 0.85 (0.38-1.87)Total 94 386,212 P trend = 0.01 82 588,475 P trend = 0.61
0 25 166,244 - 10 171,226 -> 0 - 20 78 186,124 3.22 (1.97-5.27) 68 275,688 0.93 (0.48-1.81)> 20 - 40 19 12,877 5.07 (2.72-9.43) 21 66,395 1.03 (0.48-2.19)
> 40 36 20,967 3.46 (1.99-6.02) 28 75,166 1.11 (0.54-2.29)Total 158 386,212 P trend = 0.02 127 588,475 P trend = 0.45
0 49 166,244 - 24 171,226 -> 0 - 20 162 186,124 3.69 (2.62-5.19) 169 275,688 0.96 (0.63-1.48)> 20 - 40 55 12,877 9.80 (6.59-14.6) 43 66,395 0.90 (0.54-1.49)
> 40 164 20,967 11.33 (8.03-15.9) 66 75,166 1.12 (0.70-1.79)Total 430 386,212 P trend < 0.01 302 588,475 P trend = 0.32
Cancer Site (ICD-9)
Cumulative Radon Dose
(WLM)
< = 26 Years > 26 Years
Notes:* - Adjusted for attained age and period; 'Non-est.' - risk estimate could not be estimated; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Colo
rect
al (1
53,
154,
159
.0)
Gas
tro-
inte
stin
al
Lung
(162
)
189
Table 41: Age and period adjusted relative risks of diagnoses (1964-2004) of esophageal, stomach, colorectal,
gastrointestinal, and lung cancer associated with cumulative exposure to radon decay products (Working
Level Months, 10-year lag) stratified by age at first employment for Ontario Uranium Miners, 1954-2004
Cases PY RR (95% CI)* Cases PY RR (95% CI)*
0 0 176,735 - 2 159,043 -> 0 - 20 12 257,867 Non-est 6 197,116 0,90 (0,16-4,94)> 20 - 40 6 39,450 Non-est 3 37,884 1,87 (0,28-12,4)
> 40 1 44,082 Non-est 4 49,033 1,77 (0,29-10,8)Total 19 518,134 P trend = NA 15 443,076 P trend = 0.31
0 1 176,735 - 10 159,043 -> 0 - 20 9 257,867 3,36 (0,35-31,8) 34 197,116 1,82 (0,85-3,90)> 20 - 40 1 39,450 1,53 (0,08-28,2) 13 37,884 2,80 (1,17-6,74)
> 40 2 44,082 2,33 (0,17-31.0) 16 49,033 2,43 (1,03-5,70)Total 13 518,134 P trend = 0.80 73 443,076 P trend = 0.14
0 8 176,735 - 49 159,043 -> 0 - 20 54 257,867 1,77 (0,82-3,82) 132 197,116 1,07 (0,75-1,52)> 20 - 40 15 39,450 2,70 (1,11-6,57) 32 37,884 1,28 (0,80-2,04)
> 40 18 44,082 2,58 (1,08-6,14) 51 49,033 1,43 (0,97-2,27)Total 95 518,134 P trend = 0.08 264 443,076 P trend = 0.04
0 9 176,735 - 61 159,043 -> 0 - 20 75 257,867 2,18 (1,06-4,48) 172 197,116 1,19 (0,87-1,63)> 20 - 40 22 39,450 3,39 (1,51-7,58) 48 37,884 1,55 (1,03-2,31)
> 40 21 44,082 2,56 (1,13-5,78) 71 49,033 1,55 (1,03-2,31)Total 127 518,134 P trend = 0.21 352 443,076 P trend = 0.01
0 11 176,735 - 67 159,043 -> 0 - 20 102 257,867 2,83 (1,49-5,38) 284 197,116 2,07 (1,55-2,74)> 20 - 40 37 39,450 6,14 (3,07-12,2) 83 37,884 2,64 (1,88-3,70)
> 40 75 44,082 10,1 (5,27-19,5) 188 49,033 4,27 (3,16-5,76)Total 225 518,134 P trend < 0.01 622 443,076 P trend < 0.01
Cancer Site (ICD-9)
Cumulative Radon Dose
(WLM)
< = 27 Years > 27 Years
Lung
(162
)
Notes:* - Adjusted for attained age and period; 'Non-est.' - risk estimate could not be estimated; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years; *
Colo
rect
al
(153
, 154
,
159.
0)
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Gas
tro-
inte
stin
al
190
Table 42: Age and period adjusted relative risks of deaths (1964-2004) due to esophageal, stomach,
colorectal, gastrointestinal, and lung cancer associated with cumulative exposure to radon decay
products (Working Level Months, 10-year lag) stratified by age at first employment for Ontario Uranium
Miners, 1954-2004
Deaths PY RR (95% CI)* Deaths PY RR (95% CI)*
0 0 177,081 - 4 160,389 -> 0 - 20 9 260,144 Non-est. 11 201,668 0,71 (0,21-2,33)> 20 - 40 6 40,184 Non-est. 3 39,088 0,73 (0,16-3,40)
> 40 1 45,034 Non-est. 6 51,099 0,98 (0,26-3,69)Total 16 522,443 P trend = NA 24 452,244 P trend = 0.62
0 1 177,081 - 6 160,389 -> 0 - 20 4 260,144 1,26 (0.10-15,3) 33 201,668 3,00 (1,18-7,61)> 20 - 40 1 40,184 1.27 (0.06-26,3) 9 39,088 3,17 (1,07-9,40)
> 40 3 45,034 2.91 (0.22-39.3) 12 51,099 2,94 (1,03-8,37)Total 9 522,443 P trend = 0.24 60 452,244 P trend = 0.50
0 5 177,081 - 19 160,389 -> 0 - 20 23 260,144 1,27 (0,45-3,59) 66 201,668 1,20 (0,69-2,09)> 20 - 40 6 40,184 1,51 (0,43-5,29) 15 39,088 1,17 (0,57-2,38)
> 40 11 45,034 2,14 (0,69-6,69) 31 51,099 1,71 (0,92-3,18)Total 45 522,443 P trend = 0.12 131 452,244 P trend = 0.07
0 6 177,081 - 29 160,389 -> 0 - 20 36 260,144 1,63 (0,64-4,10) 110 201,668 1,46 (0,93-2,27)> 20 - 40 13 40,184 2,70 (0,97-7,53) 27 39,088 1,46 (0,84-2,54)
> 40 15 45,034 2,42 (0,87-6,66) 49 51,099 1,86 (1,13-3,06)Total 70 522,443 P trend = 0.11 215 452,244 P trend = 0.05
0 10 177,081 - 63 160,389 -> 0 - 20 84 260,144 2,21 (1,13-4,35) 247 201,668 1,78 (1,32-2,39)> 20 - 40 30 40,184 4,29 (2,04-8,97) 68 39,088 2,12 (1,48-3,05)
> 40 54 45,034 6,10 (3,02-12,3) 176 51,099 3,92 (2,86-5,35)Total 178 522,443 P trend < 0.01 554 452,244 P trend < 0,01
Notes:* - Adjusted for attained age and period; 'Non-est.' - risk estimate could not be estimated; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years; *
Colo
rect
al
(153
, 154
,
159.
0)Cancer Site
(ICD-9)
Cumulative Radon Dose
(WLM)
< = 27 Years > 27 Years
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Gas
tro-
inte
stin
al
Lung
(162
)
191
Chapter 5: Summary Discussion and Conclusions
Chapter 5: Summary Discussion and Conclusions24
192
Summary Discussions Adverse health effects associated with exposure to radiation has been a
topic of intense research since soon after the discovery of radioactivity in the
late 1800s. It was clear from the beginning that exposure to radiation at high
doses had immediate and severe consequences including burns, vomiting and
even death. Later came the discovery that decaying radioactive material, such
as uranium-238, produces ionizing radiation capable of detaching (ionizing) the
electrons from the atoms and molecules of living tissue causing cellular damage
and alterations in genetic material producing the potential for development of
cancer.
Despite the known adverse health effects, radiation-based technology
has tremendously enhanced our quality of life through medicine, research,
construction, and energy production, the benefits of which cannot be ignored.
As such, the majority of research conducted in this area has been and
continues to be focusing on providing evidence-based knowledge to assist
regulatory bodies in establishing safe limits for radiation exposure. The existence
of multiple collaborative and international agencies such as Committees
examining the Biological Effects of Ionizing Radiation (BEIR), United Nations
Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), and
International Commission on Radiological Protection (ICRP) attests to the
importance of this subject area.
193
Cohorts of uranium miners world-wide have been invaluable in building
this knowledge base. In fact, it has become the primary data source for setting
guidelines on limits for exposure to alpha particles emitted from radon and its
decay products. Specifically, these guidelines are based almost exclusively on
the body of evidence supporting a ‘causal’ link between inhaled radon and
excess lung cancer mortality.
While the evidence of the effects of radon on lung cancer mortality is not
in question, the cancer effects on other organs, particularly major organs along
the gastrointestinal tract, remain inconclusive. The current study has been
designed to address this very knowledge gap. Specifically, this study focuses on
the potential risks associated with exposure to ingested alpha particles emitted
from radon and its decay products to the major organs located along the GI
tract. Given that Ontario uranium miners were exposed to lower doses than
other cohorts, results from this study will also contribute to the body of
knowledge about non-lung cancer effects at low doses.
In this study, significant increases were observed for cancers of the
stomach and colon-rectum for those miners with cumulative exposure of more
than 40 WLM, compared to those with 0 WLM, for both incidence and mortality.
Adjusted relative risks with a 10-year lag were 2.30 (95%CI 1.02-5.17) and 1.56
(95%CI, 1.07-2.27) for incidence of cancer of the stomach, and colorectal
cancer respectively. For mortality, significant increases were also observed for
194
stomach (RR=2.90, 95%CI 1.11-7.63) and colorectal cancers (RR=1.74, 95%CI
1.01-2.99).
Causal Inferences
While this study shows increased risk associated with exposure to ionizing
radiation for stomach and colorectal cancers, no one epidemiological
investigation can equivocally demonstrate a causal effect. Any discussion of
causality in chronic disease epidemiology will invariably evoke a discussion on
the meaning of ‘cause’ and whether the evidence supports the Bradford Hill
criteria often used in assessing causation for statistical associations found in
observational studies [1]. While the focus of this thesis is not to embark on
philosophical discussions of causality, comparisons with other studies with
respect to the biological plausibility, strength, and consistency of the
associations found in this study will aid in the interpretation of the current study’s
results in light of previous findings.
Biological Plausibility
Energy from alpha particles, such as that emitted from radon decay
products, is capable of removing electrons from molecules of living tissues [2].
This ionization has been shown to cause damage to host genetic material [2].
Although living organisms have the ability to repair damage, persistent and
repeated exposure can lead to errors in the repair mechanism that may
eventually lead to malignant diseases [2]. Genetic epidemiology has provided
195
some support for this postulate. Smerhovsky and colleagues examined
aberrations of chromosomes of 225 subjects and found that chromatid breaks
were significantly associated with radon exposure [3]. Furthermore, Meszaros
and colleagues observed that these aberrations persisted well after miners had
stopped working (i.e., after exposure has ended) [4].
An experimental study on human subjects ha also been conducted in the
past to determine “the fate of radon ingested by man” [5]. In this study, human
subjects drank known quantities of dissolved radon and its decay products and
doses to the stomach and other GI organs were estimated [5, 6]. The stomach
was shown to incur the highest body burden of ingested radon and its decay
products.
The significant increases in GI cancer risks associated with exposure to
radon decay products observed in this study are biologically consistent with the
hypothesis that direct contact with ingested radon can lead to long-term health
effects. Given that the digestion process takes approximately 41 hours to
complete (from ingestion to excretion) [7, 8], ingested radon decay products
with a short half-life of 51 minutes would have sufficient time to decay (from
radon (222Rn) to polonium (214Po)) and release their destructive energy to
organs/tissues along the GI tract [5, 9]. Although most of the dose will be to the
stomach, residual smaller doses will be delivered to the colon and rectum over a
long transit time. The inverse dose rate indicates smaller doses delivered over
longer periods can also have significant impacts.
196
Strength of Associations
The standard practice of most research is to assess the significance of
study results by comparing them to statistical or clinical criteria. From a statistical
perspective, a 95% confidence limit (or a p-value) is the arbitrary interval
commonly used as a benchmark for establishing whether or not the observed
results occurred by chance. If the lower confidence interval is above 1, the risk is
said to be ‘significantly’ increased. Conversely, if the upper confidence limit is
below 1, then the risk is said to be ‘significantly’ decreased. Once statistical
significance has been established, the size of the point estimate can be used to
assess the strength of the association. For example, one might conclude that a
hypothetical risk estimate of 4.0 (95% CI; 3.5-4.5) represents a stronger
association (4-fold increase) as compared to a risk estimate of 2.0 (95% CI; 1.5-
2.5) or no significant association (RR= 1.0, 95% CI; 0.5-1.5).
With the exception of risk estimates for esophageal cancer, results from
this study appear to satisfy this criterion in that the lower limit of the confidence
intervals for most of the risk estimates were above unity. For example, an almost
3-fold increase of risk of stomach cancer (RR=2.90, 95%CI; 1.11-7.63) was
observed for miners who had a cumulative dose of greater than 40 WLM as
compared to miners with a cumulative dose of 0 WLM, while for colorectal
cancer there was a 74 % increase in risk (RR=1.74, 95% CI; 1.01-2.99).
197
Consistency of Associations
Of the three primary cancers of interest in the current study, results for
stomach cancer mortality were most consistent with the results found in the
literature. The level of agreement appears to be modified by the size of the
study in which the risk estimates were derived. Larger studies such as the Ontario
uranium miners, the German uranium company and the pooled 11 cohorts by
Darby and colleagues showed statistically significant increases in stomach
cancer mortality associated with exposure to ionizing radiation [10, 11]. Smaller
studies such as those by the French [12], Czech [13] and in Newfoundland [14]
showed an increased risk, but not a statistically significant one.
For deaths due to esophageal cancer, consistency was difficult to assess
given that most studies (including the current study) were based on very few
observed cases. Results from the studies to date show a large degree of
variation in the risk estimates which may be due to small numbers. For colorectal
cancer mortality, consistency was also difficult to assess given that different
coding was used for this disease grouping in different studies. Tomasek [13]
coded colon (ICD-9: 152 & 153) separate from rectum (154). Darby and
colleagues [15] only looked at the rectum. Furthermore, studies conducted to
date have not examined the risk of diagnosis (incidence). Therefore, results from
incidence analyses for all three cancer types could not be compared to other
studies.
198
Healthy Worker Effect
The healthy worker effect (HWE) refers to a type of selection bias whereby
healthy workers are preferentially selected for employment. Because individuals
who are employed are generally healthier than those who are not employed,
any comparison of the health status of the workers to the general population
would likely result in an artifact of reduced risk.
The HWE is unlikely to be a major factor in this study since internal
comparisons were used as the main method of analysis rather than using
external standards. Furthermore, cancer studies were less likely to be affected
by the HWE since cancer tends to occur in older populations. Given that the
average age at first employment of miners was 29 years, these miners would not
have been subjected to selection bias based on cancer status (or cancer
potential) on the part of the employer.
Study Limitations
Potential Effects of Smoking and Diet on Risk Estimates
In this study, analysis of the Ontario Uranium Miners showed a significant
increase in cancer risk for stomach and colorectal cancers with increased
cumulative doses of radon decay products. However, the strength of this
association must be interpreted in light of its potential limitations, particularly, its
limited inability to control for other important confounding factors such as
smoking and diet.
199
By definition, a confounder must be associated with the cumulative dose
of radon decay products (exposure) and cancer diagnosis or mortality
(outcome of interest) and cannot be in the causal pathway. Smoking satisfies
this definition. Therefore, ideally, the true effect between cumulative dose of
radon decay products and GI cancer risks should take smoking into account.
Unfortunately, it was not possible to examine the effects of smoking in the
current study since the individual level data on smoking was not collected for all
uranium miners. As such, the true effect of smoking on the risk estimate could
not be assessed in this study. That said, to be a confounder, it must be
associated with both the disease and the exposure of interest. Smoking has
been associated with different cancer sites. However, there is no evidence to
believe that smoking is related to the level of radon decay products.
Despite this limitation, the potential role of smoke on GI cancer risk,
particularly for stomach cancer has been previously examined by the Industrial
Disease Standards Panel [16] that concluded that “Since cigarette smoking is at
most a weak risk factor for cancer of the stomach, any differences between the
miners and the comparison population in terms of smoking habits are probably
unimportant here.” [16], a view that is also shared by others [17, 18].
Furthermore, it has been noted that smoking was a common behaviour for the
majority of the miners [19, 20] . As such, regardless of individual smoking status,
one could argue that all miners were exposed to tobacco smoke either directly
200
or indirectly through second-hand smoke. Given these views, the lack of
smoking information will not likely have a significant impact on the risk estimate.
As in the case with smoking, no data on diet was collected from miners.
Although diet is an important factor in the development of GI cancer [21], the
relationship of diet to the primary exposure (WLM) is not clear. It is more likely
that diet is located along the causal pathway, which makes it more likely to be
an effect modifier of stomach cancer than a confounder. However, without
individual level data on diet, adjustment (or stratified analysis) for diet could not
be carried out and as such, its effects on the risks estimated cannot be known
with certainty. A sensitivity analysis was attempted using place of birth as a
crude proxy measure of diet, however, due to a large number of missing place
of birth data, number of miners with valid information for place of birth was
small, resulting in non-convergence of models due to empty cells.
Loss to Follow-up
One of the most important limitations of this study is the misclassification of
disease status due to loss to follow-up. Chapter 3 explored the potential impact
of the loss on the risk estimates. It was found that the losses can result in an
overestimation of risk due to the fact that more cases were being lost from the
lower exposed group than the higher exposed group. The issue of loss to follow-
up (or misclassification of disease status) is not unique to this study. Analysis of
the Australian cohort conducted by Woodward and colleagues revealed that
health status of 36% of cohort members could not be determined due to
201
migrant workers returning to their native countries following the employment
[22].
In order to minimize the loss to follow-up, a number of options could have
been considered if resources were unlimited. For example, manual search of the
National Death Index (NDI) of the US might lead to a few matches for miners
who immigrated to the US and experienced the event. However, this proportion
is expected to be very small and linking to the NDI will still not resolve the issue
completely since many of the miners were born in Europe (e.g., England, Italy,
and Portugal) and there is a possibility that these miners returned to their native
countries after retirement. As such, vital statistics of miners who return to Europe
(or elsewhere) would remain untraceable.
Computerized Linkage
There is little doubt regarding the value of computerized record linkage in
epidemiologic research. However, there are also limitations to CRL and these
limitations have been well documented by Howe [23]. In particular, the
limitations of computerized record linkage most relevant to this study are as
follows.
No linkage is perfect. In Chapter 3, linkage results from the current study
(provincial) were compared to the previous linkage conducted at the national
level. Deaths in Ontario were identified in the current linkage but missed by the
Muller linkage. Similarly, there were deaths found in the Muller linkage that
occurred in Ontario that were also missed in the current linkage.
202
Linkage is both quantitative and qualitative. The quantitative aspects of
linkage are at the beginning of the linkage where initial passes of the linkage
process are driven by rules and weights of unique identifiers to determine the
probability of matches between records. However, invariably, there is a
proportion of records remaining that could not be resolved through quantitative
means. Resolution of the remaining “grey area” depends on the experience
and judgment of the researcher. In this study, any potential biases associated
with resolving grey area were removed by blinding the linkage researcher to the
exposure of the worker.
Unique identifiers are not always ‘unique’. Identifiers such as social security
numbers are intended to be a unique identifier of individuals within populations.
However, there are instances where the same number was either issued to two
or more different individuals, or they are recorded in error. Such duplications can
create linkage errors.
Conclusions and Future Research
In this study, the incidence and mortality experience of a cohort of 28, 273
uranium miners in relation to their cumulative exposure to radon decay products
was investigated. The results of this analysis showed that the incidence and
mortality for stomach and colorectal cancers were significantly higher when
comparing the highest exposed group to the lowest exposed group.
203
While there are strengths to this study, it is also important to note that there
are also significant limitations that could be resolved in future investigations. In
particular is the issue of potential misclassification of disease status due to loss to
follow-up. This issue could be resolved, in part, by linking the cohort to national
level data in order to determine disease status of those who moved outside of
Ontario. While this would significantly reduce the number of miners misclassified,
miners who chose to leave Canada to return to their native country will remain
a potential, albeit, small limitation to the study.
This study focuses on GI cancer as an outcome of interest. Although
beyond the scope of this study, ionizing radiation has also been implicated in
the development of cardiovascular disease. This cohort would be amendable
to evaluating cardiovascular risks associated with exposure to ionizing radiation.
Finally, this study focused on ionizing radiation from alpha particles. It has been
observed that uranium miners are also exposed to gamma radiation. The health
effects associated with gamma radiation represent another knowledge gap in
the literature. This was not evaluated in the current study due to the lack of data
for miners working before 1981. Future work should consider developing
statistical models to estimate historical gamma doses that could potentially be
incurred by miners and the potential risk associated with these exposures.
204
Chapter 5 References
1. Hill, A.B., The Environment And Disease: Association Or Causation? Proc R Soc Med, 1965. 58: p.
295-300.
2. Wakeford, R., The cancer epidemiology of radiation. Oncogene, 2004. 23(38): p. 6404-28.
3. Smerhovsky, Z., et al., Increased risk of cancer in radon-exposed miners with elevated frequency
of chromosomal aberrations. Mutat Res, 2002. 514(1-2): p. 165-76.
4. Meszaros, G., G. Bognar, and G.J. Koteles, Long-term persistence of chromosome aberrations in
uranium miners. J Occup Health, 2004. 46(4): p. 310-5.
5. Hursh, J.B., et al., The Fate Of Radon Ingested By Man. Health Phys, 1965. 11: p. 465-76.
6. Hursh, J.B., et al., Oral ingestion of uranium by man. Health Phys, 1969. 17(4): p. 619-21.
7. International Commission on Radiological Protection (ICRP), Limits of Intake of Radionuclides by
Workers, IDRC Publication 30, Oxford: Pergamon Press,. 1979.
8. International Commission on Radiological Protection (ICRP), Human Alimentary Tract Model for
Radiological Protection, IDRC Publication 100, . 2006, Oxford, UK: Elsevier Ltd.
9. Kendall, G.M. and T.J. Smith, Doses to organs and tissues from radon and its decay products. J
Radiol Prot, 2002. 22(4): p. 389-406.
10. Darby, S.C., et al., Radon and cancers other than lung cancer in underground miners: a
collaborative analysis of 11 studies. J Natl Cancer Inst, 1995. 87(5): p. 378-84.
11. Kreuzer, M., et al., Radon and risk of extrapulmonary cancers: results of the German uranium
miners' cohort study, 1960-2003. Br J Cancer, 2008. 99(11): p. 1946-53.
205
12. Laurier, D., et al., An update of cancer mortality among the French cohort of uranium miners:
extended follow-up and new source of data for causes of death. Eur J Epidemiol, 2004. 19(2): p.
139-46.
13. Tomasek, L., et al., Radon exposure and cancers other than lung cancer among uranium miners in
West Bohemia. Lancet, 1993. 341(8850): p. 919-23.
14. Villeneuve, P.J., H.I. Morrison, and R. Lane, Radon and lung cancer risk: an extension of the
mortality follow-up of the Newfoundland fluorspar cohort. Health Phys, 2007. 92(2): p. 157-69.
15. Darby, S.C., E.P. Radford, and E. Whitley, Radon exposure and cancers other than lung cancer in
Swedish iron miners. Environ Health Perspect, 1995. 103 Suppl 2: p. 45-7.
16. Industrial Disease Standard's Panel, Report to the Workers Compensation Board on the Ontario
Gold Mining Industry. 1987: Toronto, Ontario.
17. Kusiak, R.A., et al., Mortality from stomach cancer in Ontario miners. Br J Ind Med, 1993. 50(2): p.
117-26.
18. Siemiatycki, J., et al., Degree of confounding bias related to smoking, ethnic group, and
socioeconomic status in estimates of the associations between occupation and cancer. J Occup
Med, 1988. 30(8): p. 617-25.
19. Gilliland, F.D., et al., Radon progeny exposure and lung cancer risk among non-smoking uranium
miners. Health Phys, 2000. 79(4): p. 365-72.
20. Kusiak, R.A., et al., Mortality from lung cancer in Ontario uranium miners. Br J Ind Med, 1993.
50(10): p. 920-8.
21. World Cancer Research Fund and American Institute for Cancer Research, Food, Nutrition,
Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007: Washington DC:
AICR.
206
22. Woodward, A., et al., Radon daughter exposures at the Radium Hill uranium mine and lung cancer
rates among former workers, 1952-87. Cancer Causes Control, 1991. 2(4): p. 213-20.
23. Howe, G.R., Use of computerized record linkage in cohort studies. Epidemiol Rev, 1998. 20(1): p.
112-21.
207
Appendices Appendix I: Record Layout of Work History File ................................................................. 208
Appendix II: National Dose Registry ......................................................................................... 211
Appendix III: SAS Syntax (Person Years, Grouping, and Model)................................. 212
Appendix IV: Sample Data for Miner John Doe ................................................................. 215
Appendix V: Sensitivity Analysis I – Lagging .......................................................................... 216
Appendix VI: Sensitivity Analysis II – Excluding Miners with a history of Gold
mining .................................................................................................................................................... 221
Appendix VII: Sensitivity Analysis IV – Pre-1968 (Miners who start employment
prior to 1968) ....................................................................................................................................... 221
Appendix VII: Sensitivity Analysis IV – Pre-1968 (Miners who start employment
prior to 1968) ....................................................................................................................................... 222
Appendix VIII: Ungrouped Poisson Regression Model and Statistical Test of
Interaction............................................................................................................................................ 223
208
Appendix I: Record Layout of Work History File The entire Mining Master File that contains information on approximately 83,979
miners who had ever worked as a miner (of all types of ores) in Ontario up to
1986. It contains demographic information (names, date of birth, place of birth,
and sex), and employment information (months worked, ores mined, mines and
mining areas, exposure to radon and its decay products). The MMF was
discontinued in 1986.
To examine health effects associated with exposure to ionizing radiation, a
database containing a subset of miners who had ever worked in Ontario
uranium mines was extracted for analysis. Since the focus of this extraction was
based on the work history of thee miners, this subset of data hereafter will be
refer to as the Work History File (WHF).
The Work History File (WHF) contains 312,677 records for 26,320 miners. The
original record layout and information of the original source data is maintained
in this submission for linkage in order to avoid loss of information.
Record Layout of the Work History File
The WHF consists of several types of records of variable length. Each record
contains the unique Mining Certificate Number (MCERT) and mining number
that could be concatenated to creation of a single observation for each
individual miner. For each miner, the following record was extracted in the WHF:
Record Sequence
Variable Name
Description
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
SNAME Miner's surname
FGIV Miner's first given name
SGIV Miner's second given name
ALTSUR Miner's alternate surname if it exists
ALTGIV Miner's alternate given name if it exits
DYR Year of death if miner died
First Row
X Number of employment records for miner
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
BYR Year of birth
BMTH Month of birth
BDAY Day of birth
Second Row
BPLACE Place of birth
209
Record Sequence
Variable Name
Description
USPYR Year of qualification in study
SPECIAL If = B, then miner worked in Eldorado, then total
radiation can not be determined
ASBESTOS If = Y, then miner worked in an asbestos mine,
otherwise it = No
EMILL If = Y, then miner worked in a uranium mill, then
total radiation can not be determined
U_NONT Uranium exposure outside of Ontario
URAN_EX Uranium ore in non-Ontario mine
TOTUMTHS Total months of uranium dust exposure
TOTMTHS Total months of dust exposure
GLDB4UR Total months of gold dust exposure before
uranium
MSPYR Year of qualification as a mill worker
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
SEX sex
DATEONT Date of first Ontario dust exposure
DATENONT Date of first dust exposure NOT in Ontario
AGE1FST Age at first ONTARIO exposure
YLDSEARC Year of last death search
Third Row
YOFUO Year of first uranium exposure in Ontario
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
YRFST06 First year of dust exposure in ore (asbestos)
YRLST06 Last year of dust exposure in ore (asbestos)
YRFST11 First year of dust exposure in ore (copper)
YRLST11 Last year of dust exposure in ore (copper)
YRFST01 First year of dust exposure in ore (gold)
YRLST01 Last year of dust exposure in ore (gold)
YRFST04 First year of dust exposure in ore (iron)
YRLST04 Last year of dust exposure in ore (iron)
YRFST26 First year of dust exposure in ore (nickel)
Fourth Row
YRLST26 Last year of dust exposure in ore (nickel)
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
YRFST02 First year of dust exposure in ore
(nickel/copper)
Fifth Row
YRLST02 Last year of dust exposure in ore
(nickel/copper)
210
Record Sequence
Variable Name
Description
YRFST33 First year of dust exposure in ore (quartz)
YRLST33 Last year of dust exposure in ore (quartz)
YRFST03 First year of dust exposure in ore (silver)
YRLST03 Last year of dust exposure in ore (silver)
YRFST42 First year of dust exposure in ore (thorium)
YRLST42 Last year of dust exposure in ore (thorium)
YRFST20 First year of dust exposure in ore (tin)
YRLST20 Last year of dust exposure in ore (tin)
MCERT Unique miner certificate number
NMINER Consecutive miner's number on file
NREC Number of employment records for miner
YRS Year of start of employment sequence
MOS Month and day of start of employment
sequence
WLMS Radiation exposure in WLMs
EMOS Elapse time in months for radiation exposure
MINECD Mine code
OREO Ore code
OCCUPO Occupation code
WCFO Work class factor
WHFO Work history factor
WLSTO Work level standard
Sixth Row
WLSPO Working level special
211
Appendix II: National Dose Registry
The National Dose Registry (NDR) collects and collates exposure data for all
workers in Canada potentially exposed to ionizing radiation. Uranium miners are
among the group of workers monitored by the NDR. For this study, any miners
with a history of uranium mining in Ontario were extracted for analysis. Two
separate files were received from the NDR: 1) Cohort file and 2) Exposure File.
The Cohort File of the NDR contained personal information of the miners such as names, sex, date of birth, place of birth. The Exposure File of the NDR contained information on work history information.
Data File Variable Name Description
Surname Surname
Given_nme_1 First given name
Given_nme_2 Second given name
Sex The sex of an individual
DOB Date of birth
Cohort File
Bplace Place of Birth
EXPOSURE_YEAR Exposure year
FREQUENC Frequency of monitoring
MAXJC Job code
EXTREMIT Parts of body radiated
PROVINCE Province where the dose occurred
GROUP_CL Industry group
SERVICE Service type
SERIAL_N Serial number corresponding to an
organization
JOB_CLAS Code for job classification
BODY_DOS For whole-body gamma/beta exposures
(EXT="0") starting 1981 only,
SKIN_DOS For radon dose (Extremity=8)
FROM_PER First period of monitoring.
TO_PERIO Last period of monitoring.
Exposure File
RECORD_C Number of dose records of an individual in a
given year at a given employer
212
Appendix III: SAS Syntax (Person Years, Grouping, and Model) /************************************************** ******************** Person-Years Calculation Adapted from Pearce & Chec koway (1987) and Villeneuve (2006) *************************************************** *************************/ DATA TEMP; *** DEFINE START YR AND LAG OF EXPOSURES; start= 1954; lagyears= 10; *** TABULATE PYs; *** PART 1 - ALIVE FOLLOW-UP; type= 0; *** NUMBER OF FOLLOW_UP YEARS; follow=(yrout-yrin+ 1); array cum_dose(yr_indx) wlm54-wlm104; RETAIN DUR ; RETAIN CD_LAG1; IF FIRST.newndrlinkid THEN DO;DUR=0;cd_lag1= 0; END; DO YR=1 TO FOLLOW; DOSE= 1;CD=0; if yr= 1 then cd_lag1= 0; yr_indx=floor(yrin+yr-start)-lagyears; if yr_indx< 1 then do; cd= 0;dur= 0; durcat= 1; end ; if yr_indx> 0 then do; if cum_dose= . then do;dose= 1;cd= 0; end ; if cum_dose= 0 then do; dose= 1;cd=cum_dose; end ; if 0<cum_dose<= 0 then do;dose= 1;cd=cum_dose; end ; if 0<cum_dose<= 20.00 then do;dose= 2;cd=cum_dose; end ; if 20.00<cum_dose<= 40 then do;dose= 3;cd=cum_dose; end ; if 40<cum_dose then do;dose= 4;cd=cum_dose; end ; if yr= 1 then do; if cd> 0 then dur= 1; if cd= 0 then dur= 0; end ; if yr> 1 then do; if cd-cd_lag1> 0 then dur=dur+ 1; end ; if 0<=dur< 1 then durcat= 1; if 1<=dur< 2 then durcat= 2; if 2<=dur< 5 then durcat= 3; if 5<=dur then durcat= 4; cd_lag1=cd; end ;
/* Age*/ age = yin-yob; year=yrin+yr- 1; agerisk=year-yob; /* Age at First Employment*/ if age < 25 then agefirst= 1; If 25 <= age < 35 then agefirst = 2; if 35 <= age < 45 then agefirst= 3; if age >= 45 then agefirst= 4; /* Years since exposure*/ if yrs_since < 10 then ryrs_since = 1; If 10 <= yrs_since < 20 then ryrs_since = 2; if 20 <= yrs_since < 30 then ryrs_since = 3;
213
if yrs_since >= 30 then ryrs_since = 4; /* Year of First Employment*/ if yrin < 1957 then yrfirst= 1; If 1957 <= yrin < 1958 then yrfirst = 2; if 1958 <= yrin < 1959 then yrfirst= 3; if yrin >= 1959 then yrfirst= 4; /*--CREATE ATTAINED AGE CATEGORIES --------*/ if agerisk< 60 then attage= 1; if 60<=agerisk< 65 then attage= 2; if 65<=agerisk< 70 then attage= 3; if agerisk>= 70 then attage= 4; /*-- CREATE PERIOD CATEGORIES ----------*/ if year< 1975 then period= 1; if 1975<=year< 1985 then period= 2; if 1985<=year< 1995 then period= 3; if 1995<=year< 2004 then period= 4; if period= '.' then period= 4; IF YR=FOLLOW THEN DO; IF LUNG=1 THEN TYPE=1; IF LUNG=0 THEN TYPE=0; END; IF YR<FOLLOW THEN DO; TYPE= 0; END; OUTPUT TEMP; END; RUN; /* Calculate Mean dose of Quartiles */ Data tempdose1; set temp; if Dose = 1; run; proc univariate data =tempdose1; var cd; run; Data tempdose2; set temp; if Dose = 2; run; proc univariate; var cd; run; Data tempdose3; set temp; if Dose = 3; run; proc univariate; var cd; run; Data tempdose4; set temp; if Dose = 4; run; proc univariate; var cd; run; /* Crosstabulation */ data temp2; set temp; PROC FREQ DATA=temp2; TABLES TYPE*DOSE*ATTAGE*PERIOD*ryrs_since*agefirst*yrfirst / OUT=r6 SPARSE NOPRINT; run; ***EXTRACT THE PYs FROM THE CROSSTABS; data t1;
214
set r6; if type= 0; if period > 0; py1=count; proc sort; by dose attage period ryrs_since; run; ***EXTRACT THE DEATHS FROM THE CROSSTABS; data t2; set r6; if type= 1; if period > 0; deaths=count;py2=count; proc sort; by dose attage period ryrs_since; proc means sum; var count deaths; run; data t3; merge t1 t2; by dose attage period ryrs_since; age2 = attage; /* Mean doses to test for trend*/ If dose= 1 then M_dose= 0; If dose= 2 then M_dose= 5.63; If dose= 3 then M_dose= 28.40; If dose= 4 then M_dose= 94.43;
run; data t4; set t3; py=py1 +py2; drop count percent type py1 py2; if py> 0; lnpyr=log(py); run; proc sort; by dose; proc means sum; var deaths py; by dose; run; Title1 'Esophagus 10 lag incidence' ; proc genmod data =t4; class dose attage period ; model deaths= dose attage period / link =log dist =poisson offset =lnpyr type3 ; estimate 'Dose 2vs1' dose - 1 1 0 0/ exp ; estimate 'Dose 3vs1' dose - 1 0 1 0/ exp ; estimate 'Dose 4vs1' dose - 1 0 0 1/ exp ; run; Title1 'Esophagus 10 lag incidence - Test for Trend' ; /* Calculating linear trend using Paul´s method*/ Proc genmod; class attage period; Model deaths= M_dose attage period / link =log dist =poisson offset =lnpyr; run;
215
Appendix IV: Sample Data for Miner John Doe M ine r y o b y rin yr o ut C D D O S E C a t ( 4 ) a ge _ f irs t a ge r is k a t tag e C a t ( 4 ) ye a r_ r isk p er iod C a t (4 )
S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 6 .2 5 2 2 8 2 8 1 19 6 0 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 6 .8 8 2 2 8 2 9 1 19 6 1 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 .3 5 2 2 8 3 0 1 19 6 2 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 4 0 .6 2 4 2 8 3 1 1 19 6 3 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 7 4 .7 2 4 2 8 3 2 1 19 6 4 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 3 1 19 6 5 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 4 1 19 6 6 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 5 1 19 6 7 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 6 1 19 6 8 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 7 1 19 6 9 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 8 1 19 7 0 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 3 9 1 19 7 1 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 0 1 19 7 2 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 1 1 19 7 3 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 2 1 19 7 4 1S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 3 1 19 7 5 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 4 1 19 7 6 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 5 1 19 7 7 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 6 1 19 7 8 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 7 1 19 7 9 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 8 1 19 8 0 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 4 9 1 19 8 1 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 0 1 19 8 2 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 1 1 19 8 3 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 2 1 19 8 4 2S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 3 1 19 8 5 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 4 1 19 8 6 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 5 1 19 8 7 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 6 1 19 8 8 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 7 1 19 8 9 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 8 1 19 9 0 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 5 9 1 19 9 1 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 0 2 19 9 2 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 1 2 19 9 3 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 2 2 19 9 4 3S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 3 2 19 9 5 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 4 2 19 9 6 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 5 3 19 9 7 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 6 3 19 9 8 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 7 3 19 9 9 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 8 3 20 0 0 4S J o hn D o e 1 93 2 1 9 6 0 2 0 0 1 8 9 .4 2 4 2 8 6 9 3 20 0 1 4
L e ge n dy o b Y e a r o f b ir thy r in Y e a r o f e n tryy ro ut Y e a r o f e x it ( d iag n o s is /d e ath /e nd o f fo llo w -u p )C D C u m u la t iv e d o s eD O S E C a t ( 4) D e r iv e d v a r ia ble b a s e d o n c u m u lat iv e d o s e ( 4 c a teg o r ies )a g e _ firs t - D e r iv e d f ie ld b a s ed o n ye a r o f b ir th a n d ye a r o f e n trya tta g e C a t ( 4 ) D e r iv e d v a r ia ble b a s e d o n a ge a t ris k ( 4 c a te g or ie s )y e a r_ r is k Y e a r a t r is kP e rio d D e r iv e d v a r ia ble b a s e d o n ye a r a t r is k ( 4 c a teg o r ie s )
216
Appendix V: Sensitivity Analysis I – Lagging
No Lagging applied
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 2 80,291 - 3 81,583 -> 0 - 20 18 648,666 1,23 (0,28-5,29) 21 655,830 1,00 (0,30-3,38)> 20 - 40 9 105,475 3,14 (0,67-14,6) 9 107,413 1,92 (0,52-7,11)
> 40 5 126,778 1,35 (0,26-7,03) 7 129,861 1,08 (0,28-4,19)Total 34 961,210 P trend = 0.71 40 974,687 P trend = 0.84
0 3 80,291 - 3 81,583 -> 0 - 20 49 648,666 2,37 (0,73-7,62) 39 655,830 1,96 (0,61-6,35)> 20 - 40 13 105,475 2,72 (0,78-9,55) 10 107,413 2,06 (0,57-7,48)
> 40 21 126,778 3,09 (0,93-10,4) 17 129,861 2,41 (0,71-8,24)Total 86 961,210 P trend = 0.17 69 974,687 P trend = 0.32
0 40 80,291 - 17 81,583 -> 0 - 20 198 648,666 0,66 (0,47-0,93) 93 655,830 0,78 (0,47-1,32)> 20 - 40 50 105,475 0,88 (0,58-1,34) 23 107,413 0,87 (0,47-1,63)
> 40 71 126,778 0,95 (0,65-1,41) 43 129,861 1,19 (0,67-2,10)
Total 359 961,210 P trend = 0.04 176 974,687 P trend = 0.04
0 45 80,291 - 23 81,583 -> 0 - 20 265 648,666 0,80 (0,58-1,10) 153 655,830 0,97 (0,62-1,50)> 20 - 40 72 105,475 1,10 (0,76-1,59) 42 107,413 1,16 (0,69-1,93)
> 40 97 126,778 1,11 (0,78-1,59) 67 129,861 1,33 (0,83-2,14)Total 479 961,210 P trend = 0.02 285 974,687 P trend = 0.03
0 55 80,291 - 52 81,583 -> 0 - 20 399 648,666 0,99 (0,74-1,31) 344 655,830 0,92 (0,67-1,34)> 20 - 40 116 105,475 1,43 (1,04-1,98) 96 107,413 1,22 (0,87-1,72)
> 40 277 126,778 2,54 (1,91-3,41) 240 129,861 2,24 (1,66-3,03)Total 847 961,210 P trend < 0.01 732 974,687 P trend < 0.01
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Incidence (1964-2004) Mortality (1954-2004)
Lung
(162
)
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years;
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Colo
rect
al
(153
, 154
,
159.
0)
Gas
tro-
inte
stin
al
217
218
Five year lag applied
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 2 208,268 - 4 209,672 -> 0 - 20 18 551,736 1,81 (0,41-7,96) 20 558,805 1,04 (0,34-3,10)> 20 - 40 9 91,391 4,51 (0,95-21,4) 9 93,319 2,01 (0,61-6,70)
> 40 5 109,815 1,94 (0,37-10,3) 7 112,891 1,13 (0,32-3,96)Total 34 961,210 P trend = 0.66 40 974,687 P trend = 0.80
0 5 208,268 - 5 209,672 -> 0 - 20 48 551,736 2,84 (1,11-7,24) 38 558,805 2,20 (0,85-5,71)> 20 - 40 13 91,391 3,19 (1,12-9,11) 10 93,319 2,29 (0,76-6,85)
> 40 20 109,815 3,46 (1,27-9,43) 16 112,891 2,54 (0,91-7,12)Total 86 961,210 P trend = 0.16 69 974,687 P trend = 0.33
0 47 208,268 - 18 209,672 -> 0 - 20 193 551,736 0,92 (0,66-1,27) 92 558,805 1,14 (0,68-1,91)> 20 - 40 48 91,391 1,15 (0,77-1,75) 23 93,319 1,24 (0,66-2,33)
> 40 71 109,815 1,30 (0,89-1,90) 43 112,891 1,70 (0,96-2,99)Total 359 961,210 P trend = 0.02 176 974,687 P trend = 0.02
0 54 208,268 - 27 209,672 -> 0 - 20 259 551,736 1,13 (0,83-1,53) 150 558,805 1,32 (0,86-2,01)> 20 - 40 70 91,391 1,49 (1,03-2,14) 42 93,319 1,57 (0,95-2,57)
> 40 96 109,815 1,53 (1,08-2,15) 66 112,891 1,77 (1,12-2,83)Total 479 961,210 P trend = 0.01 285 974,687 P trend = 0.02
0 60 208,268 - 56 209,672 -> 0 - 20 396 551,736 1,74 (1,32-2,29) 342 558,805 1,52 (1,14-2,03)> 20 - 40 116 91,391 2,43 (1,77-3,33) 97 93,319 1,98 (1,42-2,77)
> 40 275 109,815 4,26 (3,20-5,68) 237 112,891 3,53 (2,62-4,77)Total 847 961,210 P trend < 0.01 732 974,687 P trend < 0.01
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Incidence (1964-2004) Mortality (1954-2004)Lung
(162
)
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years;
Eso
phag
us
(1
50)
Sto
mac
h
(151
)
Colo
rect
al
(153
, 154
,
159.
0)
Gas
tro-
inte
stin
al
219
15 year lag applied
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 2 461,533 - 4 463,784 -> 0 - 20 19 359,141 4,25 (0,86-21,0) 20 365,539 2,07 (0,63-6,65)> 20 - 40 8 63,623 8,72 (1,60-47,3) 10 65,564 4,17 (1,18-14,78)
> 40 5 76,913 4,18 (0,70-24,9) 6 79,800 1,82 (0,46-7,15)Total 34 961,210 P trend = 0.59 40 974,687 P trend = 0.88
0 18 461,533 - 15 463,784 -> 0 - 20 39 359,141 1,68 (0,85-3,31) 31 365,539 1,49 (0,70-3,20)> 20 - 40 13 63,623 2,13 (0,94-4,83) 9 65,564 1,61 (0,62-4,14)
> 40 16 76,913 1,91 (0,87-4,23) 14 79,800 1,80 (0,75-4,32)Total 86 961,210 P trend = 0.35 69 974,687 P trend = 0.36
0 79 461,533 - 31 463,784 -> 0 - 20 172 359,141 1,15 (0,85-1,55) 85 365,539 1,25 (0,77-2,02)> 20 - 40 46 63,623 1,41 (0,95-2,10) 20 65,564 1,22 (0,66-2,26)
> 40 62 76,913 1,42 (0,98-2,06) 40 79,800 1,78 (1,04-3,05)
Total 359 961,210 P trend = 0.08 176 974,687 P trend = 0.03
0 99 461,533 - 50 463,784 -> 0 - 20 230 359,141 1,31 (1,00-1,72) 136 365,539 1,40 (0,95-2,05)> 20 - 40 67 63,623 1,69 (1,20-2,38) 39 65,564 1,61 (1,00-2,57)
> 40 83 76,913 1,56 (1,12-2,17) 60 79,800 1,80 (1,16-2,78)Total 479 961,210 P trend = 0.04 285 974,687 P trend = 0.03
0 126 461,533 - 106 463,784 -> 0 - 20 369 359,141 2,20 (1,74-2,78) 316 365,539 2,07 (1,60-2,68)> 20 - 40 114 63,623 2,92 (2,21-3,88) 100 65,564 2,76 (2,03-3,74)
> 40 238 76,913 4,58 (3,55-5,88) 210 79,800 4,28 (3,24-5,64)Total 847 961,210 P trend < 0.01 732 974,687 P trend < 0.01
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Incidence (1964-2004) Mortality (1954-2004)
Lung
(162
)
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years;
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Colo
rect
al
(153
, 154
,
159.
0)
Gas
tro-
inte
stin
al
220
20 year lag applied
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 3 583,373 - 6 586,583 -> 0 - 20 18 265,104 5,27 (1,16-24,0) 19 270,855 2,04 (0,70-5,91)> 20 - 40 8 51,326 11,1 (2,18-55,4) 9 53,198 3,78 (1,16-12,27)
> 40 5 61,402 5,44 (0,98-30,2) 6 64,051 1,91 (0,53-6,81)Total 34 961,205 P trend = 0.43 40 974,687 P trend = 0.74
0 26 583,373 - 22 586,583 -> 0 - 20 34 265,104 1,53 (0,78-3,01) 27 270,855 1,26 (0,59-2,67)> 20 - 40 11 51,326 1,81 (0,78-4,19) 7 53,198 1,16 (0,43-3,14)
> 40 15 61,402 1,88 (0,86-4,13) 13 64,051 1,62 (0,69-3,83)Total 86 961,205 P trend = 0.25 69 974,687 P trend = 0.32
0 105 583,373 - 42 586,583 -> 0 - 20 155 265,104 1,22 (0,91-1,64) 77 270,855 1,23 (0,77-1,94)> 20 - 40 47 51,326 1,58 (1,08-2,32) 22 53,198 1,38 (0,77-2,49)
> 40 52 61,402 1,33 (0,91-1,95) 35 64,051 1,64 (0,96-2,80)Total 359 961,205 P trend = 0.28 176 974,687 P trend = 0.08
0 134 583,373 - 70 586,583 -> 0 - 20 207 265,104 1,35 (1,04-1,76) 123 270,855 1,32 (0,91-1,90)> 20 - 40 66 51,326 1,80 (1,29-2,51) 38 53,198 1,56 (0,99-2,47)
> 40 72 61,402 1,50 (1,07-2,08) 54 64,051 1,66 (1,08-2,56)Total 479 961,205 P trend = 0.11 285 974,687 P trend = 0.05
0 210 583,373 - 172 586,583 -> 0 - 20 343 265,104 1,82 (1,47-2,25) 293 270,855 1,72 (1,36-2,18)> 20 - 40 92 51,326 1,97 (1,49-2,60) 85 53,198 1,97 (1,46-2,66)
> 40 202 61,402 3,34 (2,63-4,24) 182 64,051 3,20 (2,46-4,14)Total 847 961,205 P trend < 0.01 732 974,687 P trend < 0.01
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Incidence (1964-2004) Mortality (1954-2004)Lung
(162
)
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years;
Eso
phag
us
(1
50)
Sto
mac
h
(151
)
Colo
rect
al
(153
, 154
,
159.
0)
Gas
tro-
inte
stin
al
221
Appendix VI: Sensitivity Analysis II – Excluding Miners with a history of Gold mining (miner who start after 1986 when the WHF ended was assumed to be non-gold miners)
Cases PY RR (95% CI)* Deaths PY RR (95% CI)*
0 0 187,005 - 2 187,692 -> 0 - 20 11 279,936 Non-est 13 283,723 1,46 (0,30-7,08)> 20 - 40 5 40,503 Non-est 4 41,404 2,27 (0,38-13,57)
> 40 2 46,642 Non-est 3 48,095 1,28 (0,20-8,35)Total 18 554,086 P trend = NA 22 560,914 P trend = 0.96
0 6 187,005 - 4 187,692 -> 0 - 20 24 279,936 1,53 (0,57-4,14) 17 283,723 1,78 (0,52-6,05)> 20 - 40 4 40,503 1,25 (0,32-4,78) 4 41,404 1,96 (0,43-8,78)
> 40 7 46,642 1,64 (0,50-5,39) 6 48,095 2,21 (0,54-8,99)Total 41 554,086 P trend = 0.71 31 560,914 P trend = 0.47
0 29 187,005 - 13 187,692 -> 0 - 20 98 279,936 1,03 (0,65-1,63) 41 283,723 0,83 (0,41-1,66)> 20 - 40 23 40,503 1,36 (0,76-2,43) 9 41,404 0,89 (0,36-2,21)
> 40 35 46,642 1,60 (0,94-2,73) 19 48,095 1,41 (0,64-3,06)Total 185 554,086 P trend = 0.02 82 560,914 P trend = 0.08
0 35 187,005 - 19 187,692 -> 0 - 20 133 279,936 1,18 (0,78-1,78) 71 283,723 1,08 (0,61-1,89)> 20 - 40 32 40,503 1,56 (0,93-2,61) 17 41,404 1,26 (0,62-2,54)
> 40 44 46,642 1,66 (1,03-2,69) 28 48,095 1,55 (0,82-2,94)Total 244 554,086 P trend = 0.03 135 560,914 P trend = 0.08
0 38 187,005 - 31 187,692 -> 0 - 20 184 279,936 1,82 (1,25-2,65) 160 283,723 1,78 (1,17-2,69)> 20 - 40 54 40,503 2,92 (1,89-4,53) 41 41,404 2,40 (1,00-1,87)
> 40 109 46,642 4,56 (3,07-6,78) 95 48,095 4,22 (2,72-6,55)Total 385 554,086 P trend < 0.01 327 560,914 P trend < 0.01
Lung
(162
)
Notes:* - Adjusted for attained age and period; WLM – Working Level Month, RR - Relative Risk; CI-Confidence Interval; and, ICD-9-International Classification of Diseases, 9th Revision; GI - Gastrointestinal Cancer (ICD-9: 150, 151, 153, 154, 159.0); and PY- Person Years;
Cancer Site
(ICD-9)
Cumulative Radon Dose (WLM)
Incidence (1964-2004) Mortality (1954-2004)
Eso
phag
us
(150
)
Sto
mac
h
(151
)
Colo
rect
al
(153
, 154
,
159.
0)
Gas
tro-
inte
stin
al
222
Appendix VII: Sensitivity Analysis IV – Pre-1968 (Miners who start employment prior to 1968)
C ases P Y R R (95% C I)* D eath s P Y R R (95% C I)*
0 2 1 8 0.6 8 7 - 3 1 8 1.3 7 6 -> 0 - 20 1 5 2 5 6.6 4 7 1 ,4 0 (0 ,3 0-6 ,6 1) 1 7 2 6 0.7 9 4 0 ,9 9 (0 ,2 8 -3 ,5 7 )
> 2 0 - 40 9 7 2.4 5 7 2 ,9 3 (0 ,5 9-1 4 ,7) 9 7 4.2 8 0 1 ,7 4 (0 ,4 5 -6 ,7 6 )> 4 0 5 9 2.4 6 3 1 ,2 1 (0 ,2 1-6 ,7 1) 7 9 5.4 6 1 0 ,9 6 (0 ,2 3 -3 ,8 8 )T o tal 3 1 6 0 2.2 5 4 P t re n d = 0 .8 6 3 6 6 1 1.9 1 1 P tre nd = 0.9 1
0 6 1 8 0.6 8 7 - 6 1 8 1.3 7 6 -> 0 - 20 3 5 2 5 6.6 4 7 2 ,3 7 (0 ,9 2-6 ,1 1) 2 9 2 6 0.7 9 4 1 ,9 8 (0 ,7 5 -5 ,2 4 )
> 2 0 - 40 1 4 7 2.4 5 7 3 ,1 4 (1 ,1 2-8 ,8 4) 1 0 7 4.2 8 0 2 ,2 3 (0 ,7 4 -6 ,6 9 )> 4 0 1 8 9 2.4 6 3 2 ,8 4 (1 ,0 3-7 ,8 4) 1 5 9 5.4 6 1 2 ,3 2 (0 ,8 1 -6 ,6 1 )T o tal 7 3 6 0 2.2 5 4 P t re n d = 0 .2 5 6 0 6 1 1.9 1 1 P tre nd = 0.3 6
0 2 7 1 8 0.6 8 7 - 1 7 1 8 1.3 7 6 -> 0 - 20 1 1 4 2 5 6.6 4 7 0 ,9 7 (0 ,6 1-1 ,5 3) 6 7 2 6 0.7 9 4 0 ,9 4 (0 ,5 2 -1 ,6 9 )
> 2 0 - 40 4 6 7 2.4 5 7 1 ,3 3 (0 ,8 0-2 ,2 2) 1 8 7 4.2 8 0 0 ,8 4 (0 ,4 1 -1 ,7 0 )> 4 0 6 8 9 2.4 6 3 1 ,4 1 (0 ,8 7-2 ,3 0) 4 2 9 5.4 6 1 1 ,3 8 (0 ,7 4 -2 ,5 7 )
T o tal 2 5 5 6 0 2.2 5 4 P t re n d = 0 .0 1 1 4 4 6 1 1.9 1 1 P tre nd = 0.0 5
0 3 5 1 8 0.6 8 7 - 2 6 1 8 1.3 7 6 -> 0 - 20 1 6 4 2 5 6.6 4 7 1 ,2 1 (0 ,8 1-1 ,8 2) 1 1 3 2 6 0.7 9 4 1 ,1 6 (0 ,7 2 -1 ,8 6 )
> 2 0 - 40 6 9 7 2.4 5 7 1 ,7 3 (1 ,1 1-2 ,6 9) 3 7 7 4.2 8 0 1 ,2 6 (0 ,7 3 -2 ,1 6 )> 4 0 9 1 9 2.4 6 3 1 ,6 4 (1 ,0 6-2 ,5 1) 6 4 9 5.4 6 1 1 ,5 3 (0 ,9 2 -2 ,5 2 )T o tal 3 5 9 6 0 2.2 5 4 P tr e n d = 0 . 2 4 0 6 1 1.9 1 1 P tre nd = 0.0 5
0 3 8 1 8 0.6 8 7 - 4 3 1 8 1.3 7 6 -> 0 - 20 2 8 8 2 5 6.6 4 7 2 ,4 5 (1 ,7 1-3 ,5 4) 2 5 0 2 6 0.7 9 4 1 ,7 8 (1 ,2 5 -2 ,5 4 )
> 2 0 - 40 1 1 0 7 2.4 5 7 3 ,1 9 (2 ,1 5-4 ,7 3) 9 4 7 4.2 8 0 2 ,2 4 (1 ,5 2 -3 ,3 1 )> 4 0 2 6 1 9 2.4 6 3 5 ,4 6 (3 ,7 7-7 ,9 1) 2 2 8 9 5.4 6 1 3 ,8 9 (2 ,7 1 -5 ,5 7 )
T o tal 6 9 7 6 0 2.2 5 4 P t re n d < 0 .0 1 6 1 5 6 1 1.9 1 1 P tre nd < 0.0 1
Lu
ng
(162
)
N ote s :* - A djus te d fo r a tta in ed a g e a n d pe r io d ; W L M – W o rk in g L eve l M o nth , R R - R e la ti ve R isk ; C I-C on fid e n ce In te rva l; a n d , IC D -9 -In te rna tio n al C las s ifica tion o f D ise a se s , 9th R e v is io n ; G I - G a s troin te s tin a l C an ce r ( IC D -9 : 1 5 0, 1 5 1 , 1 5 3 , 15 4 , 1 59 .0 ) ; a n d P Y - P e rso n Y ea rs ;
Ca nce r Si te
(ICD -9 )
Cu mu la tive Ra do n D o se ( W L M )
In c ide n c e (1 9 64 -2 0 04 ) M o rta lity (1 9 5 4 -2 0 0 4 )
Eso
pha
gu
s
(150
)
Sto
mac
h
(151
)
Col
ore
ctal
(153
, 154
,
159
.0)
Gas
tro
-
inte
stin
al
223
Appendix VIII: Ungrouped Poisson Regression Model and Statistical Test of
Interaction
Although Poisson regression using grouped data is a well accepted
approach to model disease as a function of covariates in occupational
epidemiology [1, 2] a more recent paper published by Loomis and colleagues
[3] indicates that it might be more beneficial to use ungrouped data. Arguments
presented for ungrouped data include better statistical power and avoiding the
need to categorize data that was originally measured on a continuous scale [3].
Furthermore, Loomis and colleagues [3]also suggest that ungrouped data is
preferred when looking at interactions of covariates especially those that are
subject to change over time (i.e., time dependent covariates). Given that the
current thesis used grouped data and examined effect modification through
stratification, the Loomis publication provides the basis to re-examine study
results using ungrouped data and formal examination interactions using
modelling approaches [3].
Data Preparation
The initial data preparation stage for grouped and ungrouped data
analysis is the same. Both approaches start with identifying cohort members and
followed until an event of interest or end of follow-up, which ever occurred first.
An analytical data set is constructed for each unit of person-time at risk. For
grouped data analysis, person-data are then cross classified. In this thesis,
cumulative dose, age at risk (attained age), and period at risk are cross
classified into four categories. Cumulative doses are grouped into 20 WLM
(referent group = 0 WLM) increments for ease of interpretation of dose response
relationships. An example of the continuous and of cross-classified data for
miner ‘John Doe’ is shown in appendix IV of this thesis.
224
Data Analysis
SAS procedure ‘PROC GENMOD’ is used to derive risk estimates for both
grouped and ungrouped data. However, in grouped data, an offset (person-
years) is used to account for the duration of follow-up. In ungrouped data, all
observations contribute equal weight and therefore, the offset term need not
be specified when fitting the Poisson regression model to ungrouped data. As
such, the ungrouped approach assumes that each person-year is independent
of another for the same person.
In this analysis, effect modification by duration of employment on the
association between cumulative exposure to radon decay products (WLM) and
cancer deaths is examined. Two cancer sites were selected (colorectal and
lung cancer deaths) due to large number of cases. Although effect modifiers
can be determined through stratification, in this section formal statistical
methods are used to test for the interaction of the product term.
Log (λ) = β0 + β1 (AGE) + β2 (YEAR) + β3 (WLM) + β4 (DUR) + β5 (WLM*DUR)
Where λ is estimated by the ratio of observed events and corresponding sum of
follow-up, βs are coefficient for continuous covariates age (AGE), year of
exposure (YEAR), radon (WLM), duration of employment (DUR) and the
interaction tem between exposures and duration (WLM*DUR).
Model Fit
For each model, a deviance statistics was computed. The deviance
provides an absolute measure of the measure of the residual (unexplained)
variation [2]. The deviance has an approximate chi-square distribution with n-p
degrees of freedom (DF) where n represent the number of observations and p is
the number of predictor variables. When a model fits the data well, the ratio of
the deviance to DF approximates 1. A ratio above 1 indicates over-dispersion
while one less than 1 indicates under-dispersion.
225
Results
For both colorectal and lung cancer deaths, age at risk is positively
related to cancer deaths while year at risk is inversely related to cancer risks
(lower risk for more recent years).
Model 1 of Tables 1 and 2 show the effects of cumulative doses on
colorectal and lung cancer mortality risks respectively. In both instances, they
are positively associated with cumulative doses of radon decay products.
However, the effects are approximately 3 times higher for lung cancer (β=
0.0043) than colorectal cancer (β =0.0016). This is expected given that radiation
dosimetry indicates that most of the doses from radon decay products are to
the lungs rather than the colorectal area. Model 2 of Tables 1 and 2 show the
effects of duration of employment on colorectal and lung cancer mortality risks
respectively. Duration of exposure is also an important factor in both colorectal
(β= 0.0547) and lung cancer (β= 0.0932) deaths. Model 3 of Tables 1 and 2 shows
the effects of the interaction between cumulative doses and duration of
employment on colorectal and lung cancer risks respectively. In both instances,
the beta coefficients of the main effects indicate that as dose and duration of
employment increases, the risk of both colorectal and lung cancer also
increases. However, as dose and duration increases, the risk decreases as
confirmed by a small but statistically significant (p < 0.01) interaction term
between dose and duration of exposure. These observations confirm results of
stratified grouped analyses shown in Tables 14 and 15 for incidence and
mortality respectively.
226
Table 1: Estimated regression beta coefficients, standard errors, and model fit
statistics for colorectal cancer deaths associated with cumulative radon decay
products exposure (10-year lag) and duration of employment for Ontario
uranium miners.
Model
Model 1: Age, Year, Radon (WLM) β (SE) P-value Deviance/DF
Age at risk (Age) 0,0503 (0,0012) <0,0001 0,0562
Year at risk (Year) -0,0731 (0,0013) <0,0001
Cumulative Radon (WLM) 0,0016 (0,0003) <0,0001
Model 2: Age, Year, Duration
Age at risk (Age) 0,0498 (0,0012) <0,0001 0,0561
Year at risk (Year) -0,0773 (0,0014) <0,0001
Duration of Employment (DUR) 0,0547 (0,0040) <0,0001
Model 3: Age, Year, Radon (WLM), Duration, Radon (WLM)*Duration
Age at risk (Age) 0,0498 (0,0012) <0,0001 0,0560
Year at risk (Year) -0,0796 (0,0014) <0,0001
Cumulative Radon (WLM) 0,0019 (0,0006) 0,0019
Duration of Employment (DUR) 0,0922 (0,0063) <0,0001
Radon (WLM)*Duration -0,0005 (0,0001) <0,0001
Note: SE- Standard error, DF- degrees of freedom, WLM-radon decay products measured in Working Level Months
Colorectal Cancer (1954-2004)
227
Table 2: Estimated regression beta coefficients, standard errors, and model fit
statistics for lung cancer deaths associated with cumulative radon decay
products exposure (10-year lag) and duration of employment for Ontario
uranium miners.
Model
Model 1: Age, Year, Radon (WLM) β (SE) P-value Deviance/DF
Age at risk (Age) 0,0466 (0,0006) <0,0001 0,1565
Year at risk (Year) -0,0786 (0,0007) <0,0001
Cumulative Radon (WLM) 0,0043 (0,0001) <0,0001
Model 2: Age, Year, Duration
Age at risk (Age) 0,0466 (0,0006) <0,0001 0,1556
Year at risk (Year) -0,0866 (0,0007) <0,0001
Duration of Employment (DUR) 0,0932 (0,0017) <0,0001
Model 3: Age, Year, Radon (WLM), Duration, Radon (WLM)*Duration
Age at risk (Age) 0,0452 (0,0006) <0,0001 0,1553
Year at risk (Year) -0,0856 (0,0007) <0,0001
Cumulative Radon (WLM) 0,0029 (0,0002) <0,0001
Duration of Employment (DUR) 0,0804 (0,0025) <0,0001
Radon (WLM)*Duration -0,0001 (0,0000) 0,0002
Note: SE- Standard error, DF- degrees of freedom, WLM-radon decay products measured in Working Level Months
Lung Cancer (1954-2004)
References:
1. Breslow, N.E. and N.E. Day, Statistical Methods in Cancer Research,
Volume II - The Design and Analysis of Cohort Studies, ed. I.A.R.C. 1987.
p.3.
2. Frome, E.L. and H. Checkoway, Epidemiologic programs for computers
and calculators. Use of Poisson regression models in estimating incidence
rates and ratios. Am J Epidemiol, 1985. 121(2): p. 309-23.
3. Loomis, D., D.B. Richardson, and L. Elliott, Poisson regression analysis of
ungrouped data. Occup Environ Med, 2005. 62(5): p. 325-9.